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We are pleased to present Volume 3, No.1 of JEHDI.  The wide variety of disciplines represented 
in Early Hearing Detection and Intervention is reflected in the articles we are publishing and the 
astounding number of downloads of each issue.  Our authors, editors, reviewers, and the NCHAM 
staff have done an exceptional job of assembling relevant and current information on the many topics 
necessary to accomplish the goals of EHDI.  We encourage you to share your expertise with this 
vibrant and exciting community of professionals. 
Les R. Schmeltz, AuD
Editor-in-Chief
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Hearing loss affects one to six of every 1000 newborns in 
the United States (American Speech-Language-Hearing 
Association, n.d.) and approximately 32 million children 
worldwide (World Health Organization, 2016). In the United 
States, 98% of newborns receive a hearing screening 
(Centers for Disease Control and Prevention, 2015), and 
this early identification offers important developmental 
advantages by providing opportunities to begin intervention 
within the first few weeks of life. Early identification 
coupled with advanced hearing technology and specialized 
intervention services provides opportunities for children to 
learn to communicate using spoken language, regardless 
of the degree of their hearing loss. Early identification, 
however, also presents challenges for parents and 
professionals. Most parents of children who are deaf or 
hard of hearing (DHH) have normal hearing (Mitchell 
and Karchmer, 2004), and need complete and accurate 
information as they make decisions to support their child’s 
development. For spoken language development, access 
to sound using hearing technology, also described as 
aided audibility (i.e., hearing aids, cochlear implants, bone-
conduction hearing aids) is an important factor. Children 
have better outcomes when they receive amplification 
early, have their devices optimally programmed for their 
hearing loss, and wear their devices consistently (Tomblin, 
Oleson, Ambrose, Walker, & Moeller, 2014; McCreery, 
Bentler, & Roush, 2013).
There are parent and professional factors that can 
influence how consistently children receive adequate 
audibility. Parents have reported experiencing an array 
of challenges related to daily management of their child’s 
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hearing needs (e.g., child behavior, parent emotions, lack 
of confidence) that negatively influence hours of hearing 
aid use (Muñoz et al., 2016; Caballero et al., 2017; Muñoz, 
Preston, & Hicken, 2014; Walker et al., 2013). Parents are 
central to the intervention process and practices to support 
and educate parents are vital. When professionals engage 
parents within a therapeutic relationship, they can help 
manage challenges that arise, so the parents effectively 
implement skills into their daily life.
In addition to parent education, it is critical that 
professionals employ practices to ensure children who use 
hearing technology experience consistent and effective 
audibility. All professionals do not have the same level of 
expertise in working with young children who are DHH, 
and it cannot be assumed that best practices for this 
population are occurring. For example, McCreery et al. 
(2013) investigated the proximity of pediatric fittings to 
prescriptive targets for hearing aid gain and found that 
more than half of the children had at least one ear that 
did not meet prescribed targets for audibility. Identifying 
professionals’ practice patterns for monitoring aided 
audibility can provide insights into gaps and areas that 
could benefit from a focused approach to training, for 
both pre-service and continuing education. Therefore, 
the purpose of this study was to better understand 
professional practices related to factors that influence 
audibility for young children using hearing devices, and to 
explore factors that influence practices for teaching skills 
to parents.
Method
This study used a cross-sectional survey design. There 
were three surveys to explore professional practice 
patterns for monitoring aided audibility for children who 
use hearing aids (HA), cochlear implants (CI), and bone-
conduction hearing aids (BCHA). Survey responses were 
anonymous. Institutional Review Board approval was 
obtained through Utah State University.
Participants and Procedures
Audiologists, speech-language pathologists, and deaf 
educators providing services to children who are DHH, 
birth to six years of age, were recruited to participate in 
the study February to December 2017. Participants were 
recruited through websites (i.e., Hear to Learn, Hands 
& Voices, AG Bell Association, Hearing First) and social 
media posts. Survey data were collected online using 
Qualtrics through a link posted on the website; a flyer was 
used to invite professionals to participate. Two-hundred 
and twenty-five surveys were submitted. Of those, 41 
were incomplete and excluded, resulting in 184 surveys 
included in the analysis (96 HA; 47 CI; 41 BCHA). There 
were participants from 33 states and 5 countries. The 
majority of the participants were audiologists (n = 139) 
and the remainder were intervention professionals, such 
as speech-language pathologists, teachers, or early 
interventionists (n = 45). Most professionals had more 
than 10 years of experience (audiologists [54%, n = 75]; 
interventionists [51%; n = 23]), approximately one-third 
had less than five years of experience (audiologists [32%, 
n = 45]; interventionists [29%; n = 13]), and the remainder 
had six to ten years of experience (audiologists [14%, n = 
19]; interventionists [20%; n = 9]). Ninety-one percent of 
the audiologists (n = 126) and 69% of the interventionists 
(n = 31) reported working in urban areas, with the 
remainder working in rural areas.
Survey Instruments
Three survey instruments (HA [17 items]; CI [16 items]; 
BCHA [16 items]) were developed by the first and second 
authors. Items were developed based on professional 
guidelines (e.g., American Academy of Audiology, 2013) 
in order to capture fundamental practices for hearing 
technology monitoring. Each survey had three sections: 
Information About You, Device Use, and Monitoring 
(instruments available in Appendix).
Data Analysis
Data were analyzed in SPSS to calculate descriptive 
statistics to report characteristics of professional practices 
related to monitoring aided audibility for children who 
use hearing devices. To observe differences between 
audiologists and interventionists, data were split and 
analyzed separately. Participants were not required to 
answer each item to continue responding to the survey; 
therefore, the total number of responses per item varies. 
Percentages are reported based on the number of 
responses for each item. For survey items that were the 
same for each survey, regardless of device type (i.e., HA, 
CI, BCHA), responses were combined. For items that 
were unique to the device type, responses were reported 
separately. Item analysis examined practices related to 
teaching skills to parents that are important regardless of 
device type, specifically: 
• Ask parents about the number of hours their child 
wears device(s);
• Ask parents about challenges with device use;
• Help parents resolve challenges with device use; 
• Talk to parents about data logging results; 
• Talk to parents about how to do a speech  
sound check; 
• Talk to parents about difficulties their child may 
have hearing in different environments;
• Talk to parents about benefits of personal 
assistive device use in addition to device; and 
• Talk to parents about monitoring personal 
assistive device use.  
The result suggested good internal consistency across 
the items (n = 184; Cronbach’s α = .765). Differences in 
teaching practices for the eight items listed above were 
explored using analysis of variance for professional type 
(i.e., audiologist; interventionist), device type (i.e., HA; CI; 




Participants were queried about hearing device use to 
explore their perceptions about how often children they 
serve in their practice are using their hearing devices, 
and the professionals they think should be talking about 
device use with parents (see Table 1). Participants 
reported, on average, that approximately two-thirds of 
the children birth to six years of age whom they serve are 
using their hearing devices all waking hours; however, 
only 29% of audiologists and 13% of interventionists 
reported that they always know hours of device use. The 
majority of audiologists and interventionists reported that 
each professional (i.e., audiologist; speech-language 
pathologist; teacher; early interventionist) should talk with 
parents about device use. The participants also felt that 
physicians, deaf mentors, counseling professionals (e.g., 
social worker), and other families of children who are DHH 
should talk with parents about device use.
Monitoring Practices
Participants indicated how often (i.e., never, sometimes, 
often, always) three practices for monitoring aided 
audibility were provided (see Table 2). Two practices 
were applicable to all hearing devices: During audiology 
appointments, how often is speech understanding tested 
while children are wearing their hearing device? and How 
often do you ask parents to complete a questionnaire 
about how their child is responding to sounds in their daily 
life (e.g., hearing in quiet, hearing in noise)? One item was 
applicable to hearing aids: When the children you work 
with get new earmolds, how often are hearing aid settings 
checked to make sure sounds are being appropriately 
amplified?
The majority of the audiologists (85%) reported 
performing aided speech testing often or always, and 
53% of interventionists reported the children they work 
with receive aided speech testing. Just over one-third of 
audiologists and fewer than one-fourth of interventionists 
reported that they ask parents to complete questionnaires 
often or always in order to monitor their child’s responses 
to sounds in daily life (audiologists 38%; interventionists 
21%). When questionnaires are completed, participants 
reported using a variety of instruments: LittlEARS 
(Audiologist 63%; Interventionist 45%); PEACH ([Parent’s 
Evaluation of Aural/Oral Performance of Children]; 
Audiologist 57%; Interventionist 10%); IT MAIS ([Infant-
Toddler Meaningful Auditory Integration Scale]; Audiologist 
42%; Interventionist 57%); SIFTER ([Preschool Screening 
Instrument For Targeting Educational Risk]; Audiologist 
30%; Interventionist 29%); CHILD ([Children’s Home 
Inventory for Listening Difficulties]; Audiologist 27%; 
Interventionist 14%); ELF ([Early Listening Function]; 
Audiologist 25%; Interventionist 17%); TEACH ([Teachers’ 
Evaluation of Aural/oral performance of Children]; 
Audiologist 9%; Interventionist 7%); COW ([Children’s 
Outcome Worksheets]; Audiologist 8%; Interventionist 
0%). Other questionnaires used (ranging from < 1% 
to 8%) included: CASLLS (Cottage Acquisition Scales 
for Listening, Language, and Speech), SSQ (Speech 
Spatial Qualities), LIFE R (Listening Inventory For 
Education – Revised), ASC (Auditory Skills Checklist), 
ALG (Auditory Learning Guide), Starting School LIFE 
(Starting School Listening Inventory For Education), 
Sanders Questionnaire, FLI (Functional Listening Index]) 
MAIS (Meaningful Auditory Integration Scale), and MUSS 
(Meaningful Use of Speech Scale). Participants reported 
hearing aid settings are checked often or always when 
new earmolds are obtained 82% of the time as reported by 
audiologists and 45% as reported by interventionists. 
Table 1  
Provider Perceptions about Hearing Device Use
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Table 2  
How Often Practices for Monitoring Aided Audibility are Provided
Table 3  
Loaner Hearing Devices Provided when Child’s Device Sent for Repair
Table 4  
Professional’s Level of Confidence
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Table 5 
Frequency Audiologists and Interventionists Teach Parents Monitoring Skills  
Loaner Devices
Participants reported how often loaner hearing devices 
are provided when a child’s device needs to be sent in for 
repair (See Table 3). Loaners were reported as always 
being provided for 27% of children using HAs, 20% using 
BCHAs, and 40% of children using CIs.  
Professionals’ Confidence Levels
Participants indicated how confident they were in four 
practices related to monitoring audibility (see Table 4), on 
a scale from not confident at all (0) to very confident (100). 
Audiologists overall reported high levels of confidence 
(M = 84 to 99) for all devices (i.e., HA, BCHA, CI). The 
lowest rating was in being able to tell when programming 
adjustments are needed for BCHA; responses for this 
item also had the greatest variance (M = 84; SD = 22.68). 
Interventionists reported a wider range of confidence 
ratings (M = 42 to 99). The highest confidence was 
reported for performing a speech sound test for all devices 
(HA [M = 93; SD = 17.80]; BCHA [M = 99; SD = 3.78]; CI 
[M = 96; SD = 9.32]). The lowest confidence was reported 
for knowing how to verify that hearing aid settings are 
appropriate (M = 42; SD = 29.23) and knowing how to 
tell when programming/mapping adjustments are needed 
(BCHA [M = 51; SD = 34.50]; CI [M = 75; SD = 19.74]).
Teaching Parents
Participants indicated how frequently (i.e., never, 
sometimes, often, always) they address a variety of topics 
with parents that are important for monitoring audibility 
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(see Table 5). Eight topics queried were applicable to all 
devices (i.e., HA; BCHA; CI), three were applicable to 
BCHA and CI, and one was applicable to only children who 
use CIs. Responses revealed variability in practices for 
teaching parents for all topics. 
For teaching practices related to all devices, the top 
three most frequently taught topics audiologists reported 
they always address included: asking parents about the 
number of hours their child wears their hearing device 
(75%), helping parents resolve challenges with hearing 
device use (74%), and asking parents about challenges 
with hearing device use (73%). The top three most 
frequently taught topics interventionists reported they 
always address included: teaching parents how to do 
a speech sound check (57%), helping parents resolve 
challenges with hearing device use (49%), and talking 
with parents about difficulties child may have hearing in 
different environments (48%). Few professionals reported 
always talking with parents about data logging results 
(audiologists 44%; interventionists 9%).
For teaching practices specific to HAs, the most frequently 
taught topic participants reported they always address 
is talking with parents about how to determine if their 
child’s devices are functioning properly (audiologists 
79%; interventionists 23%); remaining topics (how often 
earmolds need to be replaced; why earmolds need to be 
replaced; how to tell when earmolds need to be replaced; 
how to know their child’s hearing aid settings are at a level 
needed to hear well) were addressed less frequently.
For teaching practices specific to BCHA and/or CI only, 
the most frequently taught topic audiologists reported 
they always address is talking with parents about how 
to change batteries (69%) and for interventionists, how 
to interpret device indicator lights (45%). The remaining 
topics (how to monitor condition of external equipment; 
how to check CI microphone) were addressed less 
frequently.
Factors Influencing Teaching
Professional type (i.e., audiologist; interventionist), device 
type (i.e., HA; BCHA; CI), and years practicing (i.e., 
less than 10 years; 10 or more years) were explored to 
investigate their influence on eight practices for teaching 
parents applicable to all hearing devices. Analysis of 
variance showed no statistically significant effects for 
professional type F(1, 154) = 1.233, p = .269, device type 
F(2, 183) = 1.095, p = .337, or years practicing F(1, 154) = 
1.089, p = .298.
Discussion
Monitoring aided audibility for children who are DHH is 
critical for supporting spoken language outcomes. This 
study explored professionals’ perspectives on hearing 
device use and practices they include in their services for 
monitoring children’s aided hearing. The findings from this 
study revealed practice gaps and opportunities  
for improvement. 
Practice Gaps
Research findings have shown that consistent use of 
well-functioning hearing devices positively contributes to 
child outcomes, and that children who use hearing aids 
10 hours or more per day have better language outcomes 
(Tomblin et al., 2014).  The professionals in this study 
indicated multiple professionals have the responsibility 
to talk with parents about hearing device use; however, 
approximately one-quarter of the audiologists and two-
thirds of the interventionists never or only sometimes talk 
about hearing device data logging with parents. Studies 
have found that parent report of hearing aid use often 
over-estimates use when compared to device data logging 
(Walker et al., 2013; Muñoz et al., 2014), suggesting 
that parent report alone is insufficient for monitoring how 
consistently children wear their hearing devices. Hearing 
device malfunction can also disrupt audibility. When 
hearing devices are sent to the manufacturer for repair, 
audibility is compromised if children are not provided with 
loaner equipment. Participants in this study indicated at 
least one-quarter of children they work with never or only 
sometimes have access to loaner devices.  
Practices to monitor audibility can be incorporated within 
routine interactions at home and at school. Verification 
and validation are important components to include and 
are indicated in practice guidelines (American Academy 
of Audiology, 2013). Asking parents to periodically 
complete a questionnaire about how their child responds 
to sounds in their daily life (validation) is an important 
way to understand how children are hearing in various 
environments. Participants in this study reported rarely 
using this mechanism to monitor audibility; two-thirds of 
audiologists and three-fourths of interventionists reported 
never or only sometimes asking parents to complete a 
questionnaire. Most of the audiologists reported checking 
hearing aid settings (verification) after new earmolds 
are obtained; however, 18% reported they do not verify 
settings. As children grow their earmolds need to be 
replaced and hearing aid settings adjusted to maintain 
audibility. When hearing aid settings are not monitored, 
children are at risk for under amplification as they grow. 
Both audiologists and interventionists reported lacking 
confidence in knowing when programming adjustments are 
needed for children who use BCHAs.
Teaching parents about monitoring for audibility is critical 
as parents are with their children every day and are 
central to the intervention process. Participants in this 
study reported talking with parents about many aspects 
important for monitoring audibility; however, one-quarter 
of the audiologists and two-thirds of the interventionists 
reported never or only sometimes talking with parents 
about how to know that their child’s hearing devices 
are set at a level needed for their child to hear well. 
Professionals reported more frequently talking with 
parents about how to do a speech sound test. Additionally, 
approximately one-quarter of audiologists and one-half 
of the interventionists never or only sometimes talk with 
parents about how to monitor the function or performance 
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of personal assistive devices. For parents to advocate 
effectively for their children they need information about 
factors critical to audibility and support as they gain 
confidence implementing routine monitoring tasks. 
Opportunities
Several opportunities to enhance monitoring of 
aided audibility exist. For example, inter-professional 
collaboration can improve communication among service 
providers, improving continuity of care and reinforcement 
of and support for parent learning. In this study, 
audiologists reported always knowing hours of device use 
more often than did interventionists. Regularly sharing key 
information, such as hearing device data logging, results 
of aided speech understanding, and verification of device 
settings, offers opportunities to improve quality of care 
(Muñoz & Blaiser, 2011). Audiologists and interventionists 
would benefit from training opportunities to increase their 
confidence levels. For audiologists, training related to 
determining when BCHA settings need to be adjusted 
would be particularly beneficial. For interventionists, 
training related to knowing how to determine if 
programming adjustments are needed for all types of 
devices would be particularly beneficial. Improving access 
to loaner devices when repairs are necessary would 
improve consistent audibility for children. Additionally, 
asking parents to complete questionnaires reporting how 
their child is hearing at home and in other environments 
not only provides important information, but is also an 
opportunity to engage parents in the monitoring process.
Limitations and Future Research
This survey study was self-report and may not reflect 
actual practices. Self-report provides insights into 
perspectives and perceptions of practices; however, it 
may also be misleading due to conscious bias by the 
participants to look good (Baldwin, 2000). Self-selection 
to complete the survey instrument may also introduce 
bias, artificially inflating frequency of practices reported. 
Participants were recruited through sources targeting 
professionals who work with pediatric populations; 
however, the extent of their case load specific to pediatric 
hearing loss was not explored. The response rate for 
intervention professionals was low and findings cannot be 
generalized to the broader population of speech-language 
pathologists, early interventionists, and deaf educators. 
Further research is needed to identify how to increase 
professionals’ implementation of practices for monitoring 
aided audibility. Important questions include exploring to 
what extent audiologists and interventionists are prepared 
for this aspect of practice within graduate training; what 
barriers, both internal (e.g., confidence) and external (e.g., 
equipment access) exist for routine implementation of 
monitoring practices; how to increase inter-professional 
collaboration for monitoring aided audibility; and 
professionals’ attitudes related to monitoring  
aided audibility.
Conclusion
Children who are DHH and their parents rely on 
professionals to provide evidence-based practices. 
This study revealed practice gaps related to monitoring 
audibility, including infrequent use of parent questionnaires 
to explore how children are hearing at home and in other 
environments, lack of loaner equipment for some children 
when hearing devices are being repaired, and inconsistent 
monitoring of data logging to identify challenges with 
hearing aid use. Training opportunities exist to address 
provider confidence and implementation of monitoring 
practices.
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Pediatric Hearing Aid Management: Professional Practices for Monitoring Children’s Aided Hearing
The purpose of this survey is to better understand how professionals monitor audibility for children ages birth to six years 
who use hearing aids. Completing the survey should take about 5 minutes. 
Your experiences are important!






2. I have been working with children with hearing loss for:
Less than 5 years
6–10 years
More than 10 years
3. Approximately what percent of young children that you work with wear their hearing aids all waking hours?
_____________%
I don’t know





5. I work in: 
An urban area
A rural area








Consistent use of hearing aids is important for children to learn to speak. Having children wear their hearing aids  
consistently can be hard for many different reasons. Addressing hearing aid use can help identify problems.






8. Indicate how often you address each of the following when you talk with parents: 
Never Sometimes Often Always
Ask about the number of hours their child wears
hearing aids
Ask about challenges with hearing aid use
Help parents resolve challenges with hearing aid use
Talk about hearing aid data logging results
9. When the children you work with need to have their hearing aids repaired by the company, how often are they typically 







Monitoring helps you know if children are hearing well with their hearing aids or if there are problems with settings, device 
function, how earmolds fit, and hearing in noise.
10. When the children you work with get new earmolds, how often are hearing aid settings checked to make sure sounds 







11. During audiology appointments, how often is speech understanding tested while children are wearing their  






12. How often do you ask parents to complete a questionnaire about how their child is responding to sounds in their daily 






13. Indicate the questionnaires you use to monitor how children, birth to six years of age, are functioning with their hearing 
aids in daily life (mark all that apply):  
LittlEARS Auditory Questionnaire  
Parent’s Evaluation of Aural/Oral Performance of Children (PEACH)
Infant-Toddler Meaningful Auditory Integration Scale (IT-MAIS)
Early Listening Function (ELF)
Teachers’ Evaluation of Aural/Oral performance of Children (TEACH)
Preschool SIFTER: Preschool Screening Instrument For Targeting Educational Risk
Children’s Home Inventory for Listening Difficulties (CHILD)
Children’s Outcome Worksheets (COW)
Other (specify): ___________________________________
I do not use any questionnaires
14. Indicate how often you talk with parents about each of the following: 
Never Sometimes Often Always
How often earmolds need to be replaced
Why earmolds need to be replaced
How to tell when earmolds need to be replaced
How to know the hearing aid settings are at the level
needed for their child to hear well
How to determine if their child’s hearing aids are function-
ing properly (e.g., sound quality, batteries)
How to do a speech sound check (ah, ee, oo, mm, sh, s)
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15. Indicate how confident you are in your ability to: 
Recognize when earmolds need to be replaced _____ (0-100)
Verify hearing aid settings are appropriate _____ (0-100)
Conduct a speech sound check _____ (0-100)
Determine hearing aids are functioning properly _____ (0-100)
There are personal assistive devices that can help children hear better in noise. The devices work wirelessly (e.g., FM 
system, remote mic, mini mic) to send the speech signal from a transmitter worn by the speaker, directly to the child’s 
hearing aids. 
17. Indicate how often you talk with parents about each of the following:
Never Sometimes Often Always
Difficulties their child may have hearing in different  
environments
Benefits of personal assistive device use in addition to  
the hearing aids
Monitoring personal assistive device use
18. What is challenging for you in monitoring audibility for children who wear hearing aids? 
Thank You!
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Bone Conduction Hearing Aid Survey
Pediatric Bone-Conduction Hearing Aid Management (BCHA): Professional Practices for Monitoring Children’s 
Aided Hearing
The purpose of this survey is to better understand how professionals monitor audibility for children ages birth to six years 
who use a bone-conduction hearing aid (BCHA). Completing the survey should take about 5 minutes.   
Your experiences are important!






2. I have been working with children with hearing loss for:
Less than 5 years
6–10 years
More than 10 years
3. Approximately what percent of young children that you work with wear their BCHA(s) all waking hours? 
_____________%
I don’t know





5. I work in: 
An urban area
A rural area







Bone Conduction Hearing Aid Use
Consistent use of BCHA(s) is important for children to learn to speak. Having children wear their device(s) consistently 
can be hard for many different reasons. Addressing BCHA use can help identify problems.






8. Indicate how often you address each of the following when you talk with parents: 
Never Sometimes Often Always
Ask about the number of hours their child wears the BCHA
Ask about challenges with BCHA use
Help parents resolve challenges with BCHA use
Talk about BCHA data logging results
9. When the children you work with need to have their BCHA repaired by the company, how often are they typically provid-







Monitoring helps you know if children are hearing well with their hearing aids or if there are problems with settings, device 
function, how earmolds fit, and hearing in noise.







11. How often do you ask parents to complete a questionnaire about how their child is responding to sounds in their daily 






12. How often do you ask parents to complete a questionnaire about how their child is responding to sounds in their daily 






13. Indicate the questionnaires you use to monitor how children, birth to six years of age, are functioning with their BCHA 
in daily life: (mark all that apply):  
LittlEARS Auditory Questionnaire  
Parent’s Evaluation of Aural/Oral Performance of Children (PEACH)
Infant-Toddler Meaningful Auditory Integration Scale (IT-MAIS)
Early Listening Function (ELF)
Teachers’ Evaluation of Aural/Oral performance of Children (TEACH)
Preschool SIFTER: Preschool Screening Instrument For Targeting Educational Risk
Children’s Home Inventory for Listening Difficulties (CHILD)
Children’s Outcome Worksheets (COW)
Other (specify): ___________________________________
I do not use any questionnaires
14. Indicate how often you talk with parents about each of the following:
Never Sometimes Often Always
How to change batteries
How to interpret the indicator lights and beeps
How to monitor the condition of the external equipment
How to do a speech sound check (ah, ee, oo, mm, sh, s)
15. Indicate how confident you are in your ability to: 
Tell when programming adjustments are needed _____ (0-100)
Conduct a speech sound check_____ (0-100)
Check BCHA function_____ (0-100)
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There are personal assistive devices that can help children hear better in noise. The devices work wirelessly (e.g., FM 
system, remote mic, mini mic) to send the speech signal from a transmitter worn by the speaker, directly to the  
child’s BCHA. 
17. Indicate how often you talk with parents about each of the following:
Never Sometimes Often Always
Difficulties their child may have hearing in different  
environments
Benefits of personal assistive device use in addition to the 
BCHA
Monitoring personal assistive device use




Pediatric Cochlear Implant Management: Professional Practices for Monitoring Children’s Aided Hearing
The purpose of this survey is to better understand how professionals monitor audibility for children ages birth to six years 
who use cochlear implants. Completing the survey should take about 5 minutes.   
Your experiences are important!






2. I have been working with children with hearing loss for:
Less than 5 years
6–10 years
More than 10 years
3. Approximately what percent of young children that you work with wear their cochlear implant(s) all waking hours? 
_____________%
I don’t know





5. I work in: 
An urban area
A rural area








Consistent use of cochlear implants is important for children to learn to speak. Having children wear their device(s) con-
sistently can be hard for many different reasons. Addressing cochlear implant use can help identify problems.






8. Indicate how often you address each of the following when you talk with parents: 
Never Sometimes Often Always
Ask about the number of hours their child wears the co-
chlear implant(s)
Ask about challenges with cochlear implant use
Help parents resolve challenges with cochlear implant use
Talk about cochlear implant data logging results
9. When the children you work with need to have their cochlear implant repaired by the company, how often are they typi-







Monitoring helps you know if children are hearing well with their cochlear implant(s) or if there are problems with settings, 
device function, and hearing in noise. 








11. How often do you ask parents to complete a questionnaire about how their child is responding to sounds in their daily 






12. How often do you ask parents to complete a questionnaire about how their child is responding to sounds in their daily 






13. Indicate the questionnaires you use to monitor how children, birth to six years of age, are functioning with their cochle-
ar implants in daily life (mark all that apply):  
LittlEARS Auditory Questionnaire  
Parent’s Evaluation of Aural/Oral Performance of Children (PEACH)
Infant-Toddler Meaningful Auditory Integration Scale (IT-MAIS)
Early Listening Function (ELF)
Teachers’ Evaluation of Aural/Oral performance of Children (TEACH)
Preschool SIFTER: Preschool Screening Instrument For Targeting Educational Risk
Children’s Home Inventory for Listening Difficulties (CHILD)
Children’s Outcome Worksheets (COW)
Other (specify): ___________________________________
I do not use any questionnaires
14. Indicate how often you talk with parents about each of the following:
Never Sometimes Often Always
How to change batteries
How to listen to the cochlear implant microphone
How to interpret the indicator lights and beeps
How to monitor the condition of the external equipment, 
such as cables and headpiece
How to do a speech sound check (ah, ee, oo, mm, sh, s)
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There are personal assistive devices that can help children hear better in noise. The devices work wirelessly (e.g., FM 
system, remote mic, mini mic) to send the speech signal from a transmitter worn by the speaker, directly to the child’s 
cochlear implant. 
17. Indicate how often you talk with parents about each of the following:
Never Sometimes Often Always
Difficulties their child may have hearing in different  
environments
Benefits of personal assistive device use in addition to the 
cochlear implant
18. What is challenging for you in monitoring audibility for children who wear cochlear implants? 
Thank You!
15. Indicate how confident you are in your ability to: 
Tell when programming/mapping adjustments are needed ____ (0-100)
Conduct a speech sound check ____ (0-100)
Check cochlear implant function ____ (0-100)
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Introduction
The Joint Committee on Infant Hearing (JCIH) has 
established the 1-3-6 guideline for detection, diagnosis, 
and intervention for congenital hearing loss (JCIH, 2007; 
Bower & St. John, 2014). All children should undergo 
hearing screening by 1 month of age, diagnostic audiology 
assessment by 3 months of age for those who do not 
pass screening, and enrollment in early intervention by 
6 months of age for those with hearing loss. In addition, 
2017; 2(1): 21–28
Abstract: Objective. This study assessed whether children with oral clefts are appropriately classified as at-risk for 
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children with certain risk factors for hearing loss should 
undergo diagnostic audiology assessment by 24 to 30 
months of age, even if they pass their initial hearing screen 
(JCIH, 2007; Beswick, Driscoll, & Kei, 2012). To promote 
adherence to these guidelines, states have created Early 
Hearing Detection and Intervention (EHDI) programs; in 
Washington State, the program has been titled, “Early 
Hearing Detection, Diagnosis and Intervention” (EHDDI). 
These programs can monitor follow-up for children who 
do not pass hearing screening or who have risk factors for 
hearing loss (White, 2014; Gracey, 2003).
The EHDDI program relies on newborn hearing screeners 
to report hearing screening results and indicate which 
children have risk factors for delayed onset or progressive 
hearing loss. In Washington State, newborn hearing 
screenings can be performed by nursing staff, obstetric 
technicians, audiologists, midwives, and staff from 
contracted newborn hearing screening companies. 
Individuals do not need certification to conduct newborn 
hearing screenings, but EHDDI program staff provide 
training and outreach. This training includes information 
about risk factors for delayed onset and progressive 
hearing loss and how to report risk factors to the EHDDI 
program. Newborn hearing screeners may also receive 
training from the hospital, clinic, or company where they 
work. Washington State does not have legislation that 
mandates newborn hearing screening or reporting results 
to the EHDDI program. Although screening is voluntary, 
it is estimated that 96% of all infants born in Washington 
State receive a newborn hearing screening (Weisman, 
2014).
There are 29 audiology clinics throughout the state 
that provide comprehensive diagnostic audiological 
assessment for infants. These clinics meet Washington 
State’s Protocol for Diagnostic Audiological Assessment: 
Follow-up for Newborn Hearing Screening. This protocol 
is based on the JCIH 2007 position statement and was 
created by a workgroup of 22 audiologists with expertise in 
the screening and diagnosis of hearing loss in newborns 
and infants (Washington State Department of Health, 
2011).
Children with craniofacial anomalies are at greater risk 
of hearing loss (Lieu, Ratnaraj, & Ead, 2013; Yelverton 
et al., 2013; Beswick, Driscoll, Kei, Khan, & Glennon, 
2013). Most commonly, children with these anomalies 
will experience conductive hearing loss due to anatomic 
abnormalities affecting middle ear function, although 
sensorineural hearing loss can occur as well (Swibel 
Rosenthal, Caballero, & Drake, 2012). The most common 
craniofacial anomaly is cleft lip and palate, which occurs 
in approximately 10 per 10,000 live births; isolated cleft 
palate is also relatively common with an incidence of 6.5 
cases per 10,000 births (National Birth Defects Prevention 
Network, 2010). These craniofacial anomalies can be 
grouped together under the term oral clefts. Children with 
oral clefts have high rates of conductive hearing loss, most 
commonly associated with Eustachian tube dysfunction 
(Kuo et al., 2014).
The objective of this study was to determine what 
proportion of children with cleft lip and palate or 
isolated cleft palate were correctly identified as having 
a craniofacial anomaly at the time of newborn hearing 
screening, and to determine if there was an association 
between correct identification of risk factor status and 
adherence to guidelines for newborn hearing screening.
Materials and Method
Prior to investigation, approval for this study was obtained 
from the Washington State Department of Social and 
Health Services’ Human Research Review Section. In 
Washington State, the long form birth certificate records 
from January 1, 2008 to December 31, 2013 were 
electronically queried. The long form birth certificate 
includes a field for designating whether a child is born with 
an oral cleft, which includes either cleft lip and palate or 
isolated cleft palate.
Birth record numbers were then cross-referenced with the 
state’s EHDDI database to identify the cohort. The EHDDI 
database was queried to obtain information regarding birth 
weight, race and ethnicity, maternal age, and presence 
of JCIH hearing loss risk factors. The Washington State 
newborn hearing screening card includes data regarding 
five risk factors for delayed onset or progressive hearing 
loss including the following: (a) neonatal intensive care 
unit (NICU) stay greater than 5 days, (b) syndrome with 
stigmata of hearing loss, (c) family history of hearing 
loss, (d) presence of craniofacial anomalies, and (e) in-
utero infection. In addition, screeners can denote that a 
child has no risk factors present. Hearing screening and 
diagnostic audiologic test results were recorded. The 
birth hospital location and site of diagnostic audiology 
assessment were also recorded for each child. The 
demographic data were collected because factors such 
as birthweight, socioeconomic status, and geographic 
location may impact the potential association between risk 
factor misclassification and adherence to newborn hearing 
screening guidelines.
After data collection was completed, cases were reviewed 
to determine the number of children who underwent 
hearing screening and diagnostic testing, and at what 
age the testing occurred. Diagnostic testing results were 
then reviewed to determine the types and configuration of 
hearing loss.
The cohort was divided into two groups based on whether 
the child had been appropriately identified as having a 
craniofacial anomaly (risk factor 4) on EHDDI screening 
card. One group consisted of children with oral clefts 
correctly classified as having risk factor 4, while the 
other consisted of children with oral clefts who were 
misclassified by not having risk factor 4 noted at time of 
screening. Comparisons were made between the two 
groups regarding demographic characteristics, presence 
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of other risk factors, and adherence to 1-3-6 guidelines for 
screening and diagnostic testing.
All children who had completed newborn hearing 
screening by 30 days of age were considered to have met 
the guideline for screening. Children who did not have 
record of screening were noted, but excluded from further 
analysis. Among children who did not pass their hearing 
screen, those who completed diagnostic testing by 90 
days of age were considered to have met the guideline for 
diagnostic testing.
Analysis
Based on the presence or absence of craniofacial risk 
factor designation, univariate analysis was performed 
to calculate descriptive statistics, including means and 
proportions, for the two groups within the cohort. For 
continuous variables, an unpaired t-test was used for 
inferential testing; for binary variables, chi-square testing 
was used to determine significance.
Multivariate logistic regression was then used to 
investigate association between risk factor status and 
adherence to screening and diagnostic guidelines. Risk 
estimates were expressed as odds ratios (OR) and 95% 
confidence intervals (CI). The following variables were 
considered as potential confounding covariates: maternal 
age, birth weight, race or ethnicity, and distance from birth 
hospital to site of diagnostic audiology assessment. Data 
that met p < 0.05 were considered statistically significant. 
Stata 13.1 (Stata Inc, College Station, TX) statistical 
software was used for all analyses.
Results
Total number of resident births in Washington State from 
January 2008 to December 2013 was 526,774. Birth 
certificate records identified 357 children with oral cleft 
malformations born during this time period. There were 
235 children with cleft lip and palate and 116 with isolated 
cleft palate for a birth prevalence of 4.5 per 10,000 births 
and 2.2 per 10,000 births, respectively. There were 6 
children who had been erroneously designated as having 
both diagnoses. Of 357 children, only 138 (39%) were 
designated as having a craniofacial anomaly in EHDDI 
database, while 130 (36.4%) were erroneously designated 
as having no risk factor for hearing loss. The other 89 
children were not provided with risk factor classification at 
time of screening.
Table 1 contains the characteristics of the cohort based on 
whether or not they were designated as having craniofacial 
risk factor. Sixty-six percent of children with isolated cleft 
palate were misclassified compared to 59% of children 
with cleft lip and palate. Children who were correctly 
classified had a mean birthweight of 3318.9 g (SD = 600.7 
g), which was higher than the mean birthweight among 
children who were misclassified 3189.4 g (SD = 670.5 g), 
but this finding did not achieve significance with unpaired 
t-test, p-value = 0.07.
Table 1  
Characteristics of Children with Oral Clefts by Craniofacial 
Risk Factor Identification
There were no significant differences between the groups 
based on race and ethnicity, maternal age, or presence of 
other risk factors. Of the 357 children, 59 children (16.5%) 
also had NICU risk factor. No child had a risk factor for in-
utero infection, and only a small proportion of children had 
any of the other risk factors.
Mean age at first hearing screening was 5.4 days (range 
0–135 days); 217 (60.1%) underwent screening by the 
second day of life. There were 25 children (7%) who did 
not undergo newborn hearing screening; none of these 
children were correctly classified as having a craniofacial 
risk factor. Twelve children (3.6%) underwent screening 
after 30 days of age, and 16 children were of unknown age 
at time of screening.
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Of the 332 children who underwent hearing screening, 
60 (18%) did not pass their hearing screen (see Figure 
1) and 36 (60%) underwent diagnostic testing. The mean 
age at diagnostic testing for these children was 74.8 days 
(range 8–232 days). Thirty of the 60 (50%) who referred 
underwent diagnostic testing by 90 days of age.
Diagnostic results were available for an additional 14 
children who had passed their hearing screen, so that a 
total of 50 children had diagnostic results. Of these, 25 
(50%) had a final diagnosis of hearing loss: 18 conductive, 
2 mixed, and 5 unspecified.
Logistic regression was performed to investigate 
associations between risk factor status and not passing 
the newborn hearing screen. There were not significant 
differences in race/ethnicity or maternal age between 
children who were correctly classified compared with those 
who were not, so these covariates were not included in 
the regression model. Distance from a child’s birth hospital 
to the audiology center of referral was calculated and 
explored as a covariate, but it was not significant.
Low birth-weight was found to be significantly associated 
with likelihood of delayed screening. Of 12 children 
who underwent screening after 30 days of age, 6 (50%) 
weighed less than 2500 g at birth, p-value = 0.001. In 
addition, as noted above, there was a difference in the 
mean birth weight between children who were correctly 
classified on risk factor status and those who were 
Figure 1. Flowchart of screening and diagnostic characteris-
tics of children with oral clefts.
not, although this difference did not achieve statistical 
significance. Therefore, birth-weight was included in the 
model as a binary variable based on a child’s birth weight 
being less than or greater than 2500 g. After adjustment 
for birth-weight status, children who were misclassified 
were less likely to have referred on hearing screening, OR 
0.3, 95% CI [0.2, 0.5], p < 0.001, see Figure 2.
Figure 2. Among children identified as having oral clefts on 
birth certificate, those who were not identified as having a 
craniofacial risk factor at time of hearing screening were less 
likely to have referred on initial hearing screening, OR 0.3, 
95% CI [0.2, 0.5], p < 0.001.
Figure 3. Stacked bar chart compares adherence to hearing 
screening guidelines among children with oral clefts. Those 
who were not identified as having a craniofacial risk factor 
at time of hearing screening were more likely to also have 
delayed or unknown age at screening, OR 4.4, 95% CI [1.5, 
13.3], p = 0.008.
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When association between risk factor status and 
adherence to 1-3-6 guidelines was investigated, 
misclassification of risk factor status was associated 
with delayed hearing screening past 30 days of age or 
unknown age at screening, OR 4.4, 95% CI [1.5, 13.3], 
p-value = 0.008, see Figure 3. This study also found 
that misclassification may be associated with delayed 
diagnostic testing past 90 days of age or unknown age at 
testing, OR 5.7, 95% CI [0.9, 38], p = 0.07, see Figure 4. 
However, this result did not reach statistical significance. 
The results of the logistic regression models are also 
summarized in Table 2.
Discussion
In 2013, JCIH issued a statement emphasizing the 
importance of accurate data management systems for 
newborn hearing screening, stating that such systems are 
critical to facilitate timely, well-coordinated entry into early 
intervention for all children who are deaf or hard of hearing 
(DHH). Other studies have come to similar conclusions 
(Shulman et al., 2010).
States have dedicated substantial resources to early 
identification of hearing loss through the establishment 
of EHDI programs; however, debate remains as to the 
role that risk factor designation should play in hearing 
screening and surveillance. Not all states track risk factors 
for hearing loss as part of a hearing screening program. 
In a recent national survey, about 65% of states had 
databases containing information about risk factors for 
hearing loss (Houston, Behl, White, & Forsman, 2010).
Evidence supports universal screening as preferable to 
screening based upon risk factors. Universal newborn 
hearing screening is associated with improved language 
and literacy outcomes among children who are DHH 
because it facilitates their enrollment in early intervention 
services (Yoshinaga-Itano, 2003). Lack of intervention 
at a critical period in development may have long-lasting 
impact. In a prospective cohort study of children who 
were DHH, Pimperton and colleagues found that disparity 
in reading comprehension between those enrolled in 
early intervention and those who were not continued 
to widen with age (Pimperton et al., 2016). Wake and 
colleagues (2016) recently performed a population-based 
investigation of Australian states with similar demographic 
characteristics, finding that universal screening was 
associated with greater improvement in language 
outcomes than risk-factor based screening. Other studies 
have raised questions as to which risk factors for hearing 
loss are important to monitor. For example, a retrospective 
study of risk factor registry in Queensland, Australia, found 
two risk factors, family history and craniofacial anomalies, 
to predict the occurrence of postnatal hearing loss 
(Beswick et al., 2013). However, a subsequent study found 
family history of hearing loss to be of low yield in predicting 
development of hearing loss (Driscoll, Beswick, Doherty, 
D’Silva, & Cross, 2015), and it is no longer monitored as 
a risk factor in the United Kingdom (Sutton et al., 2012). 
A more recent study found that approximately 10% of 
children have a risk factor for delayed onset or progressive 
hearing loss, and of those children, 2.3% develop a 
permanent hearing loss by age 3 (Dumanch et al., 
2017).  This study also found the presence of craniofacial 
anomalies to be among the factors that placed a child at 
the highest risk for permanent postnatal hearing loss.
However, risk factor identification may be a useful 
adjunct to universal screening in that it could help 
target limited resources to those at greatest risk. EHDI 
programs across the nation continue to face challenges, 
Figure 4. Stacked bar chart compares adherence to diagnos-
tic testing guidelines among children with oral clefts who did 
not pass their hearing screen. Those who were not identified 
as having a craniofacial risk factor at time of hearing screen-
ing may be more likely to also have delayed or unknown 
age at diagnostic testing, OR 5.7, 95% CI [0.9, 38], p = 0.07; 
however, this result did not reach statistical significance.
Table 2
Logistic regression models of association between risk factor 
misclassification and newborn hearing outcome
 26
including incomplete data reporting and lack of follow-up 
(Nikolopoulos, 2015). Using a nationwide survey, Gaffney, 
Green, & Gaffney (2010) found that two-thirds of children 
who did not pass their final hearing screening in 2005 
did not have documentation of a diagnostic test result, 
primarily due to loss to follow-up. In 2014, a similar study 
found that more than one-third of children referred lacked 
a diagnostic result (Alam, Gaffney, & Eichwald, 2014). A 
recent nationwide survey of parents found that more than 
35% could not recall whether their child had undergone 
screening, and many remained unsure about guidelines 
for follow-up (Pynnonen et al., 2016). If we acknowledge 
there are limited resources available for counseling 
families regarding screening, testing, and surveillance; 
then perhaps there is a role for proper identification of risk 
factors as a way to assist efforts for targeted counseling.
The current study used birth certificate records to 
determine that only 39% of children with oral clefts were 
correctly classified as having a craniofacial risk factor 
at the time of newborn hearing screening. Children who 
were misclassified were less likely to have met 1-3-6 
guidelines for screening and diagnosis. Unfortunately, 
early intervention data were not available at the time of this 
study. JCIH guidelines call for all children with craniofacial 
anomalies to complete one diagnostic assessment by 24 
to 30 months of age. However, this study found only 50 
(14%) of 357 children with oral clefts to have diagnostic 
results in the state’s EHDDI database. Of the children who 
did not pass screening, 60% had a diagnostic test result, 
which is consistent with the national percentage (Alam et 
al., 2014).
Oral clefts are associated with conductive hearing loss 
(Schönmeyr & Sadhu, 2014); this increased risk is 
thought to be due to abnormality of the tensor veli palatini 
muscle, which inserts onto the membranous portion of 
the Eustachian tube to equilibrate the middle ear space. 
Children with cleft palate, or even submucous cleft, 
will often have persistent middle ear effusion requiring 
tympanostomy tube placement (Reiter, Brosch, Wefel, 
Schlömer, & Haase, 2011; Smillie, Robertson, Yule, 
Wynne, & Russell, 2014; Szabo 2010). Of the 25 children 
found to have hearing loss in this study, most had a 
conductive hearing loss; these findings appear similar to 
previous studies (Viswanathan, Vidler, & Richard, 2008).
Tympanostomy tube placement is frequently performed at 
the same time as cleft palate repair, often around 1 year of 
age (Kosowski, Weathers, Wolfswinkel, & Ridgway, 2012). 
Craniofacial centers typically offer pediatric audiology 
services and diagnostic assessment, especially in the 
setting of tympanostomy tube placement. Therefore, 
we need to investigate how well these results are being 
reported to EHDDI. A next step for this investigation would 
be to longitudinally track clinical records for the children 
within this cohort, perhaps at the state’s largest tertiary 
care facility, Seattle Children’s Hospital, to determine how 
many children have records of evaluation and intervention.
Given the frequency of middle ear effusion among patients 
with cleft palate, recent studies have also questioned 
whether children with oral clefts should undergo diagnostic 
audiology testing prior to tympanostomy tube placement 
(Jordan & Sidman, 2014). Perhaps provider uncertainty 
regarding the utility of current guidelines could also be 
contributing to lack of adherence to 1-3-6 guidelines 
among children with oral clefts. More qualitative data 
gathering from pediatric otolaryngologists and audiologists 
might help to clarify this point further.
As an observational cohort study, this investigation had 
several limitations. It was a population-based study, but the 
frequency of certain events was quite low, which can make 
it difficult to determine statistical significance. In addition, 
a number of children had missing data. There is also 
the potential for additional confounding by unmeasured 
factors. Previous studies found that children from rural 
settings are more likely to have delayed screening or 
diagnosis (Bush et al., 2015), but this dataset did not 
include home address information. Distance from birth 
hospital to audiology center was explored as a covariate, 
but it was found to not be significant.
If states choose to allocate resources for documentation of 
risk factors, it is important for this process to be accurate. 
This study found oral clefts, the most common craniofacial 
risk factor, to be widely under-reported. If craniofacial risk 
factors are being under-reported, it is likely that other risk 
factors are as well. These findings prompt the question of 
what can be done to improve the system.
Nationwide, efforts are underway to improve integration 
of electronic health records among clinical providers. 
Perhaps integration could expand to include public health 
programs, such as EHDI, although privacy concerns would 
have to be addressed (Uhler, Thomson, Cyr, Gabbard, 
& Yoshinaga-Itano, C., 2014). To our knowledge, efforts 
are underway to implement linkage models in Utah 
and Nebraska between birth certificate and other vital 
records and newborn screening registries (McVicar, 
2014; Northrop, 2014). It will be important to monitor how 
effective these systems are at correctly identifying risk 
factors and whether this change has any effect on rate of 
enrollment in early intervention programs.
In the meantime, additional education could be provided to 
those who perform newborn hearing screening regarding 
the importance of correctly identifying an infant’s risk factor 
status. Newborn hearing screeners are often clinical staff 
or technicians who receive training by either hospitals or 
contractor companies. One commonly used curriculum 
is provided through the National Center for Hearing 
Assessment and Management (NCHAM), but there are 
not standardized methods for assessment of screener 
competencies in the vast majority of states.
In Washington State, EHDDI staff conduct site visits 
and hold annual meetings to train screeners. About 
half of hospital newborn hearing screening programs 
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in Washington require that newborn hearing screeners 
achieve annual competencies in screening.  It might 
be helpful to develop a training curriculum for hearing 
screeners that includes education related to identification 
of risk factors for hearing loss, including oral clefts. 
Regulations could be set that require hospital screeners 
to participate in training or meet certain competencies in 
order for institutions to receive certification from states. 
For example, California is now requiring that inpatient 
hearing screening be administered by certified facilities, 
and certification is required for reimbursement for hearing 
screening services provided to MediCal eligible infants 
(California Newborn Hearing Screening Program, 2016). 
If more states had a certification process that required 
particular training elements, there may be improvement in 
screening and reporting of risk factors.
Conclusion
Using birth certificate records, this population-based 
study found that a majority of children with oral clefts were 
misclassified regarding hearing loss risk in the Washington 
state EHDDI database. Children who were misclassified 
may be less likely to meet 1-3-6 guidelines for screening 
and diagnostic audiology assessments. As states take 
steps to improve data systems and standards for hearing 
screening certification, it is important to investigate 
accuracy and effectiveness of newborn hearing screening 
systems to improve care and services for children who are 
DHH.
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In our changing landscape for children who are deaf or 
hard of hearing, some make use of personal hearing aids, 
but sound may not be adequately amplified to allow for 
the audibility of the entire speech spectrum.  Cochlear 
implants (CIs) have therefore become an efficacious 
option, especially for young children (Hammes, Novak, 
Rotz, Willis, Edmonson, & Thomas, 2002; Vohr, Jodoin-
Krauzk, Tucker, Johnson, Topol, & Ahlgren, 2008).  There 
is substantial evidence that children have better listening 
and language outcomes when they receive early cochlear 
implantation and participate in early intervention programs 
(Dornan, Hickson, Murdoch, & Houston, 2007, 2008; 
Eriks-Brophy, 2004;  Eriks-Brophy, Durieux-Smith, Olds, 
Fitzpatrick, Duquette, & Whittingham, 2006; Fitzpatrick, 
Rhoades, Dornan, Thomas, & Goldberg, 2012; Hogan, 
Stokes, White, Tyskiewicz, & Woolgar, 2008;  Rhoades, 
2001, 2006; Rhoades & Chisholm, 2001; Yoshinaga-Itano, 
Sedey, Coulter, & Mehl, 1998).
Background
Since the introduction of CIs in the United States for 
adults in 1985 and for children in 1990, there have been 
many changes in CI technology and surgical techniques 
and practices.  In the early years, unilateral cochlear 
implantation was the only option.  By the early 2000s, a 
number of patients had received bilateral CIs in an effort to 
improve their “ability to localize sound and to understand 
speech in noise” (Litovsky et al., 2004, p. 648).  
Initially there were professionals who questioned the 
notion that bilateral CIs could surpass “the impressive 
improvements in perception and linguistic development 
accrued from monaural implantation” (Papsin & Gordon, 
2008, p. 69).  But, as evidence has accumulated about 
the benefits of bilateral CIs, they have become a common 
treatment for patients with profound hearing loss in both 
ears (Bichey & Miyamoto, 2008; Scherf et al., 2009). Some 
patients receive bilateral sequential CIs, in which one ear 
is fitted with a CI and then several months (or years) later, 
in a separate surgery, the patient is fitted with a CI in the 
contralateral ear (Steffens et al., 2008).  An even more 
recent development is bilateral simultaneous cochlear 
implantation, in which the patient receives CIs in both ears 
during a single surgery.
Interestingly, in the earliest years of pediatric cochlear 
implantation, many children did not continue to wear a 
hearing aid in the contralateral ear.  Over time though, 
more patients became “bimodal” (i.e., one ear had a CI 
and the contralateral ear was fitted with a hearing aid).  A 
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concern about sequential implantation has been that the 
ears are not receiving consistent auditory stimulation in 
tandem and a lag can develop between the function of 
the ears (and the brain) and that lag can become more 
pronounced over time (Bichey & Miyamoto, 2008).
Luntz, Shpak, and Weiss (2005) have stated, “there is a 
natural tendency for the contralateral residual acoustic 
hearing in CI candidates to diminish, possibly to the point 
of complete deafness” (p. 863).  Another concern when 
an interval is created by delaying implantation of the 
second ear is that there may be negative effects on the 
patient’s binaural processing (Gordon, Valero, & Papsin, 
2007; Papsin & Gordon, 2008).  According to Gordon et al. 
(2007), most clinicians on CI teams in the United States 
attempt to minimize the interval between the first and 
second sequential implants.
With bilateral simultaneous cochlear implant surgery, lag 
time of auditory stimulation is not an issue.  Additional 
benefits of bilateral hearing include the absence of binaural 
processing challenges, improved speech perception in 
noise, the summative effect of two ears, and the feeling of 
balance (Johnson, 2012).
A host of negatives has also been raised regarding 
bilateral simultaneous CIs, including: the potential negative 
sequelae of being under anesthesia for a longer time; 
possible surgical complications (no longer considered 
a viable complication, according to Gantz et al., 2002; 
Grainger, Jonas, & Cochrane, 2012; Ramsden, Papsin, 
Leung, James, & Gordon, 2009); and negative vestibular 
side effects (Mick, Friesen, Shipp, & Chen, 2012; Papsin & 
Gordon, 2008).  Additionally, some parents want to “save 
one ear” in the hope that more advanced technologies, 
such as stem cells or better hearing technology might 
become available in the future (Zeitler et al., 2008).
It should also be mentioned that some pediatric patients 
do not want to be without sound for any period of time.  
For others, including patients with Auditory Neuropathy 
Spectrum Disorder (ANSD), some CI team members 
want to assess the outcomes of implanting a first CI 
prior to proceeding to a second CI (see Roush, Frymark, 
Venediktov, & Wang, 2011; Roush, 2011).  Therefore, 
some patients with bilateral ANSD are only initially 
“approved” for a unilateral CI.
The purpose of this research investigation was to explore 
the opinions and practices of CI audiologists about 
sequential or simultaneous bilateral cochlear implants for 
children.
Method 
Audiologists working with pediatric cochlear implant 
candidates at cochlear implant centers throughout the 
United States were recruited for participation.  The 
audiologists were contacted by email after using the 
American Cochlear Implant Alliance (ACIA) institution 
membership listing along with the “Find a Clinician” 
search bar for each of the three U.S.-based CI 
manufacturers.   A Territory Manager for Cochlear 
America also circulated the survey participation request 
to other managers in the United States.
The electronic, on-line survey was designed to collect 
information about audiologists’ opinions and practices 
regarding bilateral cochlear implantation with children. 
The survey was developed using Qualtrics.  A total of 
20 questions were set up using Likert-type scales and 
multiple-choice responses (4 demographic questions 
and 16 questions about past clinical experiences).  A 
final open-ended question was also included.  Prior to 
any data collection, the research project was reviewed 
and approved by the Human Subject Research 
Committee at the College of Wooster.
Results 
A total of 57 audiologists responded, although not all of 
the questions were answered by all of the respondents.  
All of the respondents held a Master’s degree (6%), a 
doctorate in Audiology (82%), or PhD or other doctoral 
degree (13%).  Respondents varied in their years of 
experience: 31% with 6–10 years, 26% having 1–5 
years, 20% with 11–15 years, 9% with 16–20 years, 
and 11% having more than 20 years of experience.  
Participants came from 21 different states and the most 
common work site was a hospital-based CI center 
(reported by 74% of the respondents).  The number 
of pediatric bilateral recipients the audiologists had 
worked with over the last 12 months ranged from 10 
respondents with 1–5 recipients, 13 having seen 6–10 
patients, 4 with 11–15 recipients, and 17 who had 
worked with 16 or more recipients.  Most of the patients 
seen by these audiologists had sequential cochlear 
implants (73%) and only 27% had simultaneous 
implants.
The most common interval between cochlear implants 
for the bilateral sequential patients was quite variable as 
shown in Figure 1.  A total of 73% waited 1–6 months 
and 23% waited 7–12 months between the first and 
second implants.  The shortest interval reported was 3 
months.
The respondents felt that the most important benefits of 
bilateral hearing for children included localization, the 
summation effect, better hearing in noise, and reduced 
listening effort, as shown in Figure 2.  Better hearing in 
noise was noted most frequently followed by reduced 
listening effort.
When asked why parents reported selecting sequential 
CIs over simultaneous CIs, the most common reasons 
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were concerns about risk to the contralateral ear (21%), 
parents wanting to save the contralateral ear for future 
technology (15%), surgeon or physician preference 
(13%), insurance issues (10%), and the fact that their 
facility simply did not do simultaneous surgeries (8%; 
see Figure 3).
Table 1 shows Likert-type scale ratings (with 1 reflecting 
least important through 7 for most important) about 
why sequential implants might be preferred over 
simultaneous implants.  The highest rated item was 
concern about the risk to the contralateral ear (mean 
rating of 5.1), followed by concern for patients with 
Auditory Neuropathy Spectrum Disorders (mean rating 
of 4.1).
As shown in Table 2, the most important factors 
impacting the decision-making process about whether 
to do a bilateral simultaneous implantation, included 
minimal benefit with hearing aids use (mean rating of 
6.1) and that the child was profoundly deaf in both ears 
(mean rating of 6.0).
Respondents were also asked to evaluate the primary 
disadvantages of sequential versus simultaneous CIs.  
As seen in Figure 4, the most common disadvantage 
cited for sequential CIs, was negatively impacts future 
binaural processing.
Figure 1. Surgery interval between first and second cochlear 
implants for bilateral sequential patients.
Figure 2. Audiologists’ opinions about the primary benefits associated with binaural hearing.
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Figure 3. Audiologists’ opinions about why parents select sequential implantation over simultaneous implantation.
Table 1
Factors Impacting the Decision-Making Process for Bilateral sequential
Note. ANSD = Auditory Neuropathy Spectrum Disorder.
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Respondents rated how frequently they recommended 
that their pediatric CI candidates should obtain bilateral 
sequential CIs, using a Likert-type scale of 1 (never) 
through 7 (always). The mean rating was 4.5 compared 
to a mean rating of 4.0 when asked about how 
frequently they recommended bilateral  
simultaneous CIs.
Additional questions focused on simultaneous CIs, 
beginning with a question about why clinicians definitely 
do not recommend the bilateral simultaneous option. 
Asymmetrical hearing loss or contralateral ear had 
acoustically aid-able hearing were cited by 40.5% 
as the main reasons for not proceeding immediately 
Table 2 
Factors Impacting the Decision-Making Process for Bilateral sequential
Figure 4. Primary disadvantages of bilateral sequential 
cochlear implants. 
to simultaneous CIs.  Another 18.9% indicated that 
simultaneous CIs were not recommended when a 
patient presents with ANSD.
The option of having children wear a hearing aid on the 
non-implanted ear was almost universally endorsed, 
with 89.2% of the audiologists responding with yes for 
their patients going through the sequential route.
A final question asked if there were any questions or 
concerns not addressed in the survey.  Although only 16 
participants provided a response, the common theme 
of 7 audiologists was that they would recommend either 
bilateral sequential or bilateral simultaneous CIs on 
a case-by-case basis; and 3 respondents indicated 
that insurance approval dictates whether sequential or 
simultaneous implants are done.
Discussion 
All of the audiologists responding to the survey 
supported the use of bilateral versus unilateral  
hearing, with the most important identified value of 
binaural hearing being improved listening in noise, 
followed by reduced listening effort.  The latter finding 
supports the work of Hughes and Galvin (2013) who 
similarly reported on reduced listening effort with 
binaural hearing.
Although the number of bilateral simultaneous CIs 
for the pediatric population have increased (Bichey & 
Miyamoto, 2008; Papsin & Gordon, 2008; Scherf et al., 
2009), the majority of audiologists who responded to 
this survey were seeing and/or recommending more 
sequential versus simultaneous procedures for bilateral 
cochlear implants.  But, in keeping with the long-held 
value of truly binaural hearing, the average interval 
between the patients receiving their first CI and their 
second CI was under 12 months.
The most frequent explanations for why the majority 
of the bilateral CI recipients were sequential instead of 
simultaneous was that many patients had only obtained 
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a unilateral CI when they were younger and now wanted 
to obtain a second ear.  Other frequently mentioned 
rationales included concerns about the risk to the 
contralateral ear and its residual hearing, or parents 
who desired to save the non-implanted contralateral 
ear for future technological improvements.  Additional 
reasons for the sequential CIs were asymmetrical 
hearing losses, need for insurance approval, and 
surgeon preference.  Interestingly, a number of 
sequential recipients presented with ANSD, and the 
CI team members typically opted for sequential versus 
simultaneous CI management for these patients (see 
also Roush et al., 2011).
For those patients who received a unilateral CI, almost 
all continued to wear a hearing aid on the contralateral 
ear.  This bimodal option presumably ensures that 
the non-implanted ear still receives some auditory 
stimulation and the potential for binaural hearing (Luntz 
et al., 2005).   Ultimately, more and more of these 
bimodal patients, in a fairly short period of time, become 
bilateral CI candidates, and proceed to having a second 
cochlear implant so they are able to enjoy the benefits 
of binaural hearing.
Patients who received bilateral simultaneous CIs, 
most typically presented with an early diagnosis of a 
significant hearing loss and then embarked on a hearing 
aid trial. Other bilateral simultaneous CI recipients had 
a bilateral profound degree of hearing loss and were 
demonstrating minimal or no benefit from hearing aids, 
and soon were approved for CIs for each ear during one 
surgical procedure.
Conclusions
Although the sample for this study was small and may 
not be representative of all cochlear implant audiologists 
in the country, it begins to explore some important 
issues that need to be evaluated by additional research 
with larger and more representative samples.  Four 
preliminary conclusions can be drawn from this study:
1. All of the audiologists surveyed valued  
binaural hearing.
2. The majority of these audiologists most often 
recommended and worked with sequential patients.  
This finding must be considered with some 
caution, especially due to changing CI candidacy 
criteria through the years.  Although most of the 
respondents were treating both bilateral sequential 
and simultaneous CI recipients, there were those 
who treated sequential CI recipients exclusively. 
Despite all the noted benefits of binaural hearing, 
sequential CIs were still the preferred method of 
implantation for the respondents to this survey.
3. The most common interval reported for the 
sequential CI patients was less than a year.
4. There were other outside influences and factors 
that often eliminated bilateral simultaneous CIs as 
an option—notably insurance and hospital policies.  
In addition, some parents continued to report that 
they were interested in saving the contralateral ear 
for future technological improvements.
The findings noted above suggest a number of issues 
that should be investigated further.  One important issue 
is the amount of time between the first and second 
surgeries in sequential cochlear implants.  Future 
studies should probe this topic with more discrete time 
frames regarding the interval; so instead of providing 
only the 1–6 months and 7–12 month interval choices, 
more options might include smaller interval lengths.  
In addition, a larger sample size should be strongly 
considered for future investigations.  And finally, future 
studies should investigate evidence-based practices 
regarding the therapy options for bilateral simultaneous 
and sequential cochlear implants (Kuhn-Inacker, 
Shehata-Dieler, Muller, & Helms, 2004).
As we consider the changing landscape of deafness, 
the introduction of bilateral CIs appears to be a most 
important and positive development.  If the sky is the 
limit for children who are deaf and hard of hearing, 
gaining access to truly binaural hearing will help 
in their journey to hear from both sides; and in so 
doing, optimize their speech, language, and auditory 
outcomes.
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Approximately 3 to 4 per 1000 infants are born each year 
in the United States whose hearing thresholds indicate 
they are moderately, severely, or profoundly deaf or hard 
of hearing (DHH; Mercer, 2015). Early Hearing Detection 
and Intervention (EHDI) systems work to ensure timely 
identification and intervention for infants and toddlers 
who are DHH and include public health surveillance of 
newborn hearing screening (NBHS). The EHDI system 
has promoted 1-3-6 guidelines, recommending newborn 
screening no later than 1 month of age, evaluation of 
those infants who do not pass their hearing screening by 
3 months of age, and enrollment in early intervention by 6 
months of age. 1-3-6 has been shown to positively impact 
speech and language development for those identified as 
DHH (Moeller, White, & Shisler, 2006). More than 95% 
of all newborns1 in the United States have their hearing 
screened at birth through NBHS with federal and state 
support (Muñoz, Shisler, Moeller, & White, 2009). 
Progress in genetics has led to the identification of multiple 
genes causing non-syndromic and syndromic impacts on 
hearing levels, with over 400 genes now identified (Toriello, 
Reardon, & Gorlin, 2004). The majority of genetic causes 
(about 70%) are non-syndromic with more than half of 
identifiable variants or gene changes in two genes, GJB2 
and GJB6. These genes are associated with moderate 
to profound bilateral, sensorineural, and non-progressive 
impacts on hearing levels (Shearer, Hildebrand, & Smith, 
2017). About 30% of children who are DHH with a genetic 
component have associated physical and clinical features 
such as retinitis pigmentosa (Usher syndrome), inner ear 
deformities and thyroid goiter (Pendred syndrome), cardiac 
arrhythmias (Jervell and Lange-Nelson syndrome), and 
renal malformations (Branchiootorenal syndrome; Shearer 
et al., 2017). The co-morbidities associated with these 
syndromes warrant additional medical assessments in 
newborns who are DHH. Previous studies have described 
how genetics evaluations can be incorporated into the 
EHDI process and benefit the parents of children with 
hearing impairment (Mercer, 2015; Muñoz et al., 2009; 
Schimmenti et al. 2004; White, 2004).
The benefits of an early genetic evaluation of newborns 
who are identified as DHH are numerous. First, a genetic 
evaluation can help families understand why their child 
is DHH, potentially reducing unnecessary concerns. 
Second, genetic evaluation can provide families with 
additional information about the services that might be 
helpful for their child and family. Given this information, 
families may consider reaching out to other families who 
have children with similar genetic backgrounds, building 
a stronger support system. Third, genetic evaluation can 
support a more thorough formation of a personalized 
medical care plan, thereby empowering families to obtain 
better care. This formation of a medical care plan can also 
provide additional connections to necessary medical and 
psychosocial support services. Further, an early genetic 
evaluation may help families better understand the  
link between hearing loss and genetics, and can  
provide an opportunity to discuss recurrence risk with 
genetic professionals.
Recent literature indicates that genetic services are 
under-utilized. A 2005 survey conducted by the National 
Center for Hearing Assessment and Management 
(NCHAM) indicated only 8.8% of physicians (n = 1,968) 
routinely refer a child who is DHH to a geneticist (Moeller 
et al., 2006). The referral rate for audiologists and 
otolaryngologists was higher, with 56% of audiologists 
reporting that they would often or always refer a hearing 
couple with one child who is DHH for genetic counseling 
(Connelly, 2010). When asked what initial set of tests 
they use in an infant with confirmed nonsyndromic 
sensorineural hearing loss, 49% of otolaryngologists 
reported they order a genetics evaluation (Duncan, 
Prucka, Wiatrak, Smith, & Robin, 2007). A simulation-
based survey found that 37% of otolaryngologists and 
geneticists ordered a genetic consultation on the first 
encounter of sensorineural hearing loss and 30% did so 
on the second encounter (Jayawardena, Shearer, & Smith, 
2015). Although physicians recognize the importance of 
genetics evaluation for children that are DHH, various 
challenges continue to persist in making physician referrals 
to genetics services. The 2005 NCHAM survey found that 
90% of physicians perceived there being somewhat of 
a need or a great need for training and/or resources on 
genetics and DHH (Moeller et al., 2006). Furthermore, 
physicians have cited lack of appropriate education 
or training to make referrals and uncertainty about the 
usefulness of genetics (Connelly, 2010).
Because of the known under-utilization of genetic services 
by primary care providers caring for individuals who are 
DHH, we sought to assess primary health care providers’ 
knowledge and use of genetic services for children who 
are DHH. We further sought to identify areas in which 
health care providers can be supported in increasing family 
education and referral of families for genetic consultation. 
The long-term goal of this study is to improve services for 
infants and children who are DHH as well as their families 
by integrating genetic services into the management of 
patients who are DHH.
Method 
Instrument
The hearing loss needs assessment was developed 
through a collaboration between the New York–Mid-
Atlantic Consortium for Genetic & Newborn Screening 
Services (NYMAC) and the National Center for Hearing 
Assessment and Management (NCHAM). NYMAC is 
one of seven regional genetics collaboratives funded 
by the Health Resources and Services Administration 
(HRSA). The region encompasses the District of 
Columbia, Delaware, Maryland, New Jersey, New York, 
Pennsylvania, Virginia, and West Virginia. Two previous 
NCHAM surveys (distributed in 2005 and 2012), 
1An updated percentage of newborns receiving hearing screening can be found at https://www.cdc.gov/ncbddd/hearingloss/ehdi-data2015.html
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literature reviews, and ongoing discussions with the 
NYMAC region EHDI coordinators and the Leadership 
Education in Neurodevelopmental and Related 
Disabilities (LEND) faculty guided the design of the 
survey. The survey was designed to identify the unmet 
needs of children, families, and professionals regarding 
use of genetics in hearing loss screening, diagnosis, 
and referral.
The 10–20 minute survey was available in paper 
and electronic format and consisted of 32 questions 
divided into four sections: (a) demographic information, 
(b) knowledge and beliefs about genetic referrals 
for children with hearing loss, (c) current practice 
regarding referrals for children with hearing loss, and 
(d) resources and strategies needed (see Appendix for 
a copy of the survey). The survey also included links 
to available resources, including the American College 
of Medical Genetics and Genomics (ACMG) Action 
Sheet on patients who are DHH and genetics. Notably, 
DHH was defined as permanent, bilateral or unilateral, 
sensorineural or conductive hearing loss of an average 
loss of 30 decibels or more in the frequency range 
important for speech recognition. 
The Johns Hopkins University and the Utah State 
University Institutional Review Boards approved the 
study.
Participants and Procedures 
EHDI coordinators in the NYMAC region were contacted 
by NCHAM with study information, the paper survey, a 
pre-addressed and stamped envelope, instructions for 
completion, and a URL to the electronic version of the 
survey. EHDI coordinators then contacted pediatricians, 
family medicine physicians, nurse practitioners, and 
physician assistants within their states to invite them 
to complete the needs assessment. Respondents 
were encouraged to share the survey link with fellow 
providers to enhance uptake. Respondents were asked 
to complete only one survey (paper or electronic). 
Contact information for NYMAC and NCHAM  
was provided. 
A follow-up email reminder to the target population 
was sent via Medical Marketing Services, Inc. (MMS), 
a professional service provider. MMS estimated that 
17,974 physicians, 4,837 advance practice nurse or 
nurse practitioners, and 1,373 physician assistants 
received the email blast. Two written reminders and 
one e-mailed reminder were sent to EHDI coordinators 
to encourage providers in their states to complete the 
needs assessment. The paper survey was re-sent to 
providers in the state of Delaware only.
Analytic Strategy
Responses to demographic questions, questions related 
to knowledge and beliefs about genetic hearing loss 
referrals, current practices for hearing loss referrals, and 
resources and strategies are reported. All comparisons 
across groups (i.e., disciplines) herein were carried out 
using chi-square tests of independence. All analyses 
were conducted using the R statistical environment 
version 3.4.2 (R Core Team, 2018).2 
Differences in the number of genetic referrals, timing of 
genetic referrals, and reasons for genetic referrals were 
examined by professional discipline. Differences in the 
perceived frequencies of challenges (not a challenge, 
sometimes a challenge, always a challenge, not 
applicable) relating to typical challenges experienced by 
clinical professionals were examined by reasons for the 
genetic referrals as well.
Results 
Sample Characteristics
A total of 266 participants across 8 states and the 
District of Columbia completed the survey. Participants 
were allowed to skip questions; therefore, the response 
rate varied per question. Table 1 presents demographic 
information regarding the participants, including their 
specialty, experience, and practice information. Of the 
respondents, 47% were pediatricians, 53% worked in 
private practice, most (68%) worked in either a large 
or small metropolitan area, and 42% had more than 20 
years of experience.
Table 1
Demographic Information about the Participants
2All code and data used in the present study are provided at: https://osf.io/8thwf
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Provider Knowledge and Beliefs
A total of 266 participants across 8 states and the 
District of Columbia completed the survey. Participants 
were allowed to skip questions; therefore, the response 
rate varied per question. Table 1 presents demographic 
information regarding the participants, including their 
specialty, experience, and practice information. Of the 
respondents, 47% were pediatricians, 53% worked in 
private practice, most (68%) worked in either a large 
or small metropolitan area, and 42% had more than 20 
years of experience.
Table 2 shows the responses regarding the participants’ 
levels of confidence in speaking with parents of a child 
with permanent hearing loss about the genetic causes 
(52% not confident), the importance of genetic referrals 
(33% not confident), the logistics of genetic referrals 
(3% not confident), and the significance of genetics in 
hearing loss due to ototoxic medication exposure (43% 
not confident).
Current Practice
Approximately 41% of the participants have referred 
a family to a genetics specialist because there was a 
family history of hearing loss, 4.3% because the parents 
Table 2 
Responses about the Confidence Level in Speaking with  
Parents of a Child with Permanent Hearing Loss about  




were discussing another pregnancy, and 3.9% because 
the parents asked for a referral. However over a third 
(37.1%) of the participants stated that they had not 
made a genetic referral. Nearly 40% of all participants 
indicated they have not consulted with a genetics 
specialist without a formal referral, with another 39% 
rarely consulting with a genetics specialist. The majority 
of participants (59%) had never ordered eConnexin 26 
testing in infants with nonsyndromic hearing loss. 
Table 3 shows the number of referrals, when referrals 
are made, and for what reason by discipline. Although 
there was a statistically significant difference of the 
reason for referral by discipline (p < .001), further 
analyses showed that physician assistants (12%), family 
medicine physicians (46%), and nurse practitioners 
(51%) were less likely to have made a referral as 
compared to pediatricians (84%; p < .001). Beyond this, 
there were no differences between disciplines regarding 
reasons for a referral (p = .435).
In addition, several participants indicated that they did 
not have tracking in place for failed newborn hearing 
screening (30%), failed newborn blood spot screening 
(26%), delayed developmental milestones (31%), and 
follow-up after referrals (32%). Of those that received 
reports of the newborn hearing screening, nearly 
80% say they sometimes or often refer children to a 
genetics referral. Notably, however, this differed by 
discipline with family medicine physicians rarely making 
a genetic referral in these situations compared to other 
professionals (p = .002).
Figure 1. Responses regarding challenges faced about the genetics of hearing loss. 
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Challenges and Opportunities
A final question was asked regarding challenges 
professionals face in respect to making genetic referrals 
for hearing loss (see Figure 1). The greatest challenge 
perceived by the survey participants when making 
genetic referrals were the parent/family priorities about 
genetic referrals (78.5% indicating always or sometimes 
a challenge) followed by the family’s inability to attend 
an appointment due to logistics, such as transportation 
or child care coverage (72.7% saying always or 
sometimes a challenge). More than half of participants 
indicated that lack of information to make the referral 
was a challenge as well. Neonatologists (83%) and 
pediatricians (65%) said lack of information/resources 
was not a challenge compared to family medicine 
physicians (11%), nurse practitioners (21%), and 
physician assistants (24%; p < .001).
A majority (84%) reported that a handout with resources 
on genetics of hearing loss for providers and families 
would be very helpful (Figure 2). Similar responses were 
given for both a quick reference guide about genetic 
referrals (82%) and contact information about genetic 
professionals in their area (74%). Educational webinars 
were far less popular with only 36.3% of participants 
indicating that webinars would be very helpful.
Figure 2. Perceived needs of the participants regarding training, information, and other resources about genetics and  
hearing loss (HL). 
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Discussion 
These results strongly support the need for education 
on genetics and patients who are DHH for primary care 
providers, as 43% of respondents indicated they lack 
information on this topic. Data from the current study 
supports a prior physician survey on congenital hearing 
loss, in which approximately 40% of respondents 
perceived a great need for training and/or resources on 
genetics and DHH (Moeller et al., 2006).
In addition to education on genetics and patients who 
are DHH, there is a need for public health surveillance 
to ensure newborns identified as DHH through hearing 
screening have a genetic evaluation. As noted in 
our results, many participants do not have tracking 
mechanisms in place for NBHS and other infant health 
processes. However, several states in the NYMAC 
region do have existing mechanisms for incorporating 
genetics into their EHDI program activities. In Virginia, 
parents are called after a newborn is identified as DHH 
to verify enrollment in early intervention services and 
the completion of the diagnostic work-up, including 
a genetics evaluation. In New Jersey, primary care 
providers are sent a checklist of necessary post-
diagnosis evaluations including genetics after 
identification. In Delaware, all newborns are referred 
to audiology at a single site, which allows for tracking 
of the post-diagnostic work-up. Going forward, HRSA-
funded EHDI programs will be held responsible for 
improving care coordination through the patient/
family-centered medical home model. Programs are 
required to report the number of care coordination 
plans developed with the parent or family and the 
number of care coordination plans that are shared 
across providers. This new, funded activity provides 
EHDI programs an opportunity to incorporate genetic 
evaluations into care plans and to include the sharing of 
care plans with the genetics provider.
Primary care provider education and public health 
surveillance are key to improving access to genetic 
services for newborns that are DHH, but based on our 
results, other barriers exist. Although we found that 
primary care providers perceive family acceptance 
as a barrier, a previous survey of parents of children 
who are DHH indicated that about 96% of parents—of 
whom none were DHH and about a quarter reported 
a family member born deaf—had a positive attitude 
toward genetic evaluation. A broader community of 
hearing, deaf, and hard-of-hearing adults supported 
genetic evaluation for newborns and expressed their 
willingness to engage in genetic counseling. Most 
families of children who are DHH value the availability of 
genetic testing as a means of better understanding the 
cause of the hearing loss and promoting discussion of 
the condition. (Geelhoed, Harrison, Davey, & Walpole, 
2009).
Response to Needs
In response to the identified need for genetics 
education, NYMAC conducted an educational campaign 
using professional marketing (Figure 3) from May 1, 
2017 through May 29, 2017. The campaign targeted 
pediatricians from New York, Delaware, Washington 
DC, Maryland, New Jersey, Pennsylvania, Virginia, and 
West Virginia. Standard desktop and tablet banners 
were placed on the American Academy of Pediatrics 
and AAP Publications websites. The campaign reached 
215,949 pediatricians. This campaign represents 
one approach to provide education on genetics and 
hearing loss, but novel methods for ongoing education 
is needed—not only for this topic, but for genetics as a 
whole. In the survey, providers indicated a preference 
for handouts (83.9%), a quick reference guide (82.4%), 
and contact information about genetic professionals 
(73.7%). Although preparation of these materials is 
straightforward, incorporating them into practice is likely 
to be more challenging.
Figure 3. Ad used for educational campaign on the effect of 
genetics on being deaf or hard of hearing in the New York–
Mid-Atlantic Consortium for Genetic & Newborn Screening 
Services Region.
Results also showed that providers perceive 
appointment logistics as a barrier to families receiving 
genetics evaluations. NYMAC is piloting several 
methods to reduce barriers related to appointment 
logistics. These methods include a phone line for 
help identifying a genetic service provider, expansion 
of telegenetics services, primary care provider 
education, and a formal relationship between primary 
care providers and a geneticist to review cases. The 
HRSA-funded Regional Genetics Networks are piloting 
different approaches to improve access to genetic 
services. Individuals with a variety of genetic conditions, 
including children who are DHH, will benefit from these 
nationwide activities.
 43
Notably, there are a number of limitations to the study. 
First, the survey response rate was low, with only 266 
of more than 24,000 professionals returning the survey. 
This indicates that the sampling may be biased toward 
certain groups. It is therefore difficult to assess the 
generalizability of this single sample. However, this 
may not be a major limitation given the corroboration 
between these results and prior results mentioned 
earlier. Second, there were missing values for many 
questions. For all tables, the number of participants that 
answered each question was noted.
Conclusion 
Ultimately, this study may highlight the challenges and 
needs for healthcare professionals in their work with 
children who are DHH. Results indicate that there is a 
need for integrated, targeted, and user-friendly genetics 
education strategies for providers of children who are 
DHH, to ensure adequate awareness and delivery of 
genetics services for these children. This could include 
early intervention providers, as they may be able to 
encourage families to learn more about the genetic 
evaluation process if they have not pursued this. With 
recommendations coming from multiple sources, 
parents/family members may progressively become 
more interested in understanding their child’s genetic 
background.
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Appendix 
The following is what was presented to the online surveys. The paper surveys are extremely similar in appearance.
Each year, 3 in 1,000 infants are born in the US with moderate, severe, or profound hearing loss (HL). By age 19, 15% of 
adolescents have HL in one or both ears. Newborn hearing screening (NBHS) is included in the Recommended Universal 
Screening Panel for newborns. The national and state Early Hearing Detection and Intervention (EHDI) programs funded 
by the Centers for Disease Control & Prevention (CDC) and the Maternal & Child Health Bureau (MCHB) of the Health 
Resources and Services Administration (HRSA), in cooperation with professional societies, support families of children 
with HL and their providers based on the EHDI 1-3-6 guidelines: 
• Screening by 1 month of age
• Diagnosis of HL by 3 months of age
• Entry into early intervention (EI) services by 6 months of age
 
The objectives of this research survey are to 
• Determine the unmet needs of physicians and health care providers related to genetics services for children in the 
HL screening, diagnosis, and referral continuum and 
• Identify areas where appropriate assistance can be provided to support physicians to increase family education 
about and genetic referrals for HL.
This research survey’s long-term goal is to use the findings to improve services for infants and children with HL as well as 
their families by integrating genetic services into the management of patients and families with HL.
Your completion of this survey or questionnaire will serve as your consent to be in this research study. Please take about 
10–20 minutes to tell us about your experiences. Your responses are completely confidential and will be used to improve 
services for infants and young children with hearing loss. Your participation is greatly appreciated.
























5. Year(s) of practice with pediatric population: 





More than 20 years
Hearing Screening Genetics
Hearing Loss that is permanent, bilateral or unilateral, sensorineural or conductive, and averaging loss of 30 decibels or 
more in the frequency range important for speech recognition. The following questions are about children who were identi-
fied through newborn hearing screening (NBHS) as having hearing loss.
6. Do you receive reports about children who have failed their newborn hearing screening (NBHS)?
Yes
No
7. Have you referred parents who have a child with hearing loss identified through NBHS to genetics professionals? (If 
you answered “No” to this question, you will skip to Question #11)
Yes
No














10. For infants identified through NBHS as having hearing loss, what is your best estimate of the earliest stage at which:
Parents/family need 




At the time of
enrollment in
early intervention
At the time of
screening




Other Identification and Genetics
The following questions are about children who were identified as having hearing loss via means OTHER THAN newborn 
hearing screening (NBHS). 
11. Have you referred parents who have a child with hearing loss identified through means other than NBHS to genetics 
professionals? (If you answered “No” to this question, you will skip to Q15)
Yes
No
12. If/When you have a child with hearing loss identified through means other than NBHS, how often do you refer the 






13. In the last year, approximately how many patients did you refer for genetic evaluation of hearing loss after identifica-






14. For patients identified through a means other than NBHS as having hearing loss what is your best estimate of the 
earliest stage at which:
Parents/family need 




At the time of
enrollment in
early intervention
At the time of
screening




All Children with Hearing Loss and Genetics
The following questions are about ALL children with hearing loss, regardless of how they were identified.
15. Which is the primary reason why you refer families to a genetics professional for hearing loss?
Parents ask for a referral
There is a family history of hearing loss
Parents are discussing another pregnancy
I have not referred to a genetics professional for hearing loss
Other____________________________________________
16. How often do you consult with (i.e., do not make a formal referral) geneticists and genetic counselors  







17. What challenges have you experienced when referring parents/families for a genetic evaluation of the infant/child?
Lack of information/ 












Lack of family support
Transient families
Parents/families may not 
consider genetic referral 
a priority
Lack of local genetics 
provider
Lack of telehealth options
Other
Other _______________________________________________________


















19. For parents/families who already have a diagnosis of hearing loss, do  you discuss with them the genetics of  





20. It is possible that infants with nonsydromic hearing loss have indentifiable gene changes in Connexin 26 and/or 30 
(GJB2/GJB6). At what age (in months) do you thing connexin testing should be offered in a failed newborn hearing screen 
workup when there are not dysmorphic features/anomalies or a known genetic condition?
Age (in months)  ___________________________________________
Don’t think connexin testing should be ordered
Don’t know/not familiar


















I don’t knowNo Yes Not Applicable




Preauthorization for HL 
genetic testing
Follow up after referrals





25. How informed do you think you are about...
The genetics of HL
The importance of  
genetic referrals
Somewhat InformedUninformed Very Informed
26. Do you have a designated system (i.e., person or computer system/database) for tracking...
Genetic causes of HL
The importance of ge-
netic referrals
The logistics of genetic 
referral for HL
The significance of 
genetics in HL due to 
ototoxic medication 
exposure
Somewhat InformedUninformed Very Informed
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29. Would you implement the following strategies to faciliate (or ensure) tracking of genetic referrals?
Implement a system to follow up with 
patients and families
Yes No
Engage case managers in the  
EHDI programs
Increase genetics education efforts




30. Have you used the following strategies to facilitate (or ensure) tracking of genetics referrals?
Implement a system to follow up with 
patients and families
Yes No
Engage case managers in the  
EHDI programs
Increase genetics education efforts





31. If you have used the following strategies to facilitate (or ensure) tracking of genetic referrals did it work?
Implement a system to 
follow up with patients 
and families
Engage case managers 
in the EHDI programs
YesNo Somewhat Have Not Used
Increase genetics edu-
cation efforts
Implement a system 




32. Would you implement the following strategies to enhance collaborations and communication with EHDI/EI programs 
and primary care providers regarding genetic referrals and follow-up?
Genetics of HL Reference guide
No Yes
Handout of HL genetic testing
List of available resources on  
HL genetics
State/district-specific contact  





33. Have you used the following strategies to enhance collaboration and communication with EHDI/EI programs and pri-
mary care providers regarding genetic referrals and follow-up?
Genetics of HL Reference guide
No Yes
Handout of HL genetic testing
List of available resources on  
HL genetics
State/district-specific contact  




34. If you have used the following strategies to enhance collaboration and communication with EHID/EI programs and 
primary care providers regarding genetic referrals and follow-up, did it work?
Genetics of HL refer-
ence guide
Handout of HL genetics 
testing
YesNo Somewhat Have Not Used
List of available resourc-
es on HL genetics
State/district-specific 
contact information on 
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Introduction
In March 1993, the U.S. National Institutes of Health 
(NIH) concluded, ‘‘that all infants should be screened for 
hearing impairment… This will be accomplished most 
efficiently by screening prior to discharge (from the birth 
hospital). Infants who fail hearing screening should have 
a comprehensive diagnostic hearing evaluation no later 
than 6 months of age’’ (p. 215-227). Subsequently, the 
Joint Committee on Infant Hearing (JCIH, 2007) and 
the American Academy of Pediatrics (AAP, 2008) both 
recommended that newborn hearing screening should 
be conducted by the first month of life, confirmation of 
congenital hearing loss should be made by three months 
of age, and intervention and rehabilitation plans should be 
in place by six months of age. The fact that early diagnosis 
and intervention of hearing loss has resulted in significant 
impacts on the development of children with hearing 
impairment has been well studied and documented in 
the United States since 1998 (Downs & Yoshinaga-Itano, 
1999; Yoshinaga-Itano, Sedey, Coulter, & Mehl, 1998).
Based on this, the Taipei Mackay Memorial Hospital 
in Taiwan, in collaboration with the Children’s Hearing 
Foundation, initiated a free newborn hearing screening 
program using transient evoked otoacoustic emissions 
(TEOAE) in 1998 (Lin, Shu, Chang, & Bruna, 2002). This 
was followed in 2002 by a call from the Taiwan Ministry of 
Health and Welfare for research proposals related to the 
administration of screening procedures and policies as a 
way of improving the welfare of infant hearing health. As 
a result, Taipei Mackay Memorial Hospital began to take 
part in these projects. During 2003–2013, there were four 
major phases of implementation and promotion of the 
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universal newborn hearing screening program (UNHS) 
in Taiwan initiated by the government’s Bureau of Health 
Promotion.  First, in 2003, Chang Gung Medical Hospital 
was commissioned by the Taiwan Ministry of Health 
and Welfare to evaluate the feasibility of implementing 
a newborn hearing screening program in Taiwan. The 
purpose of the project included understanding the 
feasibility of conducting newborn hearing screening in 
maternity hospitals and planning the screening procedures 
during 2003 and 2004. Since 2004, Dr. Hung-Ching Lin 
of Taipei Mackay Memorial Hospital has played a major 
role in these 4 major Taiwan UNHS promotion projects, 
including (a) establishment of the 2004 Taiwan Guidance 
of Newborn Hearing Screening Program (Bureau of Health 
Promotion, 2004), (b) completion of the 2008 Taiwan 
Consensus Statement on Newborn Hearing Screening 
(Bureau of Health Promotion, 2008), (c) implementation 
of a national government-funded UNHS program in 2012 
(Yoshinaga-Itano et al., 1998), and the 2014 Taiwan UNHS 
Revised Guidelines (Bureau of Health Promotion, 2014).
In addition, in order to raise public awareness of the 
importance of UNHS, the 2004 Taiwan Guidance of 
Newborn Hearing Screening Program (using otoacoustic 
emissions [OAE] or automated auditory brainstem 
response [aABR] at parent’s own expense) was completed 
with support from many speech and hearing professionals 
(Bureau of Health Promotion, 2004). In the same year, 
the Taiwan Speech-Language-Hearing Association 
implemented several training courses in the basic 
concepts of UNHS for speech and hearing professionals.
Nevertheless, by 2007, Taiwan national statistics 
showed that only 28.7% of medical institutions offered 
newborn hearing screening services in Taiwan (Bureau 
of Health Promotion, 2007–2008). Consequently, a 
national research project commissioned by the Ministry 
of Health and Welfare was conducted by Taipei Mackay 
Memorial Hospital with the goal of promoting and studying 
the effectiveness of UNHS in an effort to increase the 
coverage rate of newborn hearing screening in Taiwan. 
A promotion center in Taipei and four hearing screening 
service centers located in the northern, central, southern, 
and eastern parts of Taiwan were established to recruit 
more medical institutions to conduct newborn hearing 
screening. By 2008, the percentages of medical institutions 
offering newborn hearing screening service had increased 
to 39.4% (Bureau of Health Promotion, 2014). Meanwhile, 
the Taiwan Consensus Statement on Newborn Hearing 
Screening, 2008 (using aABR at parent’s own expense) 
was completed and endorsed by a panel of international 
experts from Singapore and Hong Kong (Bureau of 
Health Promotion, 2008). The four service centers, 
in collaboration with other associated organizations, 
began to hold seminars and workshops to facilitate the 
communication between hearing screening personnel and 
speech and hearing professionals, and also to improve 
their clinical skills and knowledge in the area of newborn 
hearing screening.
Through these efforts, 87% of medical institutions in 
Taiwan implemented newborn hearing screening programs 
by 2011–2012 (Bureau of Health Promotion, 2011–
2012). At that time, some counties and cities had been 
implementing newborn hearing screening using either OAE 
or automated auditory brainstem response aABR; however 
research by the authors indicated that aABR may be more 
beneficial and more practical than TEOAE (Lin, Shu, Lee, 
Lin, & Lin, 2007). Consequently, the Taiwan Ministry of 
Health and Welfare issued regulations in February 2012 
that provided government funding for universal newborn 
hearing screening using aABR, free of charge to parents, 
with the policy initiated on March 15, 2012. At the same 
time, the maternal and child health data management and 
tracking system to monitor the hearing status of newborns 
was activated.
After implementation of universal newborn screening in 
Taiwan in 2012, a monitoring center was established to 
work together with the four promotion centers across the 
island to offer consultation and quality control of hearing 
screening and diagnosis. By 2013, the coverage rate of 
Taiwan’s newborn hearing screening program reached 
97.3% (Bureau of Health Promotion, 2011–2012); 
comparable with the status in the United Kingdom, United 
States, and Australia. In addition, the 2013 confirmation 
rate of hearing diagnosis in Taiwan was 81.6%, higher 
than the 54.1% in the United States in 2012 (Muse et 
al., 2013). A revised consensus conference for newborn 
hearing screening, diagnosis, and intervention held and 
confirmed by U.S. professor Christine Yoshinaga-Itano and 
Australian professor Joseph Kei in 2014 sought to improve 
the distribution of medical resources and the referring 
procedures of early intervention with the goal of improving 
quality and outcomes of newborn hearing screening 
programs in Taiwan (Bureau of Health Promotion, 2014).
In summary, the 2016 Taiwan national statistics indicate 
that for a total of nearly 200,000 babies, the coverage 
rate of newborn hearing screening was up to 98.2%, the 
refer rate was 1.13%, the return rate of OPD referral was 
86.10%, and the incidence of congenital deafness was 
estimated to be 0.445% (Bureau of Health Promotion, 
2015–2016). This shows that the overall outcome of 
the Taiwan newborn hearing screening program has 
approached international performance levels (Huang et 
al., 2014). In the future, we will be devoted to leading 
and sharing our experience in establishing infant hearing 
screening programs to neighboring countries. From our 
experience in promotion of UNHS in Taiwan, there are five 
main points we would suggest for others creating a UNHS 
program.
1. Establish a national guidance and consensus 
statement for newborn hearing screening in order to 
bring professional experts together for the work.
2. Publish domestic UNHS related results in 
international papers to raise your government’s 
attention of its importance and to gain  
government funding.
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3. In order to increase the coverage rate, the UNHS 
program must be supported with national funding so 
that parents do not pay for screening. In Taiwan the 
coverage rate was initially only 70% when parents 
paid, later increasing to 98.3% with national free 
UNHS.
4. Monitor UNHS quality to confirm higher coverage 
and diagnosis rates through projects such as 
Taiwan’s quality control improvement project for 
newborn hearing screening and confirmed diagnosis 
(Bureau of Health Promotion, 2015–2016).
5. Create a national UNHS data tracking system. 
In Taiwan, the national UNHS data tracking system 
was monitored by Health Promotion Administration, 
Ministry of Health and Welfare, Taiwan. Our Mackay 
Memorial Hospital team was commissioned by the 
government to help audit and promote its qualities, 
to reduce inappropriately higher referral rates, and 
to increase diagnostic follow up rates and early 
intervention rates via this data tracking system.
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Introduction
Newborn hearing screening (NBHS) is one of the 31 
primary conditions included on the Recommended 
Universal Screening Panel (Health Research & Services 
Administration, 2017). However, NBHS alone does not 
ensure that a child with hearing loss (HL) is identified 
(Winston-Gerson & Hoffman, 2017). Early diagnosis 
of HL involves a series of steps and services through 
multiple providers. If an infant does not pass NBHS, it 
is crucial to determine if the infant received appropriate 
and timely follow-up diagnostic services. If HL is present, 
2018; 3(1): 57–66
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the infant needs to receive recommended intervention 
services as early as possible to reduce the likelihood for 
developmental delays (Vohr, 2003). Most U.S. states and 
territories have an EHDI program with goals to screen 
infants for HL no later than 1 month of age, diagnose 
HL no later than 3 months of age for infants who did not 
pass the hearing screening, and enroll infants identified 
with permanent HL into early intervention (EI) no later 
than 6 months of age. EHDI programs accomplish these 
1-3-6 goals through active tracking, surveillance, and 
coordination with clinical service providers and families 
(Williams, Alam, & Gaffney, 2015).
CDC supports jurisdictional EHDI programs by providing 
programs with funding and assistance to develop, 
maintain, and enhance the collection of hearing screening, 
diagnosis, and EI data. Through the Hearing Screening 
and Follow-up Survey (HSFS), CDC collects aggregate 
data based on individually identifiable records from 
jurisdictional EHDI programs about NBHS, which allows for 
evaluation of the timeliness of receipt of hearing screening, 
diagnosis, and enrollment in EI services. This survey 
tool helps assess and monitor EHDI progress nationally 
and assists states and territories in strengthening their 
programs by identifying data gaps and areas of need 
(Alam, Gaffney, & Eichwald, 2014; CDC, 2017). The 
voluntary survey is sent annually to each EHDI program.
Although the HSFS allows CDC to generate national 
reports about the number of infants screened, diagnosed, 
and enrolled in EI and to assess progress toward the 
1-3-6 goals, several limitations and questions cannot be 
addressed by the survey’s data. The use of aggregate 
data can lead to an ecological fallacy where inferences 
are incorrectly generalized to the whole jurisdictional 
population (i.e., using aggregate data to infer individual-
level relationships; King, 2013; Stewart & Tierney, 2002). 
Detailed data quality checks are not possible using 
aggregate data. Although CDC provides definitions for 
each HSFS data item, some respondents may quantify 
and aggregate their data differently when they participate 
in the survey (Alam, Satterfield, Mason, & Deng, 2016). 
Improving data standardization is not possible without 
seeing individual-level data. It is difficult to provide a 
descriptive summary of the individual services when data 
are aggregated.
Aggregate data do not allow for in-depth analyses of infant 
and family sociodemographic characteristics and the 
receipt of EHDI-related services. Aggregate data do not 
allow for answering key questions, such as the average 
age when an infant is diagnosed with HL. As a result, 
it is often not possible for CDC to use HSFS to identify 
potential program gaps and needs that would help provide 
more targeted technical assistance. To address these 
limitations, CDC implemented a pilot study in September 
2010 known as individual EHDI (iEHDI), in which the 
participating jurisdictions assembled and transmitted 
limited sets of de-identified, individual-level data to CDC. 
The objective of this article is to describe the feasibility, 
benefits, and challenges surrounding the reporting and use 
of individual-level data compared to HSFS data for EHDI.
Method
iEHDI Pilot Study
To participate, jurisdictions were required to have a 
comprehensive EHDI tracking and surveillance system 
in place and to routinely collect and maintain non-
aggregated, individual-level data on all infants born in the 
jurisdiction, as well as the hearing screening and follow-
up services they received. Three jurisdictions—Indiana, 
Iowa, and Nebraska—were selected and awarded funds 
to provide de-identified sets of specified data items to 
CDC for infants born in 2010. Two jurisdictions (Iowa and 
Nebraska) voluntarily provided these data to CDC for 
infants born in 2012.
Quarterly data sets were transmitted to CDC via a Secure 
Data Network (SDN). Jurisdictional participants and 
CDC jointly reviewed and finalized the list and format 
of data items to be transmitted. The list was based on 
items included in the HSFS and additional information 
already collected by the jurisdictional programs. Prior 
to transmission, participants were required to perform 
a data validation and verification check to identify and 
correct data format and logic errors. Format errors refer 
to errors in the type, value, or range of a single data item 
(e.g., an infant’s residence zip code coded in character 
string instead of numeric format). Logic errors occur 
when an illogical relationship is discovered when the data 
item is validated with another data item. For example, 
crosschecking the infant’s date of birth shows that the 
NBHS occurred before birth.
To maintain the data integrity and privacy, jurisdictions 
assigned each infant record a new identifier consisting 
of a 2-digit jurisdictional ID followed by a 13-digit record 
ID. The 13-digit record ID could not contain any direct 
personal identifiers or information that may indirectly 
identify the infant. The infant’s pseudonym was used to link 
records across the study period. Participating jurisdictions 
transmitted the data through an SDN operated by CDC 
Public Health Informatics and Technology Program Office. 
The data were stored in a stand-alone Microsoft Access 
database maintained by CDC Information Technology 
Services Office. Access was restricted to approved 
CDC EHDI program staff who had signed a data user 
agreement. CDC EHDI program staff performed an 
additional data review, validation, and verification check. 
All identified data errors were listed in a data quality report 
and shared with the jurisdictions to correct before re-
transmission.
When the datasets were in acceptable format and clear 
of obvious format or logic errors (e.g., an infant’s date 
of hearing screening occurring before the infant’s date 
of birth), in-depth statistical analyses were conducted 
to demonstrate the value of having individual-level data 
 59
as opposed to HSFS (aggregate) data. A summary of 
2010 and 2012 EHDI tracking and surveillance efforts 
was assembled. This information included the number 
of newborns not passing the final hearing screening, 
the status and results of diagnostic evaluation, the EI 
enrollment status, and infant and maternal characteristics 
for those diagnosed with permanent HL.
Demographic, Clinical, and Sociodemographic Variables
Descriptive variables collected from vital records were 
reported for the infant and parents, such as infant gender 
(male/female), marital status (married: yes/no). Maternal 
Age was calculated as the difference in years between 
the mother’s date of birth and the child’s date of birth, 
and categorized as ≤ 19 years, 20-34 years, ≥ 35 years. 
Ethnicity for mother and father were each categorized as 
Hispanic (Mexican/Mexican American/Chicana, Puerto 
Rican, Cuban, unspecified Hispanic, or other Spanish/
Hispanic/Latina) or Non-Hispanic. Maternal and Paternal 
Race were each categorized as White, Black or African 
American, or Other.
Infant clinical measures from birth certificates from vital 
records, including birth weight, low Appearance, Pulse, 
Grimace response, Activity, and Respiration (APGAR) 
score (score < 6 at 5 minutes: Yes/No), neonatal intensive 
care > 5 days (Yes/No), number of prenatal visits, and 
family history of permanent HL (Yes/No) were reported. 
Birth weight was categorized as Low (< 2,500 grams), 
Normal (2,500–4,000 grams), and High (≥ 4,001 grams). A 
low APGAR score is a potential risk factor that can be used 
for identifying HL in infants (Biswas, Goswami, Baruah, & 
Tripathy, 2012; Lin & Oghalai, 2011).
Socioeconomic variables included maternal education, 
principal source of payment, and receipt of women, infants 
and children (WIC) food & nutrition services (Yes/No). 
Maternal Education was categorized as Less than High 
School or Unknown (8th grade or less, 9th to 12th grade 
without a diploma, or unknown), Completed High School 
or General Education Development (GED), Some College 
or Associate’s Degree, and Bachelor’s Degree and Above 
(i.e., Bachelor’s, Master’s, Doctorate or professional 
degree). Principal source of payment included Private 
Insurance, Medicaid, and Other.
EHDI Screening, Diagnostic, and EI Variables
Tracking and surveillance variables included: screening 
methods, results of initial hearing screen, rescreen 
results, dates and results of diagnostic evaluation, and EI 
enrollment status. Table 1 provides a detailed summary 
of the EHDI screening, diagnostic, and EI variables. 
Permanent HL was described by laterality (bilateral/
unilateral), type of HL (Sensorineural, Permanent 
Conductive, Mixed, Auditory Neuropathy, Unknown Type), 
and severity (degree of HL: Mild (26-40 decibels, dB), 
Moderate (41-55 dB), Moderately Severe (56-70 dB), 
Severe (71-90 dB), Profound (91+ dB), and Unknown 
or Missing) for each ear (American Speech-Language-
Hearing, 2017a, 2017b).
Statistical Analysis
Descriptive statistics (frequency counts and 
percentages) were used to analyze infant and parental 
sociodemographic characteristics of the newborn hearing 
screening population and of the infants with permanent 
HL, and key indicators for EHDI tracking and surveillance 
efforts for infants born in 2010 and 2012. Median age 
and standard deviation were calculated for maternal age 
(years) and infant age at first diagnostic evaluation (days). 
All analyses were performed using SAS Version 9.3 (SAS 
Institute Inc., Cary, NC) and validated by two of  
the authors.
Results
Compared to HSFS data, it was feasible to receive more 
data items through the iEHDI pilot. Additional infant 
and family information not currently collected by the 
HSFS, such as maternal and paternal sociodemographic 
variables, infant birth characteristics, and risk factors 
for HL, were available through the pilot study. Table 2 
compares the data items collected by the HSFS and 
iEHDI. With an increase in the range and depth of 
individual-level data, a comparison of individual infant 
characteristics at each benchmark was feasible (e.g., 
maternal characteristics of infants screened or diagnosed 
with HL).
Table 3 provides a summary of the infant and parental 
characteristics of each jurisdiction’s infant population by 
year. Compared to HSFS data, Table 3 provides a more 
comprehensive description of the infant population in each 
jurisdiction and examples of the iEHDI information collected 
(e.g., birth weight of infant, family history of permanent 
childhood HL, and low APGAR score). As reflected in Table 
3, birth cohort size varied across the three jurisdictions, 
however the infants had similar characteristics. There were 
more male than female births and the average birth weight 
was in the normal range. Across all three jurisdictions, more 
mothers were aged between 20-34 years, White, non-
Hispanic, and had private insurance. Approximately 40% 
of the mothers received WIC food and nutrition services. 
Maternal education level varied by jurisdiction and birth 
year. A higher percentage of the fathers were White and 
non-Hispanic.
Table 4 provides summary statistics of key EHDI tracking 
and surveillance efforts by jurisdiction and birth year. The 
results of hearing screen, diagnostic evaluation for those 
not passing the screen, and the status of EI enrollment for 
those diagnosed with permanent HL revealed variations 
across the jurisdictions by cohort size and screening 
method. For example, Indiana had the largest birth cohort 
(n = 84,866) and the lowest rate of not passing the final 
hearing screen (3.0%) in 2010. The percentage of infants 
diagnosed with permanent HL varied across jurisdictions 
in 2010. Of those infants documented with permanent 
HL, 23.2% of Indiana and 28.2% of Iowa infants were not 
documented as receiving EI services in 2010. EI data were 
unavailable from Nebraska (Table 4).
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Table 1  
Summary of the Definitions Used for Early Hearing Detection and Intervention Screening, Diagnostic, and  




Comparison of Data Collected Between Hearing Screening and Follow-up Survey (HSFS) and Individual Early Hearing Detection 
and Intervention (iEHDI)
Furthermore, iEHDI allows for comparing trends of key 
tracking and surveillance indicators within a jurisdiction 
(Table 4). Between 2010 and 2012, the percentage 
of infants who did not pass the final hearing screen 
decreased from 1.7% to 1.2% for Iowa, and from 1.0% 
to 0.4% for Nebraska. This may be a direct result of an 
increase in the percentage of infants passing the initial 
hearing screen. The decrease in the percentage of infants 
who did not pass the final hearing screening subsequently 
yielded a smaller cohort of infants in need of a diagnostic 
evaluation in 2012. Between 2010 and 2012, infants in 
Iowa who were not documented as receiving a diagnostic 
evaluation decreased from 56.7% to 44.4%. Likewise, 
a decrease from 28.2% to 17.0% was also seen for 
infants in Iowa who were not documented as receiving 
EI. For Nebraska, there was a decrease from 46.4% to 
37.5% for infants who were not documented as receiving 
a diagnostic evaluation. EI enrollment data were not 
available for Nebraska in 2010. Altogether, Table 4 shows 
that it is feasible to track each infant’s EHDI process and 
to perform subset analyses (e.g., assess EI enrollment 
status among infants diagnosed with permanent HL, using 
individual-level data). In addition, individual-level data 
allow for detailed understanding of each jurisdiction’s EHDI 
process, which was otherwise not possible using  
HSFS data.
As shown in Table 4, it was feasible to calculate the 
median age of infants who did not pass the hearing 
screen and received a diagnostic evaluation. The median 
age varied across years for each jurisdiction. Between 
2010 and 2012, the median age when infants received a 
diagnostic evaluation decreased for Iowa (74 days vs. 48 
days) and increased for Nebraska (49 days vs. 65 days). 
For Indiana, the median age was younger (48 days) in 
2010. Currently, the HSFS does not gather 
this information.
Table 5 shows the summary of infant and maternal 
characteristics for infants who were a diagnosed with 
permanent HL in 2010 and 2012. Across all jurisdictions, 
regardless of the birth cohort size, 2.0 per 1,000 live born 
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Table 3





Summary of EHDI Tracking and Surveillance Efforts, iEHDI 2010 and 2012.
infants had permanent HL, reflecting combined data for 
2010 and 2012 for Iowa and Nebraska and only 2010 
data for Indiana. This prevalence rate of HL is higher than 
the national prevalence rate, which is 1.3 per 1,000 live 
born infants in 2010 and 1.4 per 1,000 live born infants 
for 2012 (CDC, 2017). Table 5 also shows that more than 
half of the infants diagnosed with permanent HL (≥ 70% 
in each jurisdiction) had bilateral HL, and most infants 
were born to married mothers and mothers who are White. 
Maternal education varied across jurisdictions. Regardless 
of laterality or jurisdiction, most infants had mild (≥ 
48% in each jurisdiction), sensorineural (≥ 60% in each 
jurisdiction) HL. Although, it is feasible to estimate the 
prevalence of HL using the HSFS data, the ability to better 
understand both the infant and maternal characteristics of 
infants diagnosed with permanent HL is not feasible using 
current HSFS data.
Discussion
As learned from the iEHDI pilot, individual-level data 
offered many opportunities for CDC. The pilot study 
allowed CDC and jurisdictional EHDI programs to 
Otoacoustic Emissions or Distortion Project
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Table 5
Summary of Infant and Maternal Characteristics for Infants Diagnosed with Permanent Hearing Loss by Jurisdiction, Individual 
Early Hearing and Detection Intervention (iEHDI) Pilot Study 2010 and 2012
Infants with Permanent Hearing Loss
 65
collaborate and identify data quality issues (e.g., an 
infant’s date of hearing screening occurring before the 
infant’s date of birth and inconsistent screening and 
diagnostic results for a baby diagnosed with no HL) and 
implement procedures to correct them. It also highlighted 
inconsistencies in data standardization, which can 
adversely affect the quality and accuracy of data (King, 
2013). For instance, the definition of passing the hearing 
screen varied from jurisdiction to jurisdiction, depending on 
the screening protocol used, which also differed between 
jurisdictions. According to Indiana’s mandate, an infant 
is referred directly for a diagnostic evaluation after not 
passing two inpatient screenings. Alternatively, Iowa and 
Nebraska require an outpatient screen only if the infant 
did not pass the initial inpatient screen. In addition, the 
pilot study revealed that the data collection and reporting 
procedures vary from jurisdiction to jurisdiction. The 
processes by which infants receive recommended follow-
up services vary in each jurisdiction. The data collection 
and process issues would not have been identified if the 
CDC EHDI program had relied only on HSFS data.
The study also allowed CDC to gain a better 
understanding of the challenges unique to each jurisdiction 
in terms of data collection and reporting. For example, 
EHDI data collected in one jurisdiction were captured from 
multiple sources and the relationship between discrete 
data items from the multiple sources were not always 
consistent. One data source might have documented a 
newborn passing the hearing screen for both ears while in 
another data source the same newborn was documented 
as failing hearing screen in one ear. Another challenge for 
jurisdictions was the time-consuming process of matching 
the newborn screening record report with the vital records 
report to create a final record with all variables for the 
iEHDI pilot. Due to the iEHDI partnership, a matching 
algorithm was used to automate this matching process. 
The algorithm enabled the jurisdictional EHDI program 
staff to match different iterations of the data or record 
by deterministic, probabilistic, or other types of similar 
measures and led to improvements in efficiency. This 
challenge would not have come to light without the pilot 
study. In terms of reporting data to CDC, one jurisdiction 
experienced the challenge of converting several data 
items in the jurisdictional database from text to numeric 
format to fulfill the iEHDI data requirements. They had 
to import certain data items from other sources (i.e., the 
Federal Information Processing Standard county code 
from the birth record into the jurisdictional database 
before transmitting the data to CDC). Another challenge 
noted in this pilot study was the increased costs for the 
participating jurisdictional EHDI programs to provide 
limited, de-identified datasets to CDC. The increased costs 
were due to the amount of personnel time and effort for the 
data management and collection required for this study, 
which were substantial for the jurisdictions. The increased 
costs were also due to upgrades made to the tracking and 
surveillance system, which in some cases, were necessary 
to make the pilot study feasible. The upgrades, while 
beneficial to the programs, are often times costly and the 
jurisdictions were challenged to find the financial means 
to make the upgrades feasible. This collaboration allowed 
for CDC to understand the challenges and the substantial 
efforts required from the participating jurisdictions to report 
individual-level data. Through this collaboration, CDC 
recognized that data standardization and more refined 
definitions are needed.
A major benefit seen in the pilot study is the availability of 
far more data items compared to HSFS (Table 2). Unlike 
HSFS, the iEHDI pilot gathered data on WIC enrollment 
status, paternal characteristics, infant birth characteristics, 
and risk factors for HL. Although these data items are 
already gathered at the jurisdictional level, the availability 
of these data items in the pilot study allowed for CDC to 
further understand each jurisdiction’s infant population 
and their EHDI process. It also allowed for more research 
opportunities.
Individual-level data allow for in-depth statistical analyses, 
which is another benefit seen in the pilot study. In addition 
to learning more about each jurisdiction’s infant population 
and their EHDI process, the individual-level data also 
allowed for more discussions between CDC and the 
jurisdictional EHDI programs. For instance, analyses 
revealed that Indiana had the largest birth cohort, yet a 
lower than expected proportion of newborns underwent 
initial newborn hearing screening. The analyses also 
revealed that even though the jurisdictions varied in birth 
cohort, the number and percentage of infants receiving 
newborn hearing screening and diagnostic evaluation were 
wide-ranging. This prompted questions about why the 
percentages seen are different and provided opportunity 
for discussions between CDC and jurisdictional EHDI 
programs, which is currently not feasible using HSFS data.
In addition, individual-level data allowed for identification 
and tracking of infants at different stages of the EHDI 
process and ability to assess the demographic and 
socioeconomic characteristics that may be associated with 
the receipt of recommended screening, diagnostic, and/
or intervention services. It was feasible to look at subsets 
of interests in further detail. For instance, we learned that 
for Indiana in 2010, 25.1% of the infants who did not pass 
the hearing screen as final result were not documented as 
having received a diagnostic evaluation (Table 4). Also for 
Indiana in 2010, we learned that 26.1% of the infants with 
permanent HL have family history of permanent childhood 
HL and 69.6% of the infants with permanent HL have 
bilateral HL (Table 5). The ability to assess subgroups in 
detail is not feasible using the current HSFS data.
This pilot study demonstrated that key measures using 
individual-level data could be calculated at the national 
level which is not currently feasible using HSFS data (e.g., 
median age at first diagnostic visit, median age at referral, 
and median age when enrolled into early intervention). 
The ability to calculate these key measures allowed for 
assessing progress toward meeting the 1-3-6 goals which 
are measured by Healthy People 2020 Objective ENT-
VSL-1 and three child health quality measures that were 
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endorsed by the National Quality Forum (NQF) in August 
2011 (NQF #1354: hearing screening before discharge 
from the hospital, NQF #1360: audiological evaluation no 
later than age 3 months [for those failing the screening], 
and NQF #1361: intervention no later than age 6 months 
[for those identified with a HL]; U.S. Department of Health 
and Human Services, 2018; National Quality Forum, 
2018). The ability to calculate key measures allowed for 
more opportunities for improvement through targeted 
technical assistance from CDC.
Conclusions
Because of the limitations of HSFS data, the iEHDI pilot 
study was implemented to explore the feasibility, benefits, 
and challenges surrounding reporting of individual-level 
data from the jurisdictional EHDI programs to CDC. 
Findings of the pilot study demonstrated that reporting 
of individual-level data to CDC is feasible and more in-
depth analyses benefit both CDC and jurisdictional EHDI 
programs. More importantly, it offered an opportunity for 
CDC and jurisdictional EHDI programs to collaborate to 
identify, discuss, and implement procedures to improve the 
quality and usefulness of data in ensuring infants receive 
recommended screening, diagnostic, and EI services. 
In-depth analyses also increased CDC’s understanding 
of each jurisdiction’s EHDI process, making it possible 
to detail EHDI tracking and surveillance efforts and for 
CDC to better understand the gaps and needs of each 
jurisdictional EHDI program. This in turn allows for CDC to 
provide more targeted and relevant technical assistance 
to the jurisdictions. All of the above are not feasible using 
the currently reported HSFS data. Although there were 
challenges in reporting individual-level data, benefits seen 
in this pilot study outweighed the challenges. Lessons 
learned from this iEHDI pilot were used to inform and 
guide current activities and procedures for expanding 
EHDI data collection at CDC. This includes refining data 
definitions and incorporating activities from the pilot study 
into the ten jurisdictional EHDI programs currently funded 
to gather and report individual-level data. 
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Others’ Publications About EHDI: October 2017 through April 2018
The Journal of Early Hearing Detection and Intervention (JEHDI) publishes peer-reviewed articles that describe current 
research, evidence-based practice, and standards of care specifically focused on newborn and early childhood hearing 
screening, diagnosis, support, early intervention, the medical home, information management, financing, and quality 
improvement that contribute to improving Early Hearing Detection and Intervention (EHDI) systems.
 
JEHDI is the only journal that focuses exclusively on improving EHDI systems, but many other journals include
articles relevant to JEHDI’s aim as a part their journal’s broader focus. To help JEHDI readers stay up-to-date about
current research and practices related to improving EHDI programs, we provide titles and abstracts of recent publica-
tions that JEHDI editors think are relevant to improving EHDI programs. Titles of all articles are hyperlinked to the source.
 
Of the 72 articles published in other journals from October 2017 through April 2018, most reported on research conduct-
ed in countries other than the United States. Clearly, EHDI continues to be a global phenomenon. Staying current with 
EHDI’s processes and accomplishments requires staying informed about what is happening in other countries. During 
this time period, the topics most frequently addressed included issues related to the identification or treatment of con-
genital cytomegalovirus (cCMV) and its relation to childhood hearing loss, the genetics of hearing loss, the use of co-
chlear implants, language outcomes for children identified in newborn hearing screening programs, and issues related to 
protocols and procedures used in newborn hearing screening, follow-up, and diagnosis.
Noted below are just some of the interesting findings from around the world.
• Cejas et al. reported that children using cochlear implants perform similarly to hearing peers on measures of 
intelligence, but those with severe comorbidities are at-risk for cognitive deficits. 
• Fitzpatrick et al. in a cross-sectional analysis of 120 children, found that children with unilateral hearing loss 
tended to perform poorer than those in the mild bilateral hearing loss or normal hearing. 
• Grasty et al. followed 348 children who underwent repair of congenital heart disease and found that that the 
prevalence of hearing loss in preschool children after heart surgery in infancy was 20-fold higher than in the 1% 
prevalence seen in the general population.
• Hao et al. demonstrated that newborn hearing genetic screening could be used in conjunction with newborn 
hearing screening to identify four genetic mutations frequently associated with congenital or late-onset hearing 
loss. Genetic mutations were found for 3.01% of the 142,417 neonates screened.
• Rawlinson et al. screened infants for cCMV using PCR of urine and saliva and found ~6% of the large sample of 
children who had failed a newborn hearing screening test were positive for cCMV. In contrast, Vancor et al., found 
only 2 of 171 (1.2%) infants who failed newborn hearing screening had confirmed cCMV based on PCR of saliva.
• Zych et al. reported on 14 years of data from the Polish Universal neonatal Hearing Screening Program.
 




Adebanjo T, Godfred-Cato S, Viens L, Fischer M, Staples JE, Kuhnert-Tallman W, Walke H, Oduyebo T, Polen K, 
Peacock G, Meaney-Delman D, Honein MA, Rasmussen SA, Moore CA Update: Interim Guidance for the Diagnosis, 
Evaluation, and Management of Infants with Possible Congenital Zika Virus Infection - United States, October 2017.
MMWR Morb Mortal Wkly Rep. 2017 Oct 20;66(41):1089-1099. doi: 10.15585/mmwr.mm6641a1.
CDC has updated its interim guidance for U.S. health care providers caring for infants with possible congenital Zika virus 
infection (1) in response to recently published updated guidance for health care providers caring for pregnant women 
with possible Zika virus exposure (2), unknown sensitivity and specificity of currently available diagnostic tests for con-
genital Zika virus infection, and recognition of additional clinical findings associated with congenital Zika virus infection. 
All infants born to mothers with possible Zika virus exposure* during pregnancy should receive a standard evaluation at 
birth and at each subsequent well-child visit including a comprehensive physical examination, age-appropriate vision 
screening and developmental monitoring and screening using validated tools (3-5), and newborn hearing screen at birth, 
preferably using auditory brainstem response (ABR) methodology (6). Specific guidance for laboratory testing and clinical 
evaluation are provided for three clinical scenarios in the setting of possible maternal Zika virus exposure: 1) infants with 
clinical findings consistent with congenital Zika syndrome regardless of maternal testing results, 2) infants without clinical 
2018; 3(1): 67–93
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findings consistent with congenital Zika syndrome who were born to mothers with laboratory evidence of possible Zika 
virus infection,† and 3) infants without clinical findings consistent with congenital Zika syndrome who were born to moth-
ers without laboratory evidence of possible Zika virus infection. Infants in the first two scenarios should receive further 
testing and evaluation for Zika virus, whereas for the third group, further testing and clinical evaluation for Zika virus are 
not recommended. Health care providers should remain alert for abnormal findings (e.g., postnatal-onset microcephaly 
and eye abnormalities without microcephaly) in infants with possible congenital Zika virus exposure without apparent 
abnormalities at birth.
 
Appelbaum EN, Howell JB, Chapman D, Pandya A, Dodson KM.
Analysis of risk factors associated with unilateral hearing loss in children who initially passed newborn hearing screening.
Int J Pediatr Otorhinolaryngol. 2018 Mar;106:100-104. doi: 10.1016/j.ijporl.2018.01.024. Epub 2018 Feb 2.
OBJECTIVE: To analyze 2007 Joint Committee on Infant Hearing (JCIH) risk factors in children with confirmed unilateral 
hearing loss (UHL) who initially passed newborn hearing screening.
METHODS: Retrospective record review of 16,108 infants who passed newborn hearing screening but had one or more 
JCIH risk factors prompting subsequent follow-up through the universal newborn hearing screening (UNHS) program in 
Virginia from 2010 to 2012. The study was reviewed and qualified as exempt by the Virginia Commonwealth University 
Institutional Review Board (IRB) and the Virginia Department of Health.
RESULTS: Over the 2-year study period, 14896 (4.9% of total births) children passed UNHS but had the presence of 
one or more JCIH risk factor. Ultimately, we identified 121 babies from this group with confirmed hearing loss (0.7%), 
with 48 babies (0.2%) showing UHL. The most common risk factors associated with the development of confirmed UHL 
after passing the initial screen were neonatal indicators, craniofacial anomalies, family history, and stigmata of syndrome 
associated with hearing loss.
CONCLUSION: Neonatal indicators and craniofacial anomalies were the categories most often found in children with 
confirmed unilateral hearing loss who initially passed their newborn hearing screen. While neonatal indicators were also 
the most common associated risk factor in all hearing loss, craniofacial abnormalities are relatively more common in 
children with UHL who initially passed newborn hearing screening. Further studies assessing the etiology underlying the 
hearing loss and risk factor associations are warranted.
 
Bianchin G, Tribi L, Formigoni P, Russo C, Polizzi V.
Sequential pediatric bilateral cochlear implantation: The effect of time interval between implants.
Int J Pediatr Otorhinolaryngol. 2017 Nov;102:10-14. doi: 10.1016/j.ijporl.2017.08.025. Epub 2017 Aug 25.
OBJECTIVE: To examine speech intelligibility in children subjected to sequential bilateral cochlear implants (CI) surgery 
and to assess the influence of the inter-stage interval duration.
INTRODUCTION: Binaural hearing recovery can have additional benefits, especially in speech and language devel-
opment in patients with congenital profound sensorineural hearing loss; so recently there has been an increase in the 
number of children receiving bilateral CI.
METHODS: Twenty-seven children who underwent sequential bilateral cochlear implant (SBCI) with a short (1-3 yrs), 
medium (4-6 yrs) and long (7-12 yrs) range interval between both implantations, respectively, were evaluated. All patients 
underwent periodic speech perception test in quiet and noise after second implant activation in three conditions: with the 
first or second implant alone and with both implants. Results were examined according to the inter-stage interval.
 RESULTS: Speech intelligibility in noise was significantly better under bilateral conditions than either ear alone, in all 
three groups. Small improvements were seen in quiet, especially in the third group (6-12 yrs).
CONCLUSION: Benefits of second implant in the early-implanted children and after a short inter-implant delay are more 
evident. However our study support that, even after a long period of deafness and despite a prolonged inter-stage inter-
val, sequential bilateral cochlear implantation should be considered.
LEVEL OF EVIDENCE: Level 4.
DISCUSSION: Prophylactic HIG administration in pregnant women after CMV primary infection seems not to reduce sig-
nificantly the rate of congenital infection, but is safe and it could have a favorable effect on the symptoms and sequelae 
of infected fetuses. The risk of long-term sequelae in fetuses without US abnormalities before HIG is low, so it could be 
an option in infected fetuses with normal imaging. On the other hand, the risk of sequelae among infected fetuses with 
abnormalities in fetal ultrasonography before HIG despite treatment is high.
 
Bostic K, Lewis RM, Chai B, Manganella JL, Barrett DL, Kawai K, Kenna MA, Stiles DJ, Clark T.
Enlarged Vestibular Aqueduct and Cochlear Implants: The Effect of Early Counseling on the Length of Time Between 
Candidacy and Implantation.
Otol Neurotol. 2018 Feb;39(2):e90-e95. doi: 10.1097/MAO.0000000000001663.
OBJECTIVE: To determine if discussing cochlear implantation (CI) with patients with enlarged vestibular aqueducts (EVA) 
and their families before reaching audiological criteria for CI candidacy effects the length of time between reaching audi-
ological candidacy and CI surgery, and to describe the universal newborn hearing screening (UNHS) results and commu-
nication modality in this sample. PATIENTS: Forty-two patients (25 females) with confirmed EVA and cochlear implants.
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INTERVENTION(S): Diagnostic CI visit.
MAIN OUTCOME MEASURES: The primary outcome measure is the difference in length of time between reaching au-
diological candidacy for CI and surgical implantation between those who had preliminary discussions regarding CI with 
their medical and healthcare providers before reaching audiological candidacy versus who had discussions after reach-
ing candidacy. The secondary outcome measure is the result of the UNHS and primary mode of communication used by 
each patient.
RESULTS: Discussing CI before reaching audiological candidacy was associated with a significantly shorter duration be-
tween reaching audiological candidacy and receiving CI (median = 3.1 mo; interquartile range [IQR] = 1.7-5.4) as compared 
with discussing CI after reaching candidacy (median = 5.8 mo; IQR = 3.2-11.2; p = 0.012). Participants born after the imple-
mentation of the UNHS, 16 of 24 patients referred on one or both ears. Communication modalities were evenly divided 
between utilizing sign-support English and oral/aural communicators only.
CONCLUSIONS: Discussion of CI in patients with EVA before reaching audiological candidacy reduces the amount  
of time the child is without adequate auditory access and contributes to a constructive and interactive  
preparatory experience.
 
Bright T, Mulwafu W, Thindwa R, Zuurmond M, Polack S.
Reasons for low uptake of referrals to ear and hearing services for children in Malawi.
PLoS One. 2017 Dec 19;12(12):e0188703. doi: 10.1371/journal.pone.0188703. eCollection 2017.
BACKGROUND: Early detection and appropriate intervention for children with hearing impairment is important for max-
imizing functioning and quality of life. The lack of ear and hearing services in low income countries is a significant chal-
lenge, however, evidence suggests that even where such services are available, and children are referred to them, uptake 
is low. The aim of this study was to assess uptake of and barriers to referrals to ear and hearing services for children in 
Thyolo District, Malawi.
 METHODS: This was a mixed methods study. A survey was conducted with 170 caregivers of children who were re-
ferred for ear and hearing services during community-based screening camps to assess whether they had attended their 
referral and reasons for non-attendance. Semi-structured interviews were conducted with 23 caregivers of children who 
did not take up their referral to explore in-depth the reasons for non-uptake. In addition, 15 stakeholders were inter-
viewed. Thematic analysis of the interview data was conducted and emerging trends were analysed.
RESULTS: Referral uptake was very low with only 5 out of 150 (3%) children attending. Seven main interacting themes 
for non-uptake of referral were identified in the semi-structured interviews: location of the hospital, lack of transport, oth-
er indirect costs of seeking care, fear and uncertainty about the referral hospital, procedural problems within the camps, 
awareness and understanding of hearing loss, and lack of visibility and availability of services.
CONCLUSION: This study has highlighted a range of interacting challenges faced by families in accessing ear and hear-
ing services in this setting. Understanding these context specific barriers to non-uptake of ear and hearing services is 
important for designing appropriate interventions to increase uptake.
LEVEL OF EVIDENCE: 1b. Laryngoscope, 127:S1-S13, 2017.
 
Cejas I, Mitchell CM, Hoffman M, Quittner AL; and the CDaCI Investigative Team.
Comparisons of IQ in Children With and Without Cochlear Implants: Longitudinal Findings and Associations With Lan-
guage.
Ear Hear. 2018 Apr 5. doi: 10.1097/AUD.0000000000000578. [Epub ahead of print]
OBJECTIVES: To make longitudinal comparisons of intelligence quotient (IQ) in children with cochlear implants (CIs) and 
typical hearing peers from early in development to the school-age period. Children with additional comorbidities and CIs 
were also evaluated. To estimate the impact of socioeconomic status and oral language on school-age  
cognitive performance.
DESIGN: This longitudinal study evaluated nonverbal IQ in a multicenter, national sample of 147 children with CIs and 
75 typically hearing peers. IQ was evaluated at baseline, prior to cochlear implantation, using the Bayley Scales of 
Infant and Toddler Development and the Leiter International Performance Scale. School-age IQ was assessed using the 
Wechsler Intelligence Scales for Children. For the current study, only the Perceptual Reasoning and Processing Speed 
indices were administered. Oral language was evaluated using the Comprehensive Assessment of Spoken Language.
RESULTS: Children in the CI group scored within the normal range of intelligence at both time points. However, children 
with additional comorbidities scored significantly worse on the Processing Speed, but not the Perceptual Reasoning 
Index. Maternal education and language were significantly related to school-age IQ in both groups. Importantly, language 
was the strongest predictor of intellectual functioning in both children with CIs and normal hearing.
CONCLUSION: These results suggest that children using cochlear implants perform similarly to hearing peers on 
measures of intelligence, but those with severe comorbidities are at-risk for cognitive deficits. Despite the strong link 
between socioeconomic status and intelligence, this association was no longer significant once spoken language per-
formance was accounted for. These results reveal the important contributions that early intervention programs, which 
emphasize language and parent training, contribute to cognitive functioning in school-age children with CIs. For families 
from economically disadvantaged backgrounds, who are at-risk for suboptimal outcomes, these early intervention pro-
grams are critical to improve overall functioning.
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Chorozoglou M, Mahon M, Pimperton H, Worsfold S, Kennedy CR.
Societal costs of permanent childhood hearing loss at teen age: a cross-sectional cohort follow-up study of universal 
newborn hearing screening.
BMJ Paediatr Open. 2018 Feb 24;2(1):e000228. doi: 10.1136/bmjpo-2017-000228. eCollection 2018.
Objective: To investigate the effects in adolescence of bilateral permanent childhood hearing loss (PCHL) > 40 dB and of 
exposure to universal newborn hearing screening (UNHS) on societal costs accrued over the preceding 12 months.
Design setting participants: An observational cohort study of a sample of 110 adolescents aged 13-20 years, 73 with 
PCHL and 37 in a normally hearing comparison group (HCG) closely similar in respect of place and date of birth to those 
with PCHL, drawn from a 1992-1997 cohort of 157 000 births in Southern England, half of whom had been exposed to a 
UNHS programme.
Intervention: Birth in periods with and without UNHS. Outcome measures: Resource use and costs in the preceding 
12-month period, estimated from interview at a mean age of 16.9 years and review of medical records. Effects on costs 
were examined in regression models.
Results: Mean total costs for participants with PCHL and the HCG were £15 914 and £5883, respectively (difference £10 
031, 95% CI £6460 to £13 603), primarily driven by a difference in educational costs. Compared with the HCG, additional 
mean costs associated with PCHL of moderate, severe and profound severity were £5916, £6605 and £18 437, respec-
tively. The presence of PCHL and an additional medical condition (AMC) increased costs by £15 385 (95% CI £8532 
to £22 238). An increase of one unit in receptive language z-score was associated with £1616 (95% CI £842 to £2389) 
lower costs. Birth during periods of UNHS was not associated with significantly lower overall costs (difference £3594, 
95% CI -£2918 to £10 106).
Conclusions: The societal cost of PCHL was greater with more severe losses and in the presence of AMC and was low-
er in children with superior language scores. There was no statistically significant reduction in costs associated with birth 
in periods with UNHS. Trial registration number: ISRCTN03307358, pre-results.
 
Daub O, Bagatto MP, Johnson AM, Cardy JO.
Language Outcomes in Children Who Are Deaf and Hard of Hearing: The Role of Language Ability Before Hearing Aid 
Intervention.
J Speech Lang Hear Res. 2017 Nov 9;60(11):3310-3320. doi: 10.1044/2017_JSLHR-L-16-0222.
Purpose: Early auditory experiences are fundamental in infant language acquisition. Research consistently demonstrates 
the benefits of early intervention (i.e., hearing aids) to language outcomes in children who are deaf and hard of hearing. 
The nature of these benefits and their relation with prefitting development are, however, not well understood.
Method: This study examined Ontario Infant Hearing Program birth cohorts to explore predictors of performance on the 
Preschool Language Scale-Fourth Edition at the time of (N = 47) and after (N = 19) initial hearing aid intervention.
Results: Regression analyses revealed that, before the hearing aid fitting, severity of hearing loss negatively predicted 
19% and 10% of the variance in auditory comprehension and expressive communication, respectively. After hearing aid 
fitting, children’s standard scores on language measures remained stable, but they made significant improvement in their 
progress values, which represent individual skills acquired on the test, rather than standing relative to same-age peers. 
Magnitude of change in progress values was predicted by a negative interaction of prefitting language ability and severity 
of hearing loss for the Auditory Comprehension scale.
Conclusions: These findings highlight the importance of considering a child’s prefitting language ability in interpreting 
eventual language outcomes. Possible mechanisms of hearing aid benefit are discussed.
Supplemental Materials: https://doi.org/10.23641/asha.5538868.
 
Dejaco D, Aregger FC, Hurth HV, Kegele J, Muigg V, Oberhammer L, Bunk S, Fischer N, Pinggera L, Riedl D, Otie-
no A, Agbenyega T, Adegnika AA, Riechelmann H, Lackner P, Zorowka P, Kremsner P, Schmutzhard.
Evaluation of transient-evoked otoacoustic emissions in a healthy 1 to 10 year pediatric cohort in Sub-Saharan Africa.
Int J Pediatr Otorhinolaryngol. 2017 Oct;101:65-69. doi: 10.1016/j.ijporl.2017.07.029. Epub 2017 Jul 24.
OBJECTIVE: Transient-evoked otoacoustic emissions (TEOAEs) monitor cochlear function. High pass rates have been 
reported for industrialized countries. Pass rates in low and middle income countries such as Sub-Saharan Africa are rare, 
essentially lower and available for children up to 4 years of age and frequently based on hospital recruitments. This study 
aims at providing additional TEOAE pass rates of a healthy Sub-Saharan cohort aged 1-10 years with data from Gabon, 
Ghana and Kenya. Potentially confounding factors (recruitment site, age) are taken into consideration.
METHODS: Healthy children were recruited in hospitals, schools and kindergartens. Inclusion criteria were age 1-10 
years and normal otoscopic findings. Exclusion criteria were any sickness or physical ailment potentially impairing the 
hearing capacity. Five measurements per ear were performed with Capella Cochlear Emission Analyzer (MADSEN, 
Germany). An overall wave reproducibility of above 60% served as pass-criterion. Pass rates were compared between 
recruitment sites and age groups (1-5 and 6-10 years).
RESULTS: Overall pass rate was 87.5% (n = 264; 231 passes vs. 33 fails). Of these 84.0% of hospital recruited children 
passed (n = 156; 131 passes vs. 25 fails), compared to 92.6% of community recruitments (n = 108; 100 passes vs. 8 
fails), which was significantly different p = 0.039). If analyzed by age groups, this difference was only observed in children 
younger than 6 years (p = 0.007).
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CONCLUSION: Hospitals as recruitment sites for healthy controls seem to affect TEOAE pass rates. We advise for a 
cautious approach when recruiting healthy TEOAE control collectives under the age of 6 in a hospital setting. In children 
older than 6 years conventional pure-tone audiometry remains the standard method for hearing screening.
 
Dhondt CMC, Swinnen FKR, Dhooge IJM.
Bilateral cochlear implantation or bimodal listening in the paediatric population: Retrospective analysis of  
decisive criteria.
Int J Pediatr Otorhinolaryngol. 2018 Jan;104:170-177. doi: 10.1016/j.ijporl.2017.10.043. Epub 2017 Nov 7.
INTRODUCTION: In children with bilateral severe to profound hearing loss, bilateral hearing can be achieved by either 
bimodal stimulation (CIHA) or bilateral cochlear implantation (BICI). The aim of this study was to analyse the audiologic 
test protocol that is currently applied to make decisions regarding the bilateral hearing modality in the  
paediatric population.
METHODS: Pre- and postoperative audiologic test results of 21 CIHA, 19 sequential BICI and 12 simultaneous BICI 
children were examined retrospectively.
RESULTS: Deciding between either simultaneous BICI or unilateral implantation was mainly based on the infant’s pre-
operative Auditory Brainstem Response thresholds. Evolution from CIHA to sequential BICI was mainly based on the 
audiometric test results in the contralateral (hearing aid) ear after unilateral cochlear implantation. Preoperative audio-
metric thresholds in the hearing aid ear were significantly better in CIHA versus sequential BICI children (p < 0.001 and 
p = 0.001 in unaided and aided condition, respectively). Decisive values obtained in the hearing aid ear in favour of BICI 
were: An average hearing threshold measured at 0.5, 1, 2 and 4 kHz of at least 93 dB HL without, and at least 52 dB HL 
with hearing aid together with a 40% aided speech recognition score and a 70% aided score on the phoneme discrimi-
nation subtest of the Auditory Speech Sounds Evaluation test battery.
CONCLUSIONS: Although pure tone audiometry offers no information about bimodal benefit, it remains the most ob-
vious audiometric evaluation in the decision process on the mode of bilateral stimulation in the paediatric population. A 
theoretical test protocol for adequate evaluation of bimodal benefit in the paediatric population is proposed.
 
Fitzpatrick EM, Gaboury I, Durieux-Smith A, Coyle D, Whittingham J, Nassrallah F.
Auditory and language outcomes in children with unilateral hearing loss.
Hear Res. 2018 Mar 13. pii: S0378-5955(17)30363-5. doi: 10.1016/j.heares.2018.03.015. [Epub ahead of print]
OBJECTIVES: Children with unilateral hearing loss (UHL) are being diagnosed at younger ages because of newborn 
hearing screening. Historically, they have been considered at risk for difficulties in listening and language development. 
Little information is available on contemporary cohorts of children identified in the early months of life. We examined au-
ditory and language acquisition outcomes in a contemporary cohort of early-identified children with UHL and compared 
their outcomes at preschool age with peers with mild bilateral loss and with normal hearing.
DESIGN: As part of the Mild and Unilateral Hearing Loss in Children Study, we collected auditory and spoken language 
outcomes on children with unilateral, bilateral hearing loss and with normal hearing over a four-year period. This report 
provides a cross-sectional analysis of results at age 48 months. A total of 120 children (38 unilateral and 31 bilateral mild, 
51 normal hearing) were enrolled in the study from 2010 to 2015. Children started the study at varying ages between 12 
and 36 months of age and were followed until age 36-48 months. The median age of identification of hearing loss was 
3.4 months (IQR: 2.0, 5.5) for unilateral and 3.6 months (IQR: 2.7, 5.9) for the mild bilateral group. Families completed 
an intake form at enrolment to provide baseline child and family-related characteristics. Data on amplification fitting and 
use were collected via parent questionnaires at each annual assessment interval. This study involved a range of auditory 
development and language measures. For this report, we focus on the end of follow-up results from two auditory devel-
opment questionnaires and three standardized speech-language assessments. Assessments included in this report were 
completed at a median age of 47.8 months (IQR: 38.8, 48.5). Using ANOVA, we examined auditory and language out-
comes in children with UHL and compared their scores to children with mild bilateral hearing loss and those with  
normal hearing.
RESULTS: On most measures, children with UHL performed poorer than those in the mild bilateral and normal hearing 
study groups. All children with hearing loss performed at lower levels compared to the normal hearing control group. 
However, mean standard scores for the normal hearing group in this study were above normative means for the language 
measures. In particular, children with UHL showed gaps compared to the normal hearing control group in functional 
auditory listening and in receptive and expressive language skills (three quarters of one standard deviation below) at age 
48 months. Their performance in receptive vocabulary and speech production was not significantly different from that of 
their hearing peers.
CONCLUSIONS: Even when identified in the first months of life, children with UHL show a tendency to lag behind their 
normal hearing peers in functional auditory listening and in receptive and expressive language development.
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Forli F, Giuntini G, Ciabotti A, Bruschini L, Löfkvist U, Berrettini S.
How does a bilingual environment affect the results in children with cochlear implants compared to monolingual-matched 
children? An Italian follow-up study.
Int J Pediatr Otorhinolaryngol. 2018 Feb;105:56-62. doi: 10.1016/j.ijporl.2017.12.006. Epub 2017 Dec 8.
OBJECTIVES: To compare the results after cochlear implantation achieved by monolingual and bilingual deaf children 
implanted at our Institution, with the aim of understanding if there are any differences between the two groups and if 
there is a correlation between the outcomes and some patients’ variables.
METHODS: The study group was composed by 14 bilingual deaf children and the control group by the same number 
of monolingual children implanted at our Institution. The control group was obtained by matching to each bilingual child 
a monolingual one with a similar clinical history regarding age at hearing loss diagnosis, age at first hearing-aids fitting 
and age at CI procedure. Children received a speech perception and linguistic development evaluation through specific 
structured tests. The linguistic competence of the patients both in mainstream and native language was determined by 
the Student Oral Language Observation Matrix (SOLOM).
RESULTS: We did not find any statistically significant differences between bilingual and monolingual children in speech 
perception outcomes. Nevertheless, we obtained different results concerning language skills: bilingual implanted children 
scored lower at structured language tests, even if the difference was not statistically relevant. Bilingual children scored 
significantly lower than monolingual ones at the SOLOM scale for linguistic competence.
CONCLUSION: The results reported in the present study show better language skills after cochlear implant in Italian 
monolingual cases than in bilingual ones. This seems to be related to the condition of bilingualism in Italy, mainly related 
to immigration, and frequently associated with low socio-economic levels, poor competence in the mainstream language 
and poor social integration, with a suboptimal exposure to the mainstream language and difficulties in following the reha-
bilitative program.
 
Fowler KB, Boppana SB.
Congenital cytomegalovirus infection.
Semin Perinatol. 2018 Mar 1. pii: S0146-0005(18)30008-9. doi: 10.1053/j.semperi.2018.02.002. [Epub ahead of print]
Each year, thousands of children are born with or develop permanent disabilities such as hearing loss, vision loss, motor 
and cognitive deficits from congenital CMV infection (cCMV). However, awareness of cCMV and its associated sequelae 
is very low in pregnant women and healthcare providers. Both targeted and universal approaches to screen newborns for 
CMV infection are now achievable due to recent scientific advances including the development of a rapid, high-through-
put method for detecting CMV in saliva, the efficacy of antiviral treatment in symptomatic infants, and the demonstration 
of cost effectiveness of CMV screening. Future studies are needed to address gaps in our understanding on the role of 
non-primary maternal CMV infections, the evaluation of antiviral treatment in asymptomatic infants, and the implementa-
tion of prevention strategies for cCMV.
 
Funamura JL.
Evaluation and management of nonsyndromic congenital hearing loss.
Curr Opin Otolaryngol Head Neck Surg. 2017 Oct;25(5):385-389. doi: 10.1097/MOO.0000000000000398.
PURPOSE OF REVIEW: Nonsyndromic congenital hearing loss represents the largest proportion of paediatric sensori-
neural hearing loss. The optimal evaluation and management of affected patients remains clinically challenging. Current 
controversies in the diagnostic work-up of nonsyndromic congenital hearing loss are presented in this review.
RECENT FINDINGS: The improved diagnostic yield of comprehensive genetic testing due to new sequencing technolo-
gies is changing the diagnostic for congenital hearing loss. Concerns for both ionizing radiation and general anaesthetic 
exposure are also driving shifts in imaging modality preferences for infants and toddlers.
SUMMARY: A thoughtful systematic, targeted approach taking into consideration the audiologic phenotype of the pa-
tient is recommended for the work-up of nonsyndromic congenital hearing loss.
 
Ghadersohi S, Ida JB, Bhushan B, Billings KR.
Outcomes of tympanoplasty in children with down syndrome.
Int J Pediatr Otorhinolaryngol. 2017 Dec;103:36-40. doi: 10.1016/j.ijporl.2017.10.004. Epub 2017 Oct 5.
INTRODUCTION: The prevalence of chronic otitis media with effusion (COME), and Eustachian tube dysfunction (ETD) is 
high in Down syndrome (DS) patients. This often necessitates multiple tympanostomy tube (TT) placements resulting in a 
higher rate of persistent tympanic membrane (TM) perforation requiring tympanoplasty for repair.
OBJECTIVES: To assess risk factors for persistent perforation and outcomes of tympanoplasty in DS patients.
METHODS: Retrospective case series of 91 ears in 69 DS patients with TM perforations, who were either observed or 
underwent tympanoplasty. Clinical features, surgical outcomes, and hearing outcomes were assessed.
RESULTS: 91 ears were evaluated. Sixty perforations were observed, and 31 perforations were repaired. The closure 
rate was 54.8% for primary surgery, and 70.9% after secondary surgical interventions in the Tympanoplasty Group, 
compared to 33.0% spontaneous closure rate in the Observation Group (p < 0.001). The only risk factor for failed tympa-
noplasty repair was persistent COME/ETD (OR 27.2, p = 0.001). In the Observation Group perforations diagnosed at an 
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older age, with >3 TT insertions, and with persistent COME/ETD were less likely to close spontaneously. Patients under-
going tympanoplasty had worse preoperative pure tone averages than those being observed, but significant improve-
ment in air-bone gaps were noted in the Tympanoplasty Group (p = 0.02) post-operatively. Patients were often rehabili-
tated with hearing aids regardless of intervention (53.3% Observation Group, 48.4% Tympanoplasty Group).
CONCLUSIONS: Persistent TM perforation in children with Down syndrome was associated with a history of COME/
ETD, and multiple prior TT insertions. Tympanoplasty was successful for repair in most patients who underwent surgical 
intervention, but residual hearing loss was common.
 
Giannattasio A, Di Costanzo P, De Matteis A, Milite P, De Martino D, Bucci L, Augurio MR, Bravaccio C, Ferrara T, 
Capasso L, Raimondi F.
Outcomes of congenital cytomegalovirus disease following maternal primary and non-primary infection.
J Clin Virol. 2017 Nov;96:32-36. doi: 10.1016/j.jcv.2017.09.006. Epub 2017 Sep 14.
BACKGROUND: Natural history and long term prognosis of congenital cytomegalovirus (CMV) disease according to 
maternal primary versus non-primary infection are not clearly documented.
OBJECTIVE: To investigate clinical, laboratory and neuroimaging features at onset and long term outcome of congenital-
ly CMV-infected patients born to mothers with non-primary infection compared with a group of patients born to mothers 
with primary infection.
STUDY DESIGN: Consecutive neonates born from 2002 to 2015 were considered eligible for the study. Patients under-
went clinical, laboratory and instrumental investigation, and audiologic and neurodevelopmental evaluation at diagnosis 
and during the follow up.
RESULTS: A cohort of 158 congenitally infected children was analyzed. Ninety-three were born to mothers with primary 
CMV infection (Group 1) and 65 to mothers with a non-primary infection (Group 2). Eighty-eight infants had a symptom-
atic congenital CMV disease: 49 (46.2%) in Group 1 and 39 (60%) in Group 2. Maternal and demographic characteristics 
of patients of Group 1 and Group 2 were comparable, with the exception of prematurity and a 1-min Apgar score less 
than 7, which were more frequent in Group 2 compared to Group 1. Prevalence of neuroimaging findings did not signifi-
cantly differ between the two groups. An impaired neurodevelopmental outcome was observed in 23.7% of patients of 
Group 1 and in 24.6% cases of Group 2. Similarly, the frequency of hearing loss did not differ between the two groups 
(25.8% versus 26.2%, respectively).
CONCLUSIONS: Neurodevelopmental and hearing sequelae are not affected by the type of maternal CMV infection. 
Preventing strategies should be developed for both primary and non-primary infections.
 
Goh BS, Fadzilah N, Abdullah A, Othman BF, Umat C.
Long-term outcomes of Universiti Kebangsaan Malaysia Cochlear Implant Program among pediatric implantees.
Int J Pediatr Otorhinolaryngol. 2018 Feb;105:27-32. doi: 10.1016/j.ijporl.2017.11.024. Epub 2017 Nov 24.
OBJECTIVES: Cochlear implant (CI) greatly enhances auditory performance as compared to hearing aids and has 
dramatically affected the educational and communication outcomes for profoundly deaf children. Universiti Kebangsaan 
Malaysia (UKM) pioneered CI program in 1995 in the South East Asia. We would like to report the long-term outcomes 
of UKM paediatric cochlear implantation in terms of: the proportion of children who were implanted and still using the 
device, the children’s modes of communication, their educational placements, and their functional auditory/oral perfor-
mance. We also examined the factors that affected the outcomes measured.
STUDY DESIGN: This was a cross sectional observational study. METHODS: Two sets of questionnaires were given to 
126 parents or primary caregivers of the implantees. The first set of questionnaire contained questions to assess the 
children’s usage of CI, their types of education placement, and their modes of communication. The second set of  
questionnaire was the Parent’s Evaluation Of Aural/Oral Performance of Children (PEACH) to evaluate the children’s  
auditory functionality.
RESULTS: Our study showed that among the implantees, 97.6% are still using their CI, 69.8% communicating orally, 
and 58.5% attending mainstream education. For implantees that use oral communication and attend mainstream edu-
cation, their mean age of implantation is 38 months. This is significantly lower compared to the mean age of implanta-
tion of implantees that use non-oral communication and attend non-mainstream education. Simple logistic regression 
analysis shows age of implantation reliably predicts implantees (N = 126) would communicate using oral communication 
with odds ratio of 0.974, and also predict mainstream education (N = 118) with odds ratio of 0.967. The median score of 
PEACH rating scale is 87.5% in quiet, and this significantly correlates with an earlier age of implantation  
(r = -0.235 p = 0.048).
CONCLUSIONS: UKM Cochlear Implant Program has achieved reasonable success among the pediatric implantees, 
with better outcomes seen in those implanted at the age of less than 4 years old.
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Grandpierre V, Fitzpatrick EM, Na E, Mendonca O.
School-aged Children with Mild Bilateral and Unilateral Hearing Loss: Parents’ Reflections on Services, Experiences, and 
Outcomes.
J Deaf Stud Deaf Educ. 2018 Apr 1;23(2):140-147. doi: 10.1093/deafed/enx049.
Following the establishment of newborn hearing screening programs, age of identification and length of time before 
receiving interventions has been reduced for children, including those with milder degrees of hearing loss who were 
previously not identified until school age. This population of early-identified children requires new support programs for 
parents. Although literature is emerging on how parents experience the initial years, there is limited information on sup-
port needs during early school years. The objectives were to gain insights into parents’ experiences with services during 
the early period of identification until early school years, as well as their perceptions of the consequences of hearing loss 
on their child’s overall development. A qualitative research design informed by Interpretive Description was employed. 
Individual semi-structured interviews were conducted with 12 parents of children identified with mild hearing loss. Tran-
scripts were analyzed using a constant comparative method. Four themes emerged from the data: early experiences 
with services and hearing technology, effects of hearing loss on social functioning, effects of hearing loss on language 
and academics, and experiences in early school years. From parents’ perspectives, more support during the early school 
years is needed to help ensure academic success.
 
Grasty MA, Ittenbach RF, Knightly C, Solot CB, Gerdes M, Bernbaum JC, Wernovsky G, Spray TL, Nicolson SC, 
Clancy RR, Licht DJ, Zackai E, Gaynor JW, Burnham NB.
Hearing Loss after Cardiac Surgery in Infancy: An Unintended Consequence of Life-Saving Care.
J Pediatr. 2018 Jan;192:144-151.e1. doi: 10.1016/j.jpeds.2017.09.049.
OBJECTIVES: To investigate the prevalence of hearing loss after cardiac surgery in infancy, patient and operative factors 
associated with hearing loss, and the relationship of hearing loss to neurodevelopmental outcomes.
STUDY DESIGN: Audiologic and neurodevelopmental evaluations were conducted on 348 children who underwent 
repair of congenital heart disease at the Children’s Hospital of Philadelphia as part of a prospective study evaluating 
neurodevelopmental outcomes at 4 years of age. A prevalence estimate was calculated based on presence and type of 
hearing loss. Potential risk factors and the impact of hearing loss on neurodevelopmental outcomes were evaluated.
RESULTS: The prevalence of hearing loss was 21.6% (95% CI, 17.2-25.9). The prevalence of conductive hearing loss, 
sensorineural hearing loss, and indeterminate hearing loss were 12.4% (95% CI, 8.8-16.0), 6.9% (95% CI, 4.1-9.7), and 
2.3% (95% CI, 0.6-4.0), respectively. Only 18 of 348 subjects (5.2%) had screened positive for hearing loss before this 
study and 10 used a hearing aid. After adjusting for patient and operative covariates, younger gestational age, longer 
postoperative duration of stay, and a confirmed genetic anomaly were associated with hearing loss (all P < .01). The pres-
ence of hearing loss was associated with worse language, cognition and attention (P <.01).
CONCLUSIONS: These findings suggest that the prevalence of hearing loss in preschool children after heart surgery in 
infancy may be 20-fold higher than in the 1% prevalence seen in the general population. Younger gestational age, pres-
ence of a genetic anomaly, and longer postoperative duration of stay were associated with hearing loss. Hearing loss 
was associated with worse neurodevelopmental outcomes.
 
Greczka G, Zych M, Wróbel M, Dąbrowski P, Szyfter Harris J, Szyfter W.
Analysis of follow-up at the diagnostic level in the Polish Universal Neonatal Hearing Screening Programme.
J Med Screen. 2018 Mar;25(1):13-16. doi: 10.1177/0969141317695848. Epub 2017 Mar 21.
Objectives Routine analysis showed that between 1 June and 30 November 2014, only 47.6% of expected follow-up 
visits at the diagnostic level were registered in the Polish Universal Neonatal Hearing Screening Programme central data-
base. We attempted to detect and analyse the reasons for this low percentage.
Methods A telephone survey questionnaire was developed for parents whose children had not registered for consulta-
tion at the diagnostic level, or had not received a final diagnosis according to the programme database. Questions aimed 
to verify the database records and compare these with information received from and given to parents. From the 7888 
children not registered at the diagnostic level, 3239 records were randomly selected, i.e. 52.4% of those who had been 
expected to attend.
Results Questions were answered by 1950 parents (60.2% of the selected group). Of these, 52.1% ( n = 734) had at-
tended for diagnostic tests, but this was not recorded in the database. The most common reasons for not attending were 
the long waiting time for the visit (36.09%), lack of referral to a visit (25.9%) and conscious parent decision (16.35%).
Conclusion The telephone survey disclosed omissions in database registration, and that in fact 83.6% of children had 
attended at the diagnostic level.
Hao Z, Fu D, Ming Y, Yang J, Huang Q, Lin W, Zhang H, Zhang B, Zhou A, Hu X, Yao C, Dong Y, Ring HZ, Ring BZ.
Large scale newborn deafness genetic screening of 142,417 neonates in Wuhan, China.
PLoS One. 2018 Apr 10;13(4):e0195740. doi: 10.1371/journal.pone.0195740. eCollection 2018.
Almost one third of the three million people in China suffering severe deafness are children, and 50% of these cases are 
believed to have genetic components to their etiology. Newborn hearing genetic screening can complement Universal 
Neonatal Hearing Screening for the diagnosis of congenital hearing loss as well as identifying children at risk for late-on-
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set and progressive hearing impairment. The aim of this joint academic and Ministry of Health project was to prototype a 
cost effective newborn genetic screen in a community health setting on a city-wide level, and to ascertain the prevalence 
of variation at loci that have been associated with non-syndromic hearing loss. With the participation of 143 local hos-
pitals in the city of Wuhan, China we screened 142,417 neonates born between May 2014 and Dec. 2015. The variants 
GJB2 c.235delC, SLC26A4 c.919-2A>G, and mitochondrial variants m.1555A>G and m.1494C>T were assayed using 
real time PCR. Newborns found to carry a variant were re-assayed by sequencing in duplicate. Within a subset of 707 
newborns we assayed using real-time PCR and ARMS-PCR to compare cost, sensitivity and operating procedure. The 
most frequent hearing loss associated allele detected in this population was the 235delC variant in GJB2 gene. In total, 
4289 (3.01%) newborns were found to carry at least one allele of either GJB2 c.235delC, SLC26A4 c.919-2A>G or two 
assayed MT-RNR1 variants. There was complete accordance between the real-time PCR and the ARMS PCR, though 
the real-time PCR had a much lower failure rate. Real-time PCR had a lower cost and operating time than ARMS PCR. 
Ongoing collaboration with the participating hospitals will determine the specificity and sensitivity of the association of 
the variants with hearing loss at birth and arising in early childhood, allowing an estimation of the benefits of newborn 
hearing genetic screening in a large-scale community setting.
 
He RP, Zheng Y.
[Application of multiple acoustic immittance tests in evaluation of middle ear function in infants].
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Mar 7;53(3):227-231. doi: 10.3760/cma.j.is
sn.1673-0860.2018.03.013.
Evaluation of middle ear function in infants is the key to distinguish sensorineural hearing loss and conductive hearing 
loss, and acoustic immittance test is the routine audiological evaluation of middle ear function.Because of the charac-
teristics of middle ear in infants, middle ear examination parameters of adults are not suitable for infants. This article 
reviewd the current multiple acoustic immittance methods for detecting middle ear function in infants, and summarized 
the advantages and disadvantages of these methods.
 
He X, Li X, Guo Y, Zhao Y, Dong H, Dong J, Zhong L, Shi Z, Zhang Y, Soliman M, Song C, Zhao Z.
Newborn Screening of Genetic Mutations in Common Deafness Genes With Bloodspot-Based Gene Chip Array.
Am J Audiol. 2018 Mar 8;27(1):57-66. doi: 10.1044/2017_AJA-17-0042.
Purpose: This study screens for deafness gene mutations in newborns in the Northwest China population.
Method: The 9 sites of 4 common deafness genes (GJB2, GJB3, SLC26A4, and mt 12S rRNA) were detected by blood-
spot-based gene chip array in 2,500 newborns.
Results: We detected mutations of the 4 genes in 101 (4.04%) newborns; particularly, 0.20% detected the double muta-
tions. In the Hui population, 4.58% of the newborns tested positive for mutations, whereas 4.01% of Han newborns test-
ed positive for mutations. The detective rates are as follows: 1.44% for GJB2 235delC, 1.08% for SLC26A4 IVS7-2A>G, 
0.48% for GJB2 299_300delAT, 0.28% for SLC26A4 2168A>G, 0.2% for mt 12S rRNA 1555A>G, and 0.16% for GJB3 
538C>T. The 31.25% (5/16) of infants with GJB2 235delC, 50% (3/6) with GJB2 299_300delAT, and 25% (3/12) with 
SLC26A4 IVS7-2A>G showed abnormal hearing when tested; only 1 double mutation case received the hearing test, and 
this infant showed abnormality in both ears on the hearing test.
Conclusions: High mutation rates in the common deafness genes were detected in newborns in Northwest China. Our 
study is helpful in understanding the deafness genomic epidemiology and also provides evidence for prenatal and post-
natal care as well as policy making on population health in the region.
 
Hrnčić N.
Identification of risk factors for hearing impairment in newborns: a hospital based study.
Med Glas (Zenica). 2018 Feb 1;15(1):29-36. doi: 10.17392/943-18.
Aim To identify risk factors for hearing impairment presented in neonates born in Cantonal Hospital Zenica (CHZ) and to 
estimate their influence on outcome of hearing tests in Newborn Hearing Screening (NHS).
Methods Retrospective-prospective study was done at the Department of Gynaecology and Maternity. The NHS was 
performed with transitory evoked otoacoustic emissions (TEOAE) during a six-month period using “Titan” device (Inter-
acoustics, Denmark). The questionnaire was written for the purpose of getting more structured basic information about 
every newborn and to identify risk factors for hearing impairment. Chi-square test was used to investigate the difference 
between experimental and control group refer incidence.
Results A total of 1217 newborns was screened for hearing impairment of which 259 (21.28%) with one or more known 
risk factors for hearing impairment. The following risk factors for hearing impairment were identified during the study 
period: family history of permanent childhood hearing impairment in 42 (3.45%) newborns, prematurity in 39 (3.21%), low 
APGAR scores in 29 (2.40%), asphyxia in 31 (2.55%), hyperbilirubinemia in 41 (3.37%), admission of ototoxic medication 
(aminoglycosides) after birth in 155 (12.74%).
Conclusion There were many serious risk factors for hearing loss identified in this study. Identification of risk factors for 
hearing impairment in neonates is necessary because a follow up of the children with risk factors is very important.
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Huang MP, Sheng HB, Ren Y, Li Y, Huang ZW, Wu H.
[Effects of bimodal intervention on the development of auditory and speech ability in infants with unilateral cochlear 
implantation].
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Mar 7;53(3):203-208. doi: 10.3760/cma.j.is
sn.1673-0860.2018.03.007.
Objective: To explore the effects of bimodal intervention on the development of auditory and speech ability in the infants 
with unilateral cochlear implantation(CI).
Methods: Total 35 bilateral profound sensorineural hearing loss infants with unilateral CI, aged 0.7 to 2.8 years old, were 
selected. The subjects were divided into two groups: the group with unilateral CI(cochlear implant alone, n= 15), and the 
bimodal group with CI and contralateral fitting hearing aid(n= 20). Their auditory and speech abilities were estimated at 
the different time points after switch-on(the 0th, 0.5th, 1st, 3rd, 6th, 12th, 18th, and 24th month, respectively) using Infant 
Toddler-Meaningful Auditory Integration Scale(IT-MAIS), Meaningful Use of Speech Scale(MUSS), Categories of Auditory 
Performance(CAP), and Speech Intelligibility Rating(SIR) scores.
Results: The IT-MAIS scores of bimodal group after switch-on were higher than unilateral CI group(the 0.5th, 1st, 3rd, 
6th, 12th, and 18th month), the statistical significances were identified at the 0.5th, 1st, 3rd, 6th, and 12th month, re-
spectively(P<0.05). The CAP scores of bimodal group before CI operation and after switch-on(the 0.5th, 1st, 3rd, 6th, 
12th, 18th and 24th month)were higher than unilateral CI group, the statistical significances were seen at the 3rd, 6th, 
12th, 18th and 24th month after switch-on(P<0.05). The MUSS scores of bimodal group after switch-on were higher than 
unilateral CI group(the 1st, 3rd, 6th, 12th, 18th and 24th month), the statistical significances were found at the 12th, 18th 
and 24th month, respectively(P<0.05). The SIR scores of bimodal group after switch-on were higher than unilateral CI 
group(the 3rd, 6th, 12th, 18th and 24th month), and significant differences appeared at the 12th, 18th and 24th month 
after switch-on(P<0.05).
Conclusion: Bimodal intervention could be helpful to the development of auditory and speech ability of infants.
 
Huang S, Huang B, Wang G, Kang DY, Zhang X, Meng X, Dai P.
The relationship between the GJB3 c.538C>T variant and hearing phenotype in the Chinese population.
Int J Pediatr Otorhinolaryngol. 2017 Nov;102:67-70. doi: 10.1016/j.ijporl.2017.09.001. Epub 2017 Sep 7.
BACKGROUND: Mutations in GJB3 were originally shown to underlie an autosomal dominant form of non-syndromic 
deafness in Chinese patients and the c.538C>T (p.R180*) variants caused high-frequency hearing loss. But after that, 
few reports have reported this mutation. This study investigated the relationship between the GJB3 c.538C>T variant 
and hearing phenotype in Chinese to assist with risk assessment and genetic counseling for hearing loss patients and 
their families.
METHOD: The study enrolled 5700 patients with hearing loss and 4600 normal subjects. Deafness gene mutations 
were distinguished using a gene chip. The GJB3 c.538C>T variant rate was calculated from the results. RESULT: Of the 
5700 patients, 23 (0.40%) carried a GJB3 c.538C>T heterozygous variant; of these, 11 patients had other gene (GJB2/
SLC26A4) mutations simultaneously. Most patients had moderate to profound hearing loss. All 23 patients were sporadic 
cases and had no family history of deafness. Of the 4600 normal individuals, 11 (0.24%) had GJB3 c.538C>T heterozy-
gous variant. There was no statistical difference in incidence between the two groups.
CONCLUSIONS: Our results showed that the GJB3 c.538C>T variant has a very low incidence in the Chinese popula-
tion, and there was no clear evidence to support a role of the GJB3 c.538C>T variant in the autosomal dominant form 
of non-syndromic deafness. Our findings suggested that GJB3 c.538C>T does not contribute to hearing loss, and this 
conclusion will assist with genetic counseling and risk prediction for deafness related to the GJB3 c.538C>T variant.
 
Johnson LC, Toro M, Vishnja E, Berish A, Mills B, Lu Z, Lieberman E.
Age and Other Factors Affecting the Outcome of AABR Screening in Neonates.
Hosp Pediatr. 2018 Mar;8(3):141-147. doi: 10.1542/hpeds.2017-0060.
BACKGROUND: Although the utility of universal newborn hearing screening is undisputed, testing protocols vary. In 
particular, the impact of the infant’s age at the time of automated auditory brainstem response (AABR) screening has not 
been well studied.
METHODS: We conducted a retrospective review of newborn hearing screening data in 6817 low-risk, term and late-
preterm newborns at our large, urban, academic medical center for a 1-year period to analyze the impact of age and 
other factors on the screening failure rate and referral for diagnostic testing.
RESULTS: AABR screening failure rates decreased with postnatal age over the first 48 hours; 13.3% failed at <24 hours 
versus 3.8% at ≥48 hours (P < .0001). Infants who were initially tested at ≥36 hours failed repeat testing more often than 
those who were tested at <36 hours (11.5% vs 18.9%; P = .03). Other factors that were associated with failure included 
being a boy and of a race other than white. Sensorineural hearing loss (SNHL) was diagnosed in 18.6% of infants who 
failed their final screening at ≥48 hours compared with 2.8% of those whose final screening occurred earlier (P = .03). 
SNHL was more likely in infants who failed their first screening bilaterally (21.2%) than unilaterally (4.4%); P = .03).
CONCLUSIONS: Among healthy newborns, delaying AABR screening in the first 48 hours minimized failure rates. SNHL 
was 6 times as likely in infants who failed their final screening at ≥48 hours compared with those who were screened at 
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<48 hours of age. In our study, we offer guidance for nursery directors and audiologists who determine hearing screening 
protocols and counsel families about results.
Conflict of interest statement: POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no poten-
tial conflicts of interest to disclose.
 
Kaspar A, Newton O, Kei J, Driscoll C, Swanepoel W, Goulios H.
Parental knowledge and attitudes to childhood hearing loss and hearing services in the Solomon Islands.
Int J Pediatr Otorhinolaryngol. 2017 Dec;103:87-92. doi: 10.1016/j.ijporl.2017.10.003. Epub 2017 Oct 5.
OBJECTIVE: An understanding of parental knowledge and attitudes towards childhood hearing loss is essential to the 
successful implementation of audiology services. The present study aimed to investigate parental knowledge and atti-
tudes among parents in the Solomon Islands.
METHODS AND MATERIALS: A total of 100 mothers and 50 fathers were administered a questionnaire via semi-struc-
tured interviews.
RESULTS: Highest parental awareness of aetiology of childhood hearing loss was noted for otitis media (94%), noise 
exposure (87.3%), and family history (72.7%). The highest parental awareness concerning public health initiatives to 
reduce/prevent otitis media was noted for routine childhood immunizations (84%) and breast-feeding (76%). Higher rates 
of knowledge in fathers than in mothers included otitis media (p = 0.038), noise exposure (p = 0.007), and breast-feeding 
(p = 0.031). Approximately half of parents (56%) agreed that curses may cause hearing loss. Overall parental responses 
showed positive support for infant hearing screening programs (96%) and school-based ear and hearing health examina-
tions (99.3%).
CONCLUSIONS: High levels of parental readiness and support for childhood hearing services in the Solomon Islands 
was evident. Knowledge of aetiology of childhood hearing loss was highest for otitis media, noise exposure, and family 
history. Knowledge and attitudes of fathers to childhood hearing loss and hearing services was either the same or better 
than that of mothers.
 
Keilmann A, Friese B, Lässig A, Hoffmann V.
Validation of the second version of the LittlEARS® Early Speech Production Questionnaire (LEESPQ) in German-speak-
ing children with normal hearing.
Eur Arch Otorhinolaryngol. 2018 Apr;275(4):883-888. doi: 10.1007/s00405-018-4889-4. Epub 2018 Feb 7.
INTRODUCTION: The introduction of neonatal hearing screening and the increasingly early age at which children can 
receive a cochlear implant has intensified the need for a validated questionnaire to assess the speech production of 
children aged 0‒18. Such a questionnaire has been created, the LittlEARS® Early Speech Production Questionnaire 
(LEESPQ). This study aimed to validate a second, revised edition of the LEESPQ.
METHODS AND MATERIALS: Questionnaires were returned for 362 children with normal hearing. Completed question-
naires were analysed to determine if the LEESPQ is reliable, prognostically accurate, internally consistent, and if gender 
or multilingualism affects total scores.
RESULTS: Total scores correlated positively with age. The LEESPQ is reliable, accurate, and consistent, and indepen-
dent of gender or lingual status. A norm curve was created. DISCUSSION: This second version of the LEESPQ is a valid 
tool to assess the speech production development of children with normal hearing, aged 0‒18, regardless of their gender. 
As such, the LEESPQ may be a useful tool to monitor the development of paediatric hearing device users.
CONCLUSION: The second version of the LEESPQ is a valid instrument for assessing early speech production of chil-
dren aged 0‒18 months.
 
Kim SY, Choi BY, Jung EY, Park H, Yoo HN, Park KH.
Risk factors for failure in the newborn hearing screen test in very preterm twins.
Pediatr Neonatol. 2018 Jan 31. pii: S1875-9572(17)30122-5. doi: 10.1016/j.pedneo.2018.01.014. [Epub ahead of print]
BACKGROUND: We aimed to identify prenatal and postnatal risk factors associated with abnormal newborn hearing 
screen (NHS) results and subsequently confirmed sensorineural hearing loss (SNHL) in preterm twin neonates.
METHODS: Electronic medical records of 159 twin neonates who were born alive after ≤32 weeks were retrospective-
ly reviewed for hearing loss in both ears. Histopathologic examination of the placenta was performed and clinical data, 
including method of conception and factors specific to twins, were retrieved from a computerized perinatal database. The 
main outcome measure was failure to pass the NHS test. The generalized estimation equations model was used for twins.
RESULTS: Thirty-two neonates (20.1%) had a “refer” result, and, on the confirmation test, permanent SNHL was iden-
tified in 4.4% (7/159) of all neonates. Neonates who had a “refer” result on the NHS test were more likely to be of lower 
birth weight, more likely to have been conceived with the use of in vitro fertilization (IVF), and more likely to have high-
er rates of intraventricular hemorrhage (IVH) and bronchopulmonary dysplasia. However, monochorionic placentation, 
death of the co-twin, or being born first was not associated with a “refer” result on the NHS test. Multivariable logistic 
regression revealed that conception after IVF and the presence of IVH were the only variables to be statistically signifi-
cantly associated with “refer” on the NHS test. No parameters studied were found to be significantly different between 
the SNHL and no SNHL groups, probably because of the relatively small number of cases of SNHL. CONCLUSION: In 
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preterm twin newborns, IVF and the presence of IVH were independently associated with an increased risk of abnormal 
NHS results, whereas the factors specific to twins were not associated with abnormal NHS results.
 
Konukseven O, Kaya S, Genc A, Muluk NB, Basar FS, Kirkim G, Tuncer U, Karatas E, Topcu C, Bolat H, Dincol I.
Regional differences of Turkey in risk factors of newborn hearing loss.
Int J Pediatr Otorhinolaryngol. 2017 Nov;102:49-55. doi: 10.1016/j.ijporl.2017.08.028. Epub 2017 Sep 1.
OBJECTIVE: The aim of this study was to discover Turkish regional differences in the risk factors of newborn hearing 
loss.
METHOD: A multi-centered retrospective design was used. A total of 443 children, registered to the national newborn 
hearing screening programme, with bilateral hearing loss, from five different regions of Turkey, were evaluated in terms 
of the types of hearing loss, the degree of hearing loss, the types of risk factors, parental consanguinity, age at diagnosis 
and age of auditory intervention, respectively.
RESULTS: There was no significant difference in the prevalence of hearing loss between regions (χ2 = 3.210, P = 0.523). 
Symmetric Sensorineural Hearing Loss (SSHL) was the most common type of HL in all regions (91.8%). Profound HL 
was the most common degree of HL in all regions (46.2%). There were statistically significant differences between 
regions in terms of types of HL (χ2 = 14.151, P = 0.000). As a total, 323 (72.9%) of subjects did not have any risk fac-
tors. There were statistically significant differences between regions in terms of the types of risk factors (pre, peri and 
post-natal) for SSNHL (χ2 = 16.095, P = 0.000). For all regions, the age of diagnosis was convenient with the JCIH 
criteria. However the age of hearing aid application was prolonged in some regions. There were statistically significant 
differences between regions in terms of the age of diagnosis (χ2 = 93.570, P = 0.000) and the age of auditory intervention 
(χ2 = 47.323, P = 0.000). The confounding effects of gender, age of diagnosis, age of hearing aids applications, HL in the 
family, types of risk factors for HL on SSNHL were detected. CONCLUSION: To reach the goal of a high quality newborn 
hearing screening, there is a need to develop an evidence-based standard for follow up guideline. In addition, risk factors 
should be re-evaluated according to regional differences and all regions should take their own precautions according to 
their evidence based data.
 
Kosaner J, Van Dun B, Yigit O, Gultekin M, Bayguzina S.
Clinically recorded cortical auditory evoked potentials from paediatric cochlear implant users fitted with electrically elicit-
ed stapedius reflex thresholds.
Int J Pediatr Otorhinolaryngol. 2018 May;108:100-112. doi: 10.1016/j.ijporl.2018.02.033. Epub 2018 Feb 24.
OBJECTIVES: This study aimed to objectively evaluate access to soft sounds (55 dB SPL) in paediatric CI users, all 
wearing MED-EL (Innsbruck, Austria) devices who were fitted with the objective electrically elicited stapedius reflex 
threshold (eSRT) fitting method, to track their cortical auditory evoked potential (CAEP) presence and latency, and to 
compare their CAEPs to those of normal-hearing peers.
METHODS: Forty-five unilaterally implanted, pre-lingually deafened MED-EL CI users, aged 12-48 months, underwent 
CAEP testing in the clinic at regular monthly intervals post switch-on. CAEPs were recorded in response to short speech 
tokens /m/, /g/ and /t/ presented in the free field at 55 dB SPL. Twenty children with normal hearing (NH), similarly aged, 
underwent CAEP testing once.
RESULTS: The proportion of present CAEPs increased and CAEP P1 latencies reduced significantly with post-im-
plantation duration. CAEPs were scored based on their presence and age-appropriate P1 latency. These CAEP scores 
increased significantly with post-implantation duration. CAEP scores were significantly worse for the /m/ speech token 
compared to the other two tokens. Compared to the NH group, CAEP scores were significantly smaller for all post-im-
plantation test intervals.
CONCLUSIONS: This study provides clinicians with a first step towards typical ranges of CAEP presence, latency, and 
derived CAEP score over the first months of MED-EL CI use. CAEPs within these typical ranges could validate inter-
vention whereas less than optimum CAEPs could prompt clinicians to seek solutions in a timely manner. CAEPs could 
clinically validate whether a CI provides adequate access to soft sounds. This approach could form an alternative to 
behavioural soft sound access verification.
 
Lam MYY, Wong ECM, Law CW, Lee HHL, McPherson B.
Maternal knowledge and attitudes to universal newborn hearing screening: Reviewing an established program.
Int J Pediatr Otorhinolaryngol. 2018 Feb;105:146-153. doi: 10.1016/j.ijporl.2017.12.021. Epub 2017 Dec 23.
OBJECTIVES: To facilitate early diagnosis of infants with hearing loss, a universal newborn hearing screening program 
(UNHS) has been implemented in Hong Kong’s public hospitals for over a decade. However, there have been no known 
studies investigating parent attitudes to, and satisfaction with, UNHS since its launch in Hong Kong. The present study 
aimed to investigate knowledge of UNHS as well as infant hearing development, and attitudes and satisfaction with 
UNHS, in Hong Kong mothers with newborns. The study was designed to help evaluate and improve an established 
UNHS public hospital program, based on the perspectives of service users.
METHODS: A researcher-developed questionnaire was administered to 102 mothers whose newborn had received 
UNHS in the postnatal wards of a large public hospital in Hong Kong. The questionnaire considered parental knowledge 
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of UNHS and infant hearing development, attitudes and satisfaction toward public hospital UNHS. In the knowledge 
dimension, parents’ preferred time and location for pre-test information delivery, interpretation of screening results, and 
knowledge of hearing developmental milestones were surveyed. In addition, maternal attitudes to and satisfaction with 
UNHS screening services, the potential impact of UNHS on parent emotions and parent-baby bonding, attitudes toward 
informed consent, and willingness to comply with diagnostic assessment referral were also be surveyed.
RESULTS: Mean participant scores on knowledge of infant hearing development were relatively low (M = 2.59/6.0, 
SD = 0.90). Many mothers also underestimated the potential ongoing risks of hearing impairment in babies. Around 80% 
of mothers thought an infant could not have hearing impairment after passing the screening. In addition, one-third of 
mothers thought a baby could not later develop hearing impairment in infancy or childhood. In terms of attitudes and 
satisfaction, participants gave somewhat negative ratings for questions regarding receiving sufficient information about 
the screening (M = 2.90/5.0, SD = 1.27), screening procedure (M = 2.20/5.0, SD = 1.08), and sufficiency of information 
about results (M = 2.87/5.0, SD = 1.14). Nonetheless, participants gave positive ratings concerning whether screening 
could lead to early diagnosis (M = 4.61/5.0, SD = 0.57) and over 95% of mothers supported UNHS despite potential 
for false positive results. Mothers reported a high willingness to bring their baby to follow-up assessments if required 
(M = 4.53/5.0, SD = 0.56). Participants gave positive ratings for their level of satisfaction with the time and location of 
first UNHS information provision (M = 4.34/5.0, SD = 0.80) and the way permission was asked for screening the baby 
(M = 4.04/5.0, SD = 0.97) but alternative procedures were also recommended. Most recommendations focused on pro-
viding more information about the test and a more detailed explanation of screening results.
CONCLUSIONS: The survey results highlighted the need to provide more information to parents about infant hearing 
development to support home monitoring for signs of hearing loss after UNHS, as well as more detailed explanation and 
information regarding hearing screening and the implications of results to parents. Regardless of location, surveys of this 
type may provide valuable support for UNHS program quality assurance.
 
Lanzieri TM, Chung W, Leung J, Caviness AC, Baumgardner JL, Blum P, Bialek SR, Demmler-Harrison G; Congen-
ital Cytomegalovirus Longitudinal Study Group.
Hearing Trajectory in Children with Congenital Cytomegalovirus Infection.
Otolaryngol Head Neck Surg. 2018 Apr;158(4):736-744. doi: 10.1177/0194599818758247. Epub 2018 Mar 20.
Objectives To compare hearing trajectories among children with symptomatic and asymptomatic congenital cytomeg-
alovirus infection through age 18 years and to identify brain abnormalities associated with sensorineural hearing loss 
(SNHL) in asymptomatic case patients.
Study Design Longitudinal prospective cohort study.
Setting Tertiary medical center.
Subjects and Methods The study included 96 case patients (4 symptomatic and 92 asymptomatic) identified through 
hospital-based newborn cytomegalovirus screening from 1982 to 1992 and 72 symptomatic case patients identified 
through referrals from 1993 to 2005. We used growth curve modeling to analyze hearing thresholds (0.5-8 kHz) by ear 
with increasing age and Cox regression to determine abnormal findings on head computed tomography scan associated 
with SNHL (hearing threshold ≥25 dB in any audiometric frequency) among asymptomatic case patients.
Results Fifty-six (74%) symptomatic and 20 (22%) asymptomatic case patients had SNHL: congenital/early-onset SNHL 
was diagnosed in 78 (51%) and 10 (5%) ears, respectively, and delayed-onset SNHL in 25 (17%) and 20 (11%) ears; 49 
(32%) and 154 (84%) ears had normal hearing. In affected ears, all frequency-specific hearing thresholds worsened with 
age. Congenital/early-onset SNHL was significantly worse (severe-profound range, >70 dB) than delayed-onset SNHL 
(mild-moderate range, 26-55 db). Frequency-specific hearing thresholds were significantly different between symptom-
atic and asymptomatic case patients at 0.5 to 1 kHz but not at higher frequencies (2-8 kHz). Among asymptomatic case 
patients, white matter lucency was significantly associated with SNHL by age 5 years (hazard ratio, 4.4; 95% CI, 1.3-
15.6).
Conclusion Congenital/early-onset SNHL frequently resulted in severe to profound loss in symptomatic and asymptom-
atic case patients. White matter lucency in asymptomatic case patients was significantly associated with SNHL by age 5 
years.
 
Lim CH, Lim JH, Kim D, Choi HS, Lee DH, Kim DK.
Bony cochlear nerve canal stenosis in pediatric unilateral sensorineural hearing loss.
Int J Pediatr Otorhinolaryngol. 2018 Mar;106:72-74. doi: 10.1016/j.ijporl.2018.01.015. Epub 2018 Feb 2.
OBJECTIVES: This study was performed to evaluate the frequency of bony cochlear nerve canal (BCNC) stenosis and 
its clinical significance in pediatric patients with unilateral sensorineural hearing loss (SNHL) of unknown etiology.
MATERIALS AND METHODS: We analyzed the medical records and temporal bone computed tomography (CT) results 
of patients less than 13 years of age with a diagnosis of unilateral SNHL of unknown etiology between July 2007 and 
July 2017. We compared the BCNC diameter between both sides and analyzed the age at diagnosis, degree of hearing 
loss, and accompanying inner ear anomalies.
RESULTS: In 42 patients, the mean age at diagnosis was 7.4 ± 3.6 years, and the average hearing level in the affect-
ed ear was 87.9 ± 20.0 dB HL (decibels hearing level). The average diameter of the BCNC was 1.22 ± 0.75 mm on the 
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affected side and 1.96 ± 0.52 mm on the normal side. The most suitable criterion for BCNC stenosis appeared to be a 
diameter of 1.2 mm by the recursive partitioning procedure. With application of this criterion, the rate of BCNC stenosis 
was significantly greater on the affected side than on the normal side (52.4% vs. 4.8%, respectively; P < 0.05). A narrow 
internal acoustic canal was found in two patients, and vestibular and cochlear anomalies were found in three patients 
each.
CONCLUSIONS: Our results suggest that it is reasonable to set a diameter of 1.2 mm as a cutoff for BCNC stenosis, 
and also that BCNC stenosis is a common cause of unilateral SNHL of unknown etiology in childhood.
 
Lopez AS, Lanzieri TM, Claussen AH, Vinson SS, Turcich MR, Iovino IR, Voigt RG, Caviness AC, Miller JA, William-
son WD, Hales CM, Bialek SR, Demmler-Harrison G; Congenital Cytomegalovirus Longitudinal Study Group.
Intelligence and Academic Achievement With Asymptomatic Congenital Cytomegalovirus Infection.
Pediatrics. 2017 Nov;140(5). pii: e20171517. doi: 10.1542/peds.2017-1517.
OBJECTIVES: To examine intelligence, language, and academic achievement through 18 years of age among children 
with congenital cytomegalovirus infection identified through hospital-based newborn screening who were asymptomatic 
at birth compared with uninfected infants.
METHODS: We used growth curve modeling to analyze trends in IQ (full-scale, verbal, and nonverbal intelligence), re-
ceptive and expressive vocabulary, and academic achievement in math and reading. Separate models were fit for each 
outcome, modeling the change in overall scores with increasing age for patients with normal hearing (n = 78) or with 
sensorineural hearing loss (SNHL) diagnosed by 2 years of age (n = 11) and controls (n = 40).
RESULTS: Patients with SNHL had full-scale intelligence and receptive vocabulary scores that were 7.0 and 13.1 points 
lower, respectively, compared with controls, but no significant differences were noted in these scores among patients 
with normal hearing and controls. No significant differences were noted in scores for verbal and nonverbal intelligence, 
expressive vocabulary, and academic achievement in math and reading among patients with normal hearing or with 
SNHL and controls.
CONCLUSIONS: Infants with asymptomatic congenital cytomegalovirus infection identified through newborn screening 
with normal hearing by age 2 years do not appear to have differences in IQ, vocabulary or academic achievement scores 
during childhood, or adolescence compared with uninfected children.
Copyright © 2017 by the American Academy of Pediatrics.
DOI: 10.1542/peds.2017-1517 PMCID: PMC5654402 [Available on 2018-05-01] PMID: 29066580  [Indexed for MEDLINE]
Conflict of interest statement: POTENTIAL CONFLICT OF INTEREST: Dr Demmler-Harrison’s institution has received 
funding from Merck Sharpe & Dohme Corporation since July 2016 to assist with salary support for further analysis on 
long-term outcomes of congenital cytomegalovirus infection not included in this report; the other authors have indicated 
they have no potential conflicts of interest to disclose.
 
Lu X, Qin Z.
Auditory and language development in Mandarin-speaking children after cochlear implantation.
Int J Pediatr Otorhinolaryngol. 2018 Apr;107:183-189. doi: 10.1016/j.ijporl.2018.02.006. Epub 2018 Feb 7.
OBJECTIVE: To evaluate early auditory performance, speech perception and language skills in Mandarin-speaking pre-
lingual deaf children in the first two years after they received a cochlear implant (CI) and analyse the effects of possible 
associated factors.
METHODS: The Infant-Toddler Meaningful Auditory Integration Scale (ITMAIS)/Meaningful Auditory Integration Scale 
(MAIS), Mandarin Early Speech Perception (MESP) test and Putonghua Communicative Development Inventory (PCDI) 
were used to assess auditory and language outcomes in 132 Mandarin-speaking children pre- and post-implantation.
RESULTS: Children with CIs exhibited an ITMAIS/MAIS and PCDI developmental trajectory similar to that of children 
with normal hearing. The increased number of participants who achieved MESP categories 1-6 at each test interval 
showed a significant improvement in speech perception by paediatric CI recipients. Age at implantation and socioeco-
nomic status were consistently associated with both auditory and language outcomes in the first two years post-implan-
tation.
CONCLUSION: Mandarin-speaking children with CIs exhibit significant improvements in early auditory and language 
development. Though these improvements followed the normative developmental trajectories, they still exhibited a gap 
compared with normative values. Earlier implantation and higher socioeconomic status are consistent predictors of 
greater auditory and language skills in the early stage.
 
Maas RR, Iwanicka-Pronicka K, Kalkan Ucar S, Alhaddad B, AlSayed M, Al-Owain MA, Al-Zaidan HI, Balasubra-
maniam S, Barić I, Bubshait DK, Burlina A, Christodoulou J, Chung WK, Colombo R, Darin N, Freisinger, Garcia 
Silva MT, Grunewald S, Haack TB, van Hasselt PM, Hikmat O, Hörster F, Isohanni P, Ramzan K, Kovacs-Nagy R, 
Krumina Z, Martin-Hernandez E, Mayr JA, McClean P, De Meirleir L, Naess K, Ngu LH, Pajdowska M, Rahman S, 
Riordan G, Riley L, Roeben B, Rutsch F, Santer R, Schiff M, Seders M, Sequeira S, Sperl W, Staufner C, Synofzik 
M, Taylor RW, Trubicka J, Tsiakas K, Unal, Wassmer E, Wedatilake Y, Wolff T, Prokisch H, Morava E, Pronicka E, 
Wevers RA, de Brouwer AP, Wortmann SB.
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Progressive deafness-dystonia due to SERAC1 mutations: A study of 67 cases.
Ann Neurol. 2017 Dec;82(6):1004-1015. doi: 10.1002/ana.25110.
OBJECTIVE: 3-Methylglutaconic aciduria, dystonia-deafness, hepatopathy, encephalopathy, Leigh-like syndrome (MEG-
DHEL) syndrome is caused by biallelic variants in SERAC1.
METHODS: This multicenter study addressed the course of disease for each organ system. Metabolic, neuroradiologi-
cal, and genetic findings are reported.
RESULTS: Sixty-seven individuals (39 previously unreported) from 59 families were included (age range = 5 days-33.4 
years, median age = 9 years). A total of 41 different SERAC1 variants were identified, including 20 that have not been 
reported before. With the exception of 2 families with a milder phenotype, all affected individuals showed a strikingly 
homogeneous phenotype and time course. Severe, reversible neonatal liver dysfunction and hypoglycemia were seen in 
>40% of all cases. Starting at a median age of 6 months, muscular hypotonia (91%) was seen, followed by progressive 
spasticity (82%, median onset = 15 months) and dystonia (82%, 18 months). The majority of affected individuals never 
learned to walk (68%). Seventy-nine percent suffered hearing loss, 58% never learned to speak, and nearly all had sig-
nificant intellectual disability (88%). Magnetic resonance imaging features were accordingly homogenous, with bilateral 
basal ganglia involvement (98%); the characteristic “putaminal eye” was seen in 53%. The urinary marker 3-methylglu-
taconic aciduria was present in virtually all patients (98%). Supportive treatment focused on spasticity and drooling, and 
was effective in the individuals treated; hearing aids or cochlear implants did not improve communication skills.
INTERPRETATION: MEGDHEL syndrome is a progressive deafness-dystonia syndrome with frequent and reversible 
neonatal liver involvement and a strikingly homogenous course of disease. Ann Neurol 2017;82:1004-1015.
 
Mallen JR, Hunter JB, Auerbach C, Wexler L, Vambutas A.
Characterization of newborn hearing screening failures in multigestational births.
Int J Pediatr Otorhinolaryngol. 2018 Feb;105:158-162. doi: 10.1016/j.ijporl.2017.12.017. Epub 2017 Dec 15.
OBJECTIVE: To define the rate and characterize the type of newborn hearing screening failures in multigestational births.
METHODS: Retrospective chart review of all multigestational births that occurred in a 10-year period (2002-2012) in 
which at least one newborn failed newborn hearing screening at two tertiary care hospitals in the Northwell Health Sys-
tem.
RESULTS: Out of 125,405 total births, we identified 2961 multigestational births, of which 59 (2.0%) newborns failed 
newborn hearing screening. None of their 66 twin/triplet siblings failed their newborn hearing screens. Of 43 newborns 
that returned for follow-up, 56.0% (24/43) had confirmed hearing loss, resulting in an overall rate of 0.81% in all mul-
tigestational newborns with hearing loss. Of 19 infants that passed repeat testing, two were judged to need myringotomy 
tube placement. Twenty-four infants had a confirmed hearing loss, 11 of which had sensorineural hearing loss (0.37%), 
and 13 with a conductive or mixed hearing loss (0.44%).
CONCLUSIONS: We identified a greater than expected risk of conductive hearing loss, not attributable to otitis media, 
than sensorineural hearing loss in this population. These observations are consistent with the increased risk of birth 
defects in multigestational births.
 
Matsushima K, Nakano A, Arimoto Y, Mutai H, Yamazawa K, Murayama K, Matsunaga T.
High-level heteroplasmy for the m.7445A>G mitochondrial DNA mutation can cause progressive sensorineural hearing 
loss in infancy.
Int J Pediatr Otorhinolaryngol. 2018 May;108:125-131. doi: 10.1016/j.ijporl.2018.02.037. Epub 2018 Feb 27.
OBJECTIVE: Hearing loss caused by mutation of mitochondrial DNA typically develops in late childhood or early adult-
hood, but rarely in infancy. We report the investigation of a patient to determine the cause of his early onset hearing loss.
MATERIALS AND METHODS: The proband was a boy aged 1 year and 2 months at presentation. Newborn hearing 
screening test by automated auditory brainstem response generated “pass” results for both ears. His reaction to sound 
deteriorated by 9 months. Average pure tone threshold at 0.5, 1, and 2 kHz was 55 dB by conditioned orientation re-
sponse audiometry. His father had congenital hearing loss, and his mother had progressive hearing loss since childhood. 
Invader assays and Sanger sequencing were performed to investigate genetic causes of the hearing loss in the proband, 
and heteroplasmy was assessed by PCR-restriction fragment length polymorphism, Sanger sequencing, and pyrose-
quencing. Additionally, mitochondrial function was evaluated by measurement of the oxygen consumption rate of patient 
skin fibroblasts.
RESULTS: An m.7445A > G mitochondrial DNA mutation and a heterozygous c.235delC (p.L79Cfs*3) mutation of GJB2 
were detected in the proband. His mother carried the m.7445A > G mitochondrial DNA mutation, and his father was a 
compound heterozygote for GJB2 mutations (c.[235delC]; [134G > A; 408C > A]). Tissue samples from both the proband 
and his mother exhibited a high degree of heteroplasmy. Fibroblasts from the proband exhibited markedly reduced ox-
ygen consumption rates. These data indicate that the proband had impaired mitochondrial function, resulting in hearing 
loss.
CONCLUSION: This research demonstrates that hearing loss in a proband who presented in infancy and that of his 
mother resulted from a high level of heteroplasmy for the m.7445A > G mitochondrial DNA mutation, indicating that this 
alteration can cause hearing loss in infancy.
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McKinney S.
Cochlear implantation in children under 12 months of age.
Curr Opin Otolaryngol Head Neck Surg. 2017 Oct;25(5):400-404. doi: 10.1097/MOO.0000000000000400.
PURPOSE OF REVIEW: Children with congenital hearing loss are being identified earlier, leading to earlier intervention. 
Current US Food and Drug Administration (FDA) criteria states a child must be 12 months or older for cochlear implan-
tation. The purpose of this article is to review recent publications regarding the benefits of implanting infants under 12 
months of age. Topics include: safety and efficacy of surgery, speech and language acquisition outcomes, audiologic 
components, and limitations.
RECENT FINDINGS: Since the early 1990s, the candidacy criteria evolved drastically. However, the FDA criteria for 
cochlear implantation in children has remained at 12 months of age or older since 2000. Recent research indicates im-
planting below 12 months of age a safe and effective procedure. Speech and language outcomes showed better speech 
and language advantages. In addition, infants implanted earlier showed normal auditory skills as early as 3 months post 
cochlear implant activation. This article will also address recent findings on the limitations of earlier implantation.
SUMMARY: Recent research demonstrates positive outcomes in children implanted under 12 months of age. Developing 
research on earlier implantation could lead to a change in the current FDA criteria allowing infants to reach their speech 
and hearing potential faster.
 
Montino S, Agostinelli A, Trevisi P, Martini A, Ghiselli S.
Check-list for the assessment of functional impairment in children with congenital aural atresia.
Int J Pediatr Otorhinolaryngol. 2017 Nov;102:174-179. doi: 10.1016/j.ijporl.2017.09.024. Epub 2017 Sep 28.
OBJECTIVES: Congenital Aural Atresia (CAA) is a deformity of the external ear and it is commonly associated with 
malformations of middle and inner ear and, in some cases, with other facial deformities. Very few assessment measures 
exist for evaluating the functional impairment in children with CAA. Purpose of this study is to introduce and describe an 
assessment Checklist, (nominated FOS Checklist) that covers feeding abilities (F), oralmotor skills (O), communication/
language development (S) in children with CAA. FOS wants to offer a range of assessment providing a profile of the child 
in comparison to hearing peers and it aims to make clinicians able to identify additional problems and areas of difficulties 
as well as specific abilities and skills. Secondary, we want to investigate the presence of correlations between disorders 
and side of CAA.
METHODS: a new Checklist (FOS Checklist) was administered to 68 children with CAA. RESULTS: Feeding abilities are 
age-adequate in 94,3% of all patients. 54,4% of all patients are in need for further assessment of their oral-motor skills; 
delays in language development were found in 44,1% of cases. Orofacial development delays have been observed in 
57.2% of subjects among the bilateral CAA group, in 53.9% among the right CAA group and in 53.4% among the left 
CAA group. Patients referred for further language evaluation were 42,9% in the bilateral CAA group, 33.3% in the right 
CAA group and 33.3% in the left CAA group. According to the χ2 analysis, referral for further assessment is independent 
from side of aural atresia.
CONCLUSIONS: Subjects with bilateral CAA are more likely to be referred for further assessment, both for oral motor 
aspects and for speech perception and language development. However, there is not a significant statistical difference 
between the performances of children with bilateral or unilateral CAA. FOS Checklist is simple, reliable and time effective 
and can be used in everyday clinical practice. FOS enable clinicians to identify additional problems and areas of diffi-
culties as well as specific abilities and skills; moreover, FOS allows to determine appropriate referrals and intervention 
strategies.
 
Myne S, Kennedy V.
Hyperacusis in children: A clinical profile.
Int J Pediatr Otorhinolaryngol. 2018 Apr;107:80-85. doi: 10.1016/j.ijporl.2018.01.004. Epub 2018 Jan 31.
OBJECTIVE: Hyperacusis is commonly seen in clinical paediatric practice and can be distressing for the children and 
their families. This paper looks at the clinical profile of children seen for hyperacusis in a paediatric audiology service and 
reviews the possible underlying mechanisms.
METHODS: Retrospective study of case notes of 61 children with troublesome hyperacusis seen in the paediatric audi-
ology service, looking at their clinical presentation and presence of other medical conditions.
RESULTS: Hyperacusis was the main presenting complaint in more than half of the cases (n = 31, 51%). The com-
monest age at presentation with this problem was 3-4 years (n = 33, 54%). Hearing was normal in the majority of these 
children (n = 41, 67%). An active middle ear problem was observed in nearly half (n = 29, 48%) of all the children, of 
which glue ear (otitis media with effusion, OME) was the commonest. Presence of a neurodevelopmental condition was 
found in almost half (n = 28, 46%) of these patients of which autistic spectrum disorder was the commonest (8/61, 13%). 
In nearly one-fourth of the children (23%), presence of both middle ear problems and neurodevelopmental was noted. 
Tinnitus was an accompanying symptom reported in 11% of all the patients.
CONCLUSION: Hyperacusis may commonly present at a very young age. Awareness of different clinical presentations, 
presence of other medical conditions and possible underlying pathomechanisms in children with hyperacusis can be 
helpful for clinicians in informing prognosis, counselling and in individualising management plan.
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Norrix LW, Velenovsky D.
Clinicians’ Guide to Obtaining a Valid Auditory Brainstem Response to Determine Hearing Status: Signal, Noise, and 
Cross-Checks.
Am J Audiol. 2018 Mar 8;27(1):25-36. doi: 10.1044/2017_AJA-17-0074.
Purpose: The auditory brainstem response (ABR) is a powerful tool for making clinical decisions about the presence, 
degree, and type of hearing loss in individuals in whom behavioral hearing thresholds cannot be obtained or are not reli-
able. Although the test is objective, interpretation of the results is subjective.
Method: This review provides information about evidence-based criteria, suggested by the 2013 Newborn Hearing 
Screening Program guidelines, and the use of cross-check methods for making valid interpretations about hearing status 
from ABR recordings.
Results: The use of an appropriate display scale setting, templates of expected response properties, and objective 
criteria to estimate the residual noise, signal level, and signal-to-noise ratio will provide quality data for determining ABR 
thresholds. Cross-checks (e.g., immittance measures, otoacoustic emissions testing, functional indications of a child’s 
hearing) are also needed to accurately interpret the ABR.
Conclusions: Using evidence-based ABR signal detection criteria and considering the results within the context of other 
physiologic tests and assessments of hearing function will improve the clinician’s accuracy for detecting hearing loss 
and, when present, the degree of hearing loss. Diagnostic accuracy will ensure that appropriate remediation is initiated 
and that children or infants with normal hearing are not subjected to unnecessary intervention.
 
Oliveira LS, Didoné DD, Durante AS.
Automated cortical auditory evoked potentials threshold estimation in neonates.
Braz J Otorhinolaryngol. 2018 Feb 2. pii: S1808-8694(18)30002-8. doi: 10.1016/j.bjorl.2018.01.001. [Epub ahead of print]
INTRODUCTION: The evaluation of Cortical Auditory Evoked Potential has been the focus of scientific studies in infants. 
Some authors have reported that automated response detection is effective in exploring these potentials in infants, but 
few have reported their efficacy in the search for thresholds.
OBJECTIVE: To analyze the latency, amplitude and thresholds of Cortical Auditory Evoked Potential using an automatic 
response detection device in a neonatal population.
METHODS: This is a cross-sectional, observational study. Cortical Auditory Evoked Potentials were recorded in re-
sponse to pure-tone stimuli of the frequencies 500, 1000, 2000 and 4000Hz presented in an intensity range between 0 
and 80dB HL using a single channel recording. P1 was performed in an exclusively automated fashion, using Hotelling’s 
T2 statistical test. The latency and amplitude were obtained manually by three examiners. The study comprised 39 neo-
nates up to 28 days old of both sexes with presence of otoacoustic emissions and no risk factors for hearing loss.
RESULTS: With the protocol used, Cortical Auditory Evoked Potential responses were detected in all subjects at high 
intensity and thresholds. The mean thresholds were 24.8±10.4dB NA, 25±9.0dB NA, 28±7.8dB NA and 29.4±6.6dB HL 
for 500, 1000, 2000 and 4000Hz, respectively.
CONCLUSION: Reliable responses were obtained in the assessment of cortical auditory potentials in the neonates as-
sessed with a device for automatic response detection.
 
Poonual W, Navacharoen N, Kangsanarak J, Namwongprom S, Saokaew S.
Hearing loss screening tool (COBRA score) for newborns in primary care setting.
Korean J Pediatr. 2017 Nov;60(11):353-358. doi: 10.3345/kjp.2017.60.11.353. Epub 2017 Nov 27.
Purpose: To develop and evaluate a simple screening tool to assess hearing loss in newborns. A derived score was 
compared with the standard clinical practice tool.
Methods: This cohort study was designed to screen the hearing of newborns using transiently evoked otoacoustic 
emission and auditory brain stem response, and to determine the risk factors associated with hearing loss of newborns 
in 3 tertiary hospitals in Northern Thailand. Data were prospectively collected from November 1, 2010 to May 31, 2012. 
To develop the risk score, clinical-risk indicators were measured by Poisson risk regression. The regression coefficients 
were transformed into item scores dividing each regression-coefficient with the smallest coefficient in the model, round-
ing the number to its nearest integer, and adding up to a total score.
Results: Five clinical risk factors (Craniofacial anomaly, Ototoxicity, Birth weight, family history [Relative] of congenital 
sensorineural hearing loss, and Apgar score) were included in our COBRA score. The screening tool detected, by area 
under the receiver operating characteristic curve, more than 80% of existing hearing loss. The positive-likelihood ratio of 
hearing loss in patients with scores of 4, 6, and 8 were 25.21 (95% confidence interval [CI], 14.69-43.26), 58.52 (95% CI, 
36.26-94.44), and 51.56 (95% CI, 33.74-78.82), respectively. This result was similar to the standard tool (The Joint Com-
mittee on Infant Hearing) of 26.72 (95% CI, 20.59-34.66). Conclusion: A simple screening tool of five predictors provides 
good prediction indices for newborn hearing loss, which may motivate parents to bring children for further appropriate 
testing and investigations.
Conflict of interest statement: Conflicts of interest: No potential conflict of interest relevant to this article was reported.
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Puhakka L, Lappalainen M, Lönnqvist T, Niemensivu R, Lindahl P, Nieminen T, Seuri R, Nupponen I, Pati S, Boppa-
na S, Saxen H.
The Burden of Congenital Cytomegalovirus Infection: A Prospective Cohort Study of 20 000 Infants in Finland.
J Pediatric Infect Dis Soc. 2018 Mar 15. doi: 10.1093/jpids/piy027. [Epub ahead of print]
Background: Congenital cytomegalovirus (cCMV) infection is the most common congenital infection and causes signif-
icant morbidity. This study was undertaken to evaluate the benefits of screening newborns for cCMV and to understand 
the cCMV disease burden in Finland.
Methods: Infants born in Helsinki area hospitals were screened for CMV by testing their saliva with a real-time poly-
merase chain reaction assay. The CMV-positive infants and matched controls were monitored to determine their neuro-
developmental, audiological, and ophthalmological outcomes at 18 months of age. Griffiths Mental Development Scales, 
otoacoustic emission and sound field audiometry, and ophthalmologic examination were performed.
Results: Of the 19868 infants screened, 40 had confirmed cCMV infection (prevalence, 2 in 1000 [95% confidence 
interval, 1.4-2.6 in 1000]). Four (10%) infants had symptomatic cCMV. Griffiths general quotients did not differ signifi-
cantly between the CMV-positive (mean, 101.0) and control (mean, 101.6) infants (P = .557), nor did quotients for any 
of the Griffiths subscales (locomotion, personal-social, hearing and language, eye and hand, performance) (P = .173-
.721). Four of 54 CMV-positive ears and 6 of 80 CMV-negative ears failed otoacoustic emission testing (P = 1.000). The 
mean minimal response levels over the frequencies 500 Hz to 4 kHz in the sound field audiometry did not differ between 
CMV-positive (mean, 34.31-dB hearing level) and control (mean, 32.73-dB hearing level) infants (P = .338). No CMV-relat-
ed ophthalmologic findings were observed.
Conclusions: The prevalence of cCMV was low, and outcomes at 18 months of age did not differ between the infected 
infants and healthy control infants. With such a low burden in Finland, universal newborn screening for cCMV seems 
unwarranted.
 
Pérez-Martín J, Artaso MA, Díez FJ.
Cost-effectiveness of pediatric bilateral cochlear implantation in Spain.
Laryngoscope. 2017 Dec;127(12):2866-2872. doi: 10.1002/lary.26765. Epub 2017 Aug 4.
OBJECTIVES/HYPOTHESIS: To determine the incremental cost-effectiveness of bilateral versus unilateral cochlear im-
plantation for 1-year-old children suffering from bilateral sensorineural severe to profound hearing loss from the perspec-
tive of the Spanish public health system.
STUDY DESIGN: Cost-utility analysis.
METHODS: We conducted a general-population survey to estimate the quality-of-life increase contributed by the second 
implant. We built a Markov influence diagram and evaluated it for a life-long time horizon with a 3% discount rate in the 
base case.
RESULTS: The incremental cost-effectiveness ratio of simultaneous bilateral implantation with respect to unilateral implan-
tation for 1-year-old children with severe to profound deafness is €10,323 per quality-adjusted life year (QALY). For sequential 
bilateral implantation, it rises to €11,733/QALY. Both options are cost-effective for the Spanish health system, whose willing-
ness to pay is estimated at around €30,000/QALY. The probabilistic sensitivity analysis shows that the probability of bilateral 
implantation being cost-effective reaches 100% for that cost-effectiveness threshold.
CONCLUSIONS: Bilateral implantation is clearly cost-effective for the population considered. If possible, it should be 
done simultaneously (i.e., in one surgical operation), because it is as safe and effective as sequential implantation, and 
saves costs for the system and for users and their families. Sequential implantation is also cost-effective for children 
who have received the first implant recently, but it is difficult to determine when it ceases to be so because of the lack of 
detailed data. These results are specific for Spain, but the model can easily be adapted to other countries.
LEVEL OF EVIDENCE: 2C. Laryngoscope, 127:2866-2872, 2017.
 
Ravi R, Gunjawate DR, Yerraguntla K, Rajashekhar B.
Int J Pediatr Otorhinolaryngol. 2018 Jan;104:138-144. doi: 10.1016/j.ijporl.2017.11.004. Epub 2017 Nov 9.
Systematic review of knowledge of, attitudes towards, and practices for newborn hearing screening among healthcare 
professionals.
INTRODUCTION: The success of newborn hearing screening programs lies in the timely identification, diagnosis, and 
management of children with hearing loss accomplished via a multidisciplinary newborn hearing screening (NHS) team. 
The team is typically comprised of various healthcare professionals who act as decision makers as well as facilitators 
for different stages in the screening process. Team members’ knowledge of, attitudes towards, and practices for early 
hearing detection and intervention programs are critical for success and prevention of loss to follow up. In this context, 
it becomes crucial to understand their knowledge of, attitudes towards, and practices for towards newborn hearing 
screening.
METHODS: A systematic review was conducted on the following databases; PubMed/Medline, Cumulative Index to 
Nursing and Allied Health Literature (CINAHL), Scopus, Web of Science, Science Direct and Cochrane Library. This 
search was carried out using various keywords such as practitioners, newborn hearing screening, knowledge, attitudes, 
and practices in different combinations. The review was conducted based on Preferred Reporting Items for Systematic 
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Reviews and Meta-analyses statement guidelines.
RESULTS: A total of 271 hits were obtained of which 20 articles were found suitable for inclusion in the final review. 
Overall, similar results were found regarding team members’ knowledge of NHS programs, regardless of country of 
origin. Similarly, attitudes toward NHS programs were positive. Team members’ experiences with NHS programs var-
ied from country-to-country and across healthcare professionals. Results consistently showed gaps in team members’ 
knowledge suggesting the need for outreach and professional education programs on NHS.
CONCLUSION: NHS teams members from different countries, healthcare systems, and early hearing detection and 
intervention programs show gaps in critical knowledge warranting outreach and educational programs.
 
Rawlinson WD, Palasanthiran P, Hall B, Al Yazidi L, Cannon MJ, Cottier C, van Zuylen WJ, Wilkinson M.
Neonates with congenital Cytomegalovirus and hearing loss identified via the universal newborn hearing screening pro-
gram.
J Clin Virol. 2018 May;102:110-115. doi: 10.1016/j.jcv.2018.03.006. Epub 2018 Mar 15.
BACKGROUND: Congenital cytomegalovirus (CMV) is the most common non-genetic cause of sensorineural hearing 
loss. Currently, there are no universal CMV screening programs for newborns or routine CMV testing of neonates with 
hearing loss in Australia, or elsewhere. OBJECTIVES: This study was undertaken to determine the prevalence of con-
genital CMV infection in infants with hearing loss identified using routine resources via the Australian universal neonatal 
hearing screening (UNHS) program.
STUDY DESIGN: Infants who failed UNHS, referred for audiological testing and found to have permanent hearing 
loss were screened for CMV via PCR of urine and saliva. Congenital CMV was diagnosed if CMV was detected in in-
fants ≤30 days of age, or using retrospective testing on stored new born screening cards, retrospective testing, or using 
clinical criteria if >30 days of age. The cohort was analyzed for time of testing and prevalence of congenital CMV deter-
mined. RESULTS: The Audiology Department reviewed 1669 infants who failed UNHS between 2009 and 2016. Thirty 
percent (502/1669) had permanent hearing loss confirmed, of whom 336/502 were offered CMV testing. A definite (n = 11) 
or probable (n = 8) diagnosis of congenital CMV occurred in 19/323 (5.9%), of whom definite diagnoses were made in 
4/19 on tests positive prior to 21 days of life, in 5/19 who were positive on neonatal blood screening card (NBSC) testing, 
in 2/19 who were positive on placental testing. In 8/19 probable diagnoses were made based on positive testing between 
ages 23-42 days and a consistent clinical syndrome in the absence of another cause for hearing loss after genetic and 
other testing. CMV testing mirrored the timing of audiological testing, with ∼40% completing audiology and CMV testing by 
21 days, and 64% by 30 days.
CONCLUSION: This program, utilizing existing clinical services identified probable congenital CMV in ∼6% of a large 
cohort failing UNHS with permanent hearing loss, of whom more than half were definite diagnoses. No additional assets 
were required to those already existing in this tertiary referral pediatric centre, whilst providing useful and timely data for 
clinical and audiological management.
 
Razza S, Zaccone M, Meli A, Cristofari E.
Evaluation of speech reception threshold in noise in young Cochlear™ Nucleus® system 6 implant recipients using two 
different digital remote microphone technologies and a speech enhancement sound processing algorithm.
Int J Pediatr Otorhinolaryngol. 2017 Dec;103:71-75. doi: 10.1016/j.ijporl.2017.10.002. Epub 2017 Oct 5.
OBJECTIVE: Children affected by hearing loss can experience difficulties in challenging and noisy environments even 
when deafness is corrected by Cochlear implant (CI) devices. These patients have a selective attention deficit in multiple 
listening conditions. At present, the most effective ways to improve the performance of speech recognition in noise con-
sists of providing CI processors with noise reduction algorithms and of providing patients with bilateral CIs. The aim of 
this study was to compare speech performances in noise, across increasing noise levels, in CI recipients using two kinds 
of wireless remote-microphone radio systems that use digital radio frequency transmission: the Roger Inspiro accessory 
and the Cochlear Wireless Mini Microphone accessory.
METHODS: Eleven Nucleus Cochlear CP910 CI young user subjects were studied. The signal/noise ratio, at a speech 
reception threshold (SRT) value of 50%, was measured in different conditions for each patient: with CI only, with the 
Roger or with the MiniMic accessory. The effect of the application of the SNR-noise reduction algorithm in each of these 
conditions was also assessed. The tests were performed with the subject positioned in front of the main speaker, at a 
distance of 2.5 m. Another two speakers were positioned at 3.50 m. The main speaker at 65 dB issued disyllabic words. 
Babble noise signal was delivered through the other speakers, with variable intensity.
RESULTS: The use of both wireless remote microphones improved the SRT results. Both systems improved gain of 
speech performances. The gain was higher with the Mini Mic system (SRT = -4.76) than the Roger system (SRT = -3.01). 
The addition of the NR algorithm did not statistically further improve the results.
CONCLUSION: There is significant improvement in speech recognition results with both wireless digital remote micro-
phone accessories, in particular with the Mini Mic system when used with the CP910 processor. The use of a remote 
microphone accessory surpasses the benefit of application of NR algorithm.
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Rissmann A, Koehn A, Loderstedt M, Schwemmle C, Goetze G, Bartel S, Plontke SK, Langer J, Begall K, Matulat 
P, Roehl FW, Vorwerk U.
Population-based cross-sectional study to assess newborn hearing screening program in central Germany.
Int J Pediatr Otorhinolaryngol. 2018 Apr;107:110-120. doi: 10.1016/j.ijporl.2018.01.035. Epub 2018 Jan 31.
OBJECTIVES: Airway management during adenoidectomy is traditionally performed through endotracheal intubation 
(ETT). Laryngeal mask airway (LMA) may be less stimulating to the airway and allow for shorter overall operating room 
time. Previous studies report LMA use during adenotonsillectomy with conversion rates to ETT of up to 17%. There has 
been no prior evaluation of LMA use during adenoidectomy alone. In this study, we attempt to identify the rate and con-
tributing factors of LMA failure during adenoidectomy.
METHODS: All pediatric patients undergoing adenoidectomy between January 1, 2016 and June 30, 2017 were re-
viewed. Demographic and clinical data were collected and analysed to determine the need for conversion to ETT and the 
occurrence of any complications.
RESULTS: Our study revealed 139 pediatric patients who underwent adenoidectomy during the study period. 110 pa-
tients had adenoidectomy performed with LMA and 27 patients had ETT. Two patients (1.8%) required conversion to ETT 
because of difficulty with ventilation when the mouth gag was in place. There were no complications. Mean operating 
room time was 20 min less in the LMA group (P < 0.05).
CONCLUSIONS: The use of an LMA in adenoidectomy may be a safe and effective alternative to ETT. More study is 
required to determine overall complication rates.
 
Sato T, Nakazawa M, Takahashi S, Mizuno T, Sato A, Noguchi A, Sato M, Katagiri S, Yamada T.
Leaflets and continual educational offerings led to increased coverage rate of newborn hearing screening in Akita.
Auris Nasus Larynx. 2017 Nov 28. pii: S0385-8146(17)30685-5. doi: 10.1016/j.anl.2017.11.014.
OBJECTIVE: Newborn hearing screening (NHS) has been actively performed in Japan since 2001. The NHS coverage 
rate has increased each year in Akita Prefecture. We analyzed the details of the NHS program and how the Akita leaflets 
and the many educational offerings about the importance of NHS led to the high NHS coverage rate
METHODS: A retrospective study was conducted in liveborn newborns in hospitals and in clinics where hearing screen-
ing was performed from the program’s beginning in 2001 through the end of 2015. We describe the chronological history 
of NHS. The outcome data of NHS were collected from our department and analyzed.
RESULTS: From the founding of the program in 2001 to 2015, the live birth rate in Akita continually declined. Neverthe-
less, the number of infants receiving NHS rose each year. Since 2012, the coverage rate of NHS has been over 90%. 
From 2001 to 2015, 75,331 newborns constituted the eligible population for the NHS program. Since 2012, the number 
of NHS tests has stabilized. We prepared educational leaflets for Akita Prefecture early in 2002. We also provided many 
educational classes about the importance of NHS for not only pregnant women but also professionals including obstetri-
cians and gynecologists, pediatricians and municipal staff members. The NHS program received the complete endorse-
ment of the Akita Association of Obstetricians and Gynecologists in 2010. The largest increase in the NHS coverage rate 
occurred from 2001 to 2002, and the second largest increase occurred from 2009 to 2010. The number of participating 
institutions increased the coverage rate. The coverage rate is strongly correlated with the number of participating institu-
tions (rs=0.843, p<0.001, Spearman’s rank correlation coefficient). Comparing the coverage rate for 5 years before and 
after the Akita Association of Obstetricians and Gynecologists reached their consensus on the importance of NHS, the 
coverage rate after 2010 was significantly higher than before 2010 (p<0.001, paired sample t-test).
CONCLUSION: The NHS coverage rate ultimately reached 95.4% without need for legislation or subsidization. The num-
ber of participating institutions increased each year, and the number of NHS tests and the coverage rate increased pro-
portionately. The number of participating institutions statistically has a strong correlation with the number of NHS tests 
and the coverage rate. Our research indicates that the Akita leaflets and the provision of educational sessions about the 
importance of NHS were the most significant factors in establishing the high NHS coverage rate.
 
Satterfield-Nash A, Kotzky K, Allen J, Bertolli J, Moore CA, Pereira IO, Pessoa A, Melo F, Santelli ACFES, Boyle 
CA, Peacock G.
Health and Development at Age 19-24 Months of 19 Children Who Were Born with Microcephaly and Laboratory Evi-
dence of Congenital Zika Virus Infection During the 2015 Zika Virus Outbreak - Brazil, 2017.
MMWR Morb Mortal Wkly Rep. 2017 Dec 15;66(49):1347-1351. doi: 10.15585/mmwr.mm6649a2.
In November 2015, the Brazilian Ministry of Health (MOH) declared the Zika virus outbreak a public health emergency 
after an increase in microcephaly cases was reported in the northeast region of the country (1). During 2015-2016, 15 
states in Brazil with laboratory-confirmed Zika virus transmission reported an increase in birth prevalence of microcepha-
ly (2.8 cases per 10,000 live births), significantly exceeding prevalence in four states without confirmed transmission (0.6 
per 10,000) (2). Although children with microcephaly and laboratory evidence of Zika virus infection have been described 
in early infancy (3), their subsequent health and development have not been well characterized, constraining planning for 
the care and support of these children and their families. The Brazilian MOH, the State Health Secretariat of Paraíba, and 
CDC collaborated on a follow-up investigation of the health and development of children in northeastern Brazil who were 
reported to national surveillance with microcephaly at birth. Nineteen children with microcephaly at birth and laboratory 
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evidence of Zika virus infection were assessed through clinical evaluations, caregiver interviews, and review of medi-
cal records. At follow-up (ages 19-24 months), most of these children had severe motor impairment, seizure disorders, 
hearing and vision abnormalities, and sleep difficulties. Children with microcephaly and laboratory evidence of Zika virus 
infection have severe functional limitations and will require specialized care from clinicians and caregivers as they age.
 
Schwarz Y, Kaufman GN, Daniel SJ.
Newborn hearing screening failure and maternal factors during pregnancy.
Int J Pediatr Otorhinolaryngol. 2017 Dec;103:65-70. doi: 10.1016/j.ijporl.2017.09.027. Epub 2017 Sep 28.
OBJECTIVE: Temporary conductive hearing loss due to amniotic fluid accumulation in the middle ear cavity may lead 
to failure (false positive) in newborn hearing screening tests. The aim of this study was to identify whether amniotic fluid 
index has association with failure of the initial newborn otoacoustic emission (OAE) screening test.
METHODS: A cohort study in a tertiary hospital center (Royal Victoria Hospital, Montréal) was constructed from 70 
newborns that failed the OAE test, but passed a subsequent auditory brainstem response (ABR) test, and 75 randomly 
selected newborns that passed initial otoacoustic emission testing. Maternal (including the amniotic fluid index in the 
third trimester) and newborn clinical data were extracted from medical records. Statistical association models were built 
to determine variables that influenced hearing screen passage or failure.
RESULTS: The two arms of the cohort had no significant differences in maternal or child clinical indices, including in am-
niotic fluid index. Calculated as individual odds ratios, maternal tobacco [95% CI of odds ratio: 0.04, 0.59, p = 0.0078], 
and drug use [95% CI of odds ratio: 0.0065, 0.72, p = 0.058] [borderline significance] were associated with failing the 
otoacoustic emission testing.
CONCLUSIONS: Amniotic fluid index was not found to be associated with failure of otoacoustic emission screening in 
newborns. However, our study unveiled an interesting unexpected association of OAE failure with maternal smoking and/
or drug use. This finding can help alleviate some of the time, cost and parental anxiety related to failed OAE screening. 
In selected cases of maternal smoking or drug use we might want to replace or add OAE to the ABR test in newborn 
hearing screening protocols, that don’t perform both tests before discharge.
 
Smith A, O’Connor A, Hennessy S, O’Sullivan PG, Gibson L.
Permanent Childhood Hearing Impairment: Aetiological Evaluation of Infants identified through the Irish Newborn Hearing 
Screening Programme.
Ir Med J. 2017 Dec 18;110(10):651.
The Newborn Hearing Screening Programme (NHSP) was established in Cork University Maternity Hospital (CUMH) in 
April 2011. Between April 2011 and July 2014, 42 infants were identified with a Permanent Childhood Hearing Impair-
ment (PCHI). Following this diagnosis, infants underwent a paediatric assessment according to recognised guidelines 
with the intention of identifying the underlying aetiology of the PCHI. The aim of this study was to assess the findings of 
this aetiological workup via retrospective chart review. PCHI data was obtained from the eSP database. This is a web 
based information system (eSP) used to track each baby through the screening and referral process A retrospective 
chart review of these patients was performed. Sixteen (38%) infants were diagnosed with a bilateral sensorineural hear-
ing loss. Two infants had congenital CMV infection. A Connexin 26 gene mutation was detected in one infant. Two infants 
were diagnosed with Waardenburg syndrome, One with Pendred syndrome and one with Pfeiffer syndrome. Five babies 
underwent cochlear implantation. Through adherence to the recommended protocol a possible cause of PCHI may be 
determined. This study has identified areas of future improvement for this service in Ireland.
 
Suskind DL, Leung CYY, Webber RJ, Hundertmark AC, Leffel KR, Fuenmayor Rivas IE, Grobman WA.
Educating Parents About Infant Language Development: A Randomized Controlled Trial.
Clin Pediatr (Phila). 2017 Oct 1:9922817737079. doi: 10.1177/0009922817737079. [Epub ahead of print]
A total of 427 women (aged 18-45 years) who delivered a singleton neonate without serious medical complications were 
randomized to watch either an educational intervention (n = 225) or the sudden infant death syndrome (n = 202) video. 
Linear mixed models showed that the intervention women significantly gained knowledge over time. Knowledge gain 
was largest among high-socioeconomic status (high-SES) and middle-SES English-speaking, smaller among low-SES 
Spanish-speaking, and nonsignificant among low-SES English-speaking women. Analysis of deviance revealed that the 
intervention women of all SES learned strategies fostering secure attachment and language acquisition. Participants 
considered watching an educational video alongside the universal newborn hearing screening (UNHS) conveniently 
timed. The intervention women were more likely than the control women to recognize the importance of timely UNHS 
follow-up.
 
van Beeck Calkoen EA, Merkus P, Goverts ST, van de Kamp JM, Mulder MF, Sanchez Aliaga E, Hensen EF.
Evaluation of the outcome of CT and MR imaging in pediatric patients with bilateral sensorineural hearing loss.
Int J Pediatr Otorhinolaryngol. 2018 May;108:180-185. doi: 10.1016/j.ijporl.2018.02.022. Epub 2018 Feb 15.
OBJECTIVE: To evaluate the clinically relevant abnormalities as visualized on CT and MR imaging in children with sym-
metric and asymmetric bilateral sensorineural hearing loss (SNHL), in relation to age and the severity of hearing loss.
 88
STUDY DESIGN: Retrospective cohort study.
SETTING: Tertiary referral otology and audiology center.
PATIENTS AND DIAGNOSTIC INTERVENTIONS: From January 2006 until January 2016, a total of 207 children diag-
nosed with symmetric and asymmetric bilateral SNHL were included. They underwent CT and/or MR imaging for the 
evaluation of the etiology of their hearing loss.
MAIN OUTCOME MEASURES: Radiologic abnormalities associated with SNHL.
RESULTS: 302 scans were performed in 207 children (median age of 0.8 years old) with bilateral SNHL. The most fre-
quently identified cause of bilateral SNHL was a malformation of the labyrinth. The combined diagnostic yield of CT and 
MR imaging was 32%. The diagnostic yield of MR (34%) was considerably higher than that of CT (20%). We found a 
higher rate of abnormalities in children with profound hearing loss (41%) compared to milder hearing loss (8-29%), and in 
asymmetric SNHL (52%) compared to symmetric SNHL (30%).
CONCLUSION: Imaging is essential in the etiologic evaluation of children with bilateral SNHL. The highest diagnostic 
yield is found in children with bilateral asymmetric SNHL or profound SNHL. Based on our findings, MR is the primary 
imaging modality of choice in the etiological evaluation of children with bilateral SNHL because of its high diagnostic 
yield.
 
Vancor E, Shapiro ED, Loyal J.
Results of a Targeted Screening Program for Congenital Cytomegalovirus Infection in Infants Who Fail Newborn Hearing 
Screening.
J Pediatric Infect Dis Soc. 2018 Jan 24. doi: 10.1093/jpids/pix105. [Epub ahead of print]
Background: Congenital cytomegalovirus (CMV) infection is a major cause of sensorineural hearing loss. By law, new-
borns in Connecticut who fail newborn hearing screening are tested for infection with CMV. This targeted screening is 
controversial, because most children with congenital CMV infection are asymptomatic, and CMV-related hearing loss 
can have a delayed onset. Our hospital uses a saliva polymerase chain reaction (PCR) assay (confirmed by a urine PCR 
assay) to detect CMV. Here, we report the results of the first year of our screening program.
Methods: We reviewed the medical records of newborns in the Yale New Haven Health System who failed the newborn 
hearing screening test between January 1 and December 31, 2016.
Results: Of 10964 newborns, 171 failed newborn hearing screening, and 3 of these newborns had positive saliva CMV 
PCR test results. Of these 3 newborns, 2 had positive results on the confirmatory test (for 1 of them the confirmatory 
test was not performed until the infant was 10 weeks old), and 1 had a negative result on the confirmatory test. Three 
additional newborns with congenital CMV infection were tested because of clinical indications (1 for ventriculomegaly on 
prenatal ultrasound and 2 for CMV infection of the mother). Results of audiology follow-up were available for 149 (87.1%) 
of the 171 newborns who failed newborn hearing screening; 127 (85.2%) had normal results.
Conclusion: Our targeted screening program for congenital CMV infection had a low yield. Consideration should be 
given to other strategies for identifying children at risk of hearing loss as a result of congenital CMV infection.
 
Verkerk MM, Wagner R, Fishchuk R, Fagan JJ.
Survey of otolaryngology services in Ukraine and neighbouring Central and Eastern European countries.
J Laryngol Otol. 2017 Nov;131(11):1002-1009. doi: 10.1017/S0022215117002134. Epub 2017 Oct 30.
OBJECTIVE: The present humanitarian crisis in Ukraine is putting strains on its healthcare system. This study aimed 
to assess services and training in otolaryngology, audiology and speech therapy in Ukraine and its geographical neigh-
bours.
METHOD: Survey study of 327 otolaryngologists from 19 countries.
RESULTS: Fifty-six otolaryngologists (17 per cent) from 15 countries responded. Numbers of otolaryngologists varied 
from 3.6 to 12.3 per 100 000 population (Ukraine = 7.8). Numbers of audiologists varied from 0, in Ukraine, to 2.8 per 100 
000, in Slovakia, and numbers of speech therapists varied from 0, in Bulgaria, to 4.0 per 100 000, in Slovenia (Ukraine = 
0.1). Ukraine lacks newborn and school hearing screening, good availability of otological drills and microscopes, and a 
cochlear implant programme.
CONCLUSION: There is wide variation in otolaryngology services in Central and Eastern Europe. All countries surveyed 
had more otolaryngologists per capita than the UK, but availability of audiology and speech and language therapy is 
poor. Further research on otolaryngology health outcomes in the region will guide service improvement.
 
 
Vo QT, Pham D, Choi KJ, Nguyen UTT, Le L, Shanewise T, Tran L, Nguyen N, Lee WT.
Solar-powered hearing aids for children with impaired hearing in Vietnam: a pilot study.
Paediatr Int Child Health. 2018 Feb;38(1):40-45. doi: 10.1080/20469047.2016.1276119. Epub 2017 Jan 25.
BACKGROUND: Hearing loss is a barrier to speech and social and cognitive development. This can be especially pro-
nounced in children living in low- and middle-income countries with limited resources. AIM: To determine the feasibility, 
durability and social impact of ComCare GLW solar-powered hearing aids provided for Vietnamese children with hearing 
impairment.
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METHODS: A retrospective review of data from an international, multi-discipline humanitarian visit was performed. 
Hearing aids were given to 28 children enrolled at the Khoai Chau Functional Rehabilitation School, Hung Yen Province, 
Vietnam. Device inspection and observational assessments were performed by teachers using a modified Parents’ Eval-
uation of Aural/Oral Performance of Children and an Infant Hearing Program Amplification Benefit Questionnaire. Qualita-
tive interviews were undertaken to assess the study aims.
RESULTS: Hearing aids were well tolerated for use during regular school hours. All units remained functional during the 
study period (12 months). Teachers noted increased student awareness and responsiveness to surrounding sounds, but 
the degree of response to amplification varied between children. There was no significant improvement in speech devel-
opment as all subjects had prelingual deafness. Teachers felt confident in troubleshooting any potential device malfunc-
tion.
CONCLUSIONS: A solar-powered hearing aid may be a viable option for children in low- and middle-income countries. 
This study demonstrates that device distribution, maintenance and function can be established in countries with limited 
resources, while providing feasibility data to support future studies investigating how similar devices may improve the 
quality of life of those with hearing loss.
 
Vos B, Senterre C, Boutsen M, Lagasse R, Levêque A.
Improving early audiological intervention via newborn hearing screening in Belgium.
BMC Health Serv Res. 2018 Jan 30;18(1):56. doi: 10.1186/s12913-018-2878-3.
BACKGROUND: Newborn hearing screening programs aim to lower the ages at audiological intervention among hear-
ing-impaired children. In Wallonia and Brussels (Belgium), audiological intervention data are not collected in the screen-
ing program, and the ages at initiating audiological care have never been assessed. This study aimed to assess the 
evolution in the ages at initiating audiological intervention in the context of a newborn hearing screening program imple-
mentation.
METHODS: This population-based descriptive study used data from the Belgian healthcare billing database. The main 
outcomes were the children’s ages at the initial audiological assessment, hearing-aid fitting, and cochlear implantation. 
Results were compared to the same outcomes from another Belgian regional program (Flanders) that was implemented 
one decade earlier. Annual birth cohorts from 2006 to 2011 were included in the study.
RESULTS: In Wallonia-Brussels, the median ages for all outcomes tended to decrease over time but remained high-
er than in Flanders for each birth cohort. For all outcomes except the hearing-aid fitting, differences in median ages 
between the two regions became less pronounced during the study period. In 2006, < 23% of the children from Wal-
lonia-Brussels received any audiological care before the age of 12 months and these proportions were approximately 
2-fold greater in the subsequent birth cohorts. For all outcomes, early care (< 12 months) was typically delivered less 
frequently in Wallonia-Brussels, compared to the delivery in Flanders. These region-specific differences exhibited a de-
creasing trend over time, and statistically significant differences were less common in the later birth cohorts.
CONCLUSIONS: We conclude that the hearing screening program in Wallonia and Brussels promoted earlier audiolog-
ical intervention among hearing-impaired children. However, milestones recommended by experts for an early interven-
tion were not totally encountered. We also recommend collecting audiological intervention data as part of this program, 
which can facilitate more accurate and regular program evaluation.
 
Wallis KE, Blum NJ, Waryasz SA, Augustyn M.
Bilateral Cochlear Implants: Maximizing Expected Outcomes.
J Dev Behav Pediatr. 2018 Feb/Mar;39(2):177-179. doi: 10.1097/DBP.0000000000000547.
CASE: Sonia is a 4 years 1 month-year-old girl with Waardenburg syndrome and bilateral sensorineural hearing loss who 
had bilateral cochlear implants at 2 years 7 months years of age. She is referred to Developmental-Behavioral Pediatrics 
by her speech/language pathologist because of concerns that her language skills are not progressing as expected after 
the cochlear implant. At the time of the implant, she communicated using approximately 20 signs and 1 spoken word 
(mama). At the time of the evaluation (18 months after the implant) she had approximately 70 spoken words (English 
and Spanish) and innumerable signs that she used to communicate. She could follow 1-step directions in English but 
had more difficulty after 2-step directions.Sonia was born in Puerto Rico at 40 weeks gestation after an uncomplicated 
pregnancy. She failed her newborn hearing test and was given hearing aids that did not seem to help.At age 2 years, 
Sonia, her mother, and younger sister moved to the United States where she was diagnosed with bilateral severe-to-pro-
found hearing loss. Genetic testing led to a diagnosis of Waardenburg syndrome (group of genetic conditions that can 
cause hearing loss and changes in coloring [pigmentation] of the hair, skin, and eyes). She received bilateral cochlear 
implants 6 months later.Sonia’s mother is primarily Spanish-speaking and mostly communicates with her in Spanish or 
with gestures but has recently begun to learn American Sign Language (ASL). In a preschool program at a specialized 
school for the deaf, Sonia is learning both English and ASL. Sonia seems to prefer to use ASL to communicate.Sonia 
receives speech and language therapy (SLT) 3 times per week (90 minutes total) individually in school and once per week 
within a group. She is also receiving outpatient SLT once per week. Therapy sessions are completed in English, with the 
aid of an ASL interpreter. Sonia’s language scores remain low, with her receptive skills in the first percentile, and her ex-
pressive skills in the fifth percentile.During her evaluation in Developmental and Behavioral Pediatrics, an ASL interpreter 
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was present, and the examiner is a fluent Spanish speaker. Testing was completed through a combination of English, 
Spanish, and ASL. Sonia seemed to prefer ASL to communicate, although she used some English words with errors 
of pronunciation. On the Beery Visual-Motor Integration Test, she obtained a standard score of 95. Parent and teacher 
rating scales were not significant for symptoms of attention-deficit/hyperactivity disorder.What factors are contributing to 
her slow language acquisition and how would you modify her treatment plan?
 
Wang J, Sun J, Sun J, Chen J.
Variations in electrode impedance during and after cochlear implantation: Round window versus extended round window 
insertions.
Int J Pediatr Otorhinolaryngol. 2017 Nov;102:44-48. doi: 10.1016/j.ijporl.2017.08.032. Epub 2017 Aug 31.
OBJECTIVES: To assess differences in intra- and postoperative electrode impedances following cochlear implantation 
between round window insertions (RWI) and extended round window insertions (ERWI).
METHODS: Fifty patients with congenital hearing loss received unilateral hearing implants (Sonata Ti100, Med-El GmbH, 
Innsbruck, Austria) with standard electrode arrays. The patients were divided into two groups according to the surgical 
technique used. Thirty-five procedures were performed with RWI (group A) and 15 with ERWI (group B). Electrode imped-
ance was measured and analysed during the operation, and one week and one month postoperatively.
RESULTS: There were no statistically significant differences (i.e., P > 0.05) in electrode impedance between groups A and 
B intraoperatively, or at one week or one month postoperatively. Electrode impedance at one month postoperatively was 
higher than the intraoperative and postoperative one week values in group A (P < 0.05), with similar results in group B.
CONCLUSION: There was no significant difference between RWI and ERWI in operative duration or complications of 
cochlear implantation. Moreover, no significant differences in postoperative electrode impedance values were found 
between the two surgical routes.
 
Wang X, Wu D, Zhao Y, Li D, He D.
Knowledge and attitude of mothers regarding infant hearing loss in Changsha, Hunan province, China.
Int J Audiol. 2017 Dec;56(12):997-1002. doi: 10.1080/14992027.2017.1366671. Epub 2017 Oct 16.
OBJECTIVE: The objective of this study was to explore the knowledge and attitude among mothers of newborns regard-
ing infant hearing loss (HL) in Changsha, Hunan province, China.
DESIGN: A questionnaire including 18 items was given to mothers. STUDY SAMPLE: A total of 115 mothers participated 
in the study.
RESULTS: Seven risk factors for hearing loss were identified correctly by above 60% of respondents and the top three 
were prolonged noise (88.7%), high fever (82.6%) and ear discharge (82.6%). Poor knowledge was demonstrated on 
risk factors jaundice (20.0%), measles (22.6%), convulsion (33.0%) and traditional Chinese medicine (39.1%). Mater-
nal knowledge scores in identification and intervention (2.68 ± 0.31) was slightly higher than the score in risk factors 
(2.47 ± 0.34). Ninety-nine per cent of the mothers expressed the willingness to test baby’s hearing soon after birth and 
concern about hearing.
CONCLUSIONS: Mothers were concerned about baby’s hearing and the attitude was positive. However, the correct 
recognition rate towards some risk factors for HL was low. Action needs to be taken to raise awareness about ear and 
hearing care, prevent HL caused by preventable causes and prompt early identification, early diagnosis and intervention 
of HL.
 
Wang Y, Fan X, Wang P, Fan Y, Chen X.
Hearing improvement with softband and implanted bone-anchored hearing devices and modified implantation surgery in 
patients with bilateral microtia-atresia.
Int J Pediatr Otorhinolaryngol. 2018 Jan;104:120-125. doi: 10.1016/j.ijporl.2017.11.010. Epub 2017 Nov 14.
OBJECTIVE: To evaluate auditory development and hearing improvement in patients with bilateral microtia-atresia using 
softband and implanted bone-anchored hearing devices and to modify the implantation surgery.
METHODS: The subjects were divided into two groups: the softband group (40 infants, 3 months to 2 years old, Ponto 
softband) and the implanted group (6 patients, 6-28 years old, Ponto). The Infant-Toddler Meaning Auditory Integration 
Scale was used conducted to evaluate auditory development at baseline and after 3, 6, 12, and 24 months, and visu-
al reinforcement audiometry was used to assess the auditory threshold in the softband group. In the implanted group, 
bone-anchored hearing devices were implanted combined with the auricular reconstruction surgery, and high-resolution 
CT was used to assess the deformity preoperatively. Auditory threshold and speech discrimination scores of the patients 
with implants were measured under the unaided, softband, and implanted conditions.
RESULTS: Total Infant-Toddler Meaning Auditory Integration Scale scores in the softband group improved significantly 
and approached normal levels. The average visual reinforcement audiometry values under the unaided and softband 
conditions were 76.75 ± 6.05 dB HL and 32.25 ± 6.20 dB HL (P < 0.01), respectively. In the implanted group, the audito-
ry thresholds under the unaided, softband, and implanted conditions were 59.17 ± 3.76 dB HL, 32.5 ± 2.74 dB HL, and 
17.5 ± 5.24 dB HL (P < 0.01), respectively. The respective speech discrimination scores were 23.33 ± 14.72%, 77.17 ± 
6.46%, and 96.50 ± 2.66% (P < 0.01).
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CONCLUSIONS: Using softband bone-anchored hearing devices is effective for auditory development and hearing 
improvement in infants with bilateral microtia-atresia. Wearing softband bone-anchored hearing devices before auricle 
reconstruction and combining bone-anchored hearing device implantation with auricular reconstruction surgery may 
bethe optimal clinical choice for these patients, and results in more significant hearing improvement and minimal surgical 
and anesthetic injury.
 
Wang Y, Bergeson TR, Houston DM.
Infant-Directed Speech Enhances Attention to Speech in Deaf Infants With Cochlear Implants.
J Speech Lang Hear Res. 2017 Nov 9;60(11):3321-3333. doi: 10.1044/2017_JSLHR-H-17-0149.
Purpose: Both theoretical models of infant language acquisition and empirical studies posit important roles for attention 
to speech in early language development. However, deaf infants with cochlear implants (CIs) show reduced attention to 
speech as compared with their peers with normal hearing (NH; Horn, Davis, Pisoni, & Miyamoto, 2005; Houston, Pisoni, 
Kirk, Ying, & Miyamoto, 2003), which may affect their acquisition of spoken language. The main purpose of this study 
was to determine (a) whether infant-directed speech (IDS) enhances attention to speech in infants with CIs, as compared 
with adult-directed speech (ADS), and (b) whether the degree to which infants with CIs pay attention to IDS is associated 
with later language outcomes.
Method: We tested 46 infants-12 prelingually deaf infants who received CIs before 24 months of age and had 12 months 
of hearing experience (CI group), 22 hearing experience-matched infants with NH (NH-HEM group), and 12 chronological 
age-matched infants with NH (NH-CAM group)-on their listening preference in 3 randomized blocks: IDS versus silence, 
ADS versus silence, and IDS versus ADS. We administered the Preschool Language Scale-Fourth Edition (PLS-4; Zim-
merman, Steiner, & Pond, 2002) approximately 18 months after implantation to assess receptive and expressive lan-
guage skills of infants with CIs.
Results: In the IDS versus silence block, all 3 groups looked significantly longer to IDS than to silence. In the ADS versus 
silence block, both the NH-HEM and NH-CAM groups looked significantly longer to ADS relative to silence; however, the 
CI group did not show any preference. In the IDS versus ADS block, whereas both the CI and NH-HEM groups preferred 
IDS over ADS, the NH-CAM group looked equally long to IDS and ADS. IDS preference quotient among infants with CIs 
in the IDS versus ADS block was associated with PLS-4 Auditory Comprehension and PLS-4 Expressive  
Communication measures.
Conclusions: Two major findings emerge: (a) IDS enhances attention to speech in deaf infants with CIs; (b) the degree of 
IDS preference over ADS relates to language development in infants with CIs. These results support a focus on input in 
developing intervention strategies to mitigate the effects of hearing loss on language development in infants with  
hearing loss.
 
Wang Z, Liu Y, Wang L, Shen X, Han S, Wang W, Gao F, Liang W, Peng KA.
Characteristics of electrically evoked auditory brainstem responses in patients with cochlear nerve canal stenosis receiv-
ing cochlear implants.
Int J Pediatr Otorhinolaryngol. 2018 Jan;104:98-103. doi: 10.1016/j.ijporl.2017.10.029. Epub 2017 Oct 20.
OBJECTIVE: To explore the characteristics of the electrically evoked auditory brainstem responses (EABR) in children 
with cochlear nerve canal stenosis (CNCs) following cochlear implantation (CI), and the EABR thresholds in children with 
stenotic versus normal cochlear nerve canals.
METHOD: Sixteen children with profound sensorineural hearing loss were included in this study: 8 with CNCs (CNCs 
group) and 8 with normal cochlear nerve canals (control group). All children underwent cochlear implantation with full 
insertion of all electrodes. EABR was performed 6 months postoperatively in both groups.
RESULTS: The EABR extraction rate was 100% in children with normal cochlear nerve canals and only 50% in children 
with CNCs. EABR thresholds were significantly higher in children with CNCs of electrodes No. 11and 22 than in chil-
dren with normal cochlear nerve canals (P < 0.05 for both comparisons). There was no significant difference in EABR 
thresholds among electrode No. 1, 11 and 22 in CNCs group (P > 0.05 for all comparisons); while in the control group, 
the EABR threshold at electrode No 22 was lower than those at both electrodes No. 11 and 1 (P < 0.05 for both compari-
sons), and the EABR threshold at electrode No. 11 was also lower than that at electrode No. 1 (P < 0.05).
CONCLUSION: The EABR thresholds in children with normal cochlear nerve canals vary according to the different 
locations of electrodes in the cochlea; while in children with CNCs, there was no significant difference among different 
electrode locations. The EABR thresholds in CNCs children were higher than those of children with normal cochlear 
nerve canals at electrode 11 and 22.
 
Wenjin W, Xiangrong T, Yun L, Jingrong L, Jianyong C, Xueling W, Zhiwu H, Hao W.
Neonatal hearing screening in remote areas of China: a comparison between rural and urban populations.
J Int Med Res. 2018 Feb;46(2):637-651. doi: 10.1177/0300060517706643. Epub 2017 Jun 12.
Objectives Universal neonatal hearing screening (UNHS) started late in some underdeveloped areas in China, with rel-
atively scarce screening resources and a wide regional distribution. This study aimed to compare the screening perfor-
mance between rural and urban populations, and to examine the characteristics and problems of UNHS in underdevel-
oped regions in China.
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Methods A two-step hearing screening program was used in neonates born in Liuzhou Maternal and Child Health 
Hospital and in patients who were born in other hospitals, but admitted to the neonatal intensive care unit. This program 
involved distortion product otoacoustic emission and automated auditory brainstem response. Characteristics of each 
newborn, as well as the screening outcomes and performance were compared between rural and urban populations.
Results A total of 19,098 newborns were screened with a referral rate of 17.9% at the first step. Sixty-three (0.33%) 
newborns had hearing loss. The prevalence of permanent hearing loss was 2.25‰. The average screening age was sig-
nificantly older in the rural population than in the urban population in the first ( P < 0.01) and second steps of screening ( 
P < 0.05). The rural population had a higher referral rate in both steps than the urban population ( P < 0.01). The follow-up 
rate was much lower in the rural population than in the urban population ( P < 0.05), but dramatically increased in 2014 
compared with the previous 2 years.
Conclusions A low follow-up rate is a critical issue when carrying out UNHS in developing countries, such as China, 
especially for rural populations. The government should establish more hearing referral centres to increase service cover-
age and supply financial assistance for low-income populations.
 
Wroblewska-Seniuk K, Dabrowski P, Greczka G, Szabatowska K, Glowacka A, Szyfter W, Mazela J.
Sensorineural and conductive hearing loss in infants diagnosed in the program of universal newborn hearing screening.
Int J Pediatr Otorhinolaryngol. 2018 Feb;105:181-186. doi: 10.1016/j.ijporl.2017.12.007. Epub 2017 Dec 8.
OBJECTIVE: The aim of this study was to analyze infants diagnosed with sensorineural or conductive hearing deficit and 
to identify risk factors associated with these defects.
MATERIAL AND METHODS: A retrospective analysis of infants diagnosed with hearing deficit based on the database of 
the universal newborn hearing screening program and medical records of the patients.
RESULTS: 27 935 infants were covered by the universal neonatal hearing screening program. 109 (0.39%) were diag-
nosed with hearing deficit and referred for treatment and rehabilitation. 56 (51.4%) children were diagnosed with conduc-
tive, 38 (34.9%) with sensorineural and 15 (13.8%) with mixed type of hearing deficit. Children with sensorineural hearing 
deficit more frequently suffered from hyperbilirubinemia (p < 0.05), while infants with conductive hearing loss were more 
frequently diagnosed with isolated craniofacial anomalies (p < 0.05). The prevalence of other risk factors did not differ 
between the groups. Sensorineural hearing deficit occurred almost 3 times more often bilaterally than unilaterally (p < 
0.05). In other types of hearing deficit, the difference was not significant. In children with conductive and mixed type of 
hearing loss the impairment was mainly mild while among those with sensorineural hearing deficit in almost 45% it was 
severe and profound (p < 0.05). When analyzing the consistency between hearing screening test by means of otoacous-
tic emissions and the final diagnosis of hearing deficit we found that the highest agreement rate was observed in children 
with sensorineural hearing loss (p < 0.01).
CONCLUSIONS: The prevalence of most risk factors of hearing deficit was similar in children with sensorineural, con-
ductive and mixed type of hearing loss, only hyperbilirubinemia seemed to predispose to sensorineural hearing deficit 
and isolated craniofacial malformations seemed to be associated with conductive hearing loss. Sensorineural hearing 
deficit usually occurred bilaterally and was severe or profound, while conductive and mixed type of hearing deficit were 
most often of mild degree. Most children with the final diagnosis of sensorineural hearing deficit had positive result of 
hearing screening by means of otoacoustic emissions.
 
Yamamoto R, Naito Y, Tona R, Moroto S, Tamaya R, Fujiwara K, Shinohara S, Takebayashi S, Kikuchi M, Michida T.
Audio-visual speech perception in prelingually deafened Japanese children following sequential bilateral  
cochlear implantation.
Int J Pediatr Otorhinolaryngol. 2017 Nov;102:160-168. doi: 10.1016/j.ijporl.2017.09.022. Epub 2017 Sep 23.
OBJECTIVES: An effect of audio-visual (AV) integration is observed when the auditory and visual stimuli are incongruent 
(the McGurk effect). In general, AV integration is helpful especially in subjects wearing hearing aids or cochlear implants 
(CIs). However, the influence of AV integration on spoken word recognition in individuals with bilateral CIs (Bi-CIs) has not 
been fully investigated so far. In this study, we investigated AV integration in children with Bi-CIs.
METHODS: The study sample included thirty one prelingually deafened children who underwent sequential bilateral 
cochlear implantation. We assessed their responses to congruent and incongruent AV stimuli with three CI-listening 
modes: only the 1st CI, only the 2nd CI, and Bi-CIs. The responses were assessed in the whole group as well as in two 
sub-groups: a proficient group (syllable intelligibility ≥80% with the 1st CI) and a non-proficient group (syllable intelligibility 
< 80% with the 1st CI).
RESULTS: We found evidence of the McGurk effect in each of the three CI-listening modes. AV integration responses 
were observed in a subset of incongruent AV stimuli, and the patterns observed with the 1st CI and with Bi-CIs were 
similar. In the proficient group, the responses with the 2nd CI were not significantly different from those with the 1st CI 
whereas in the non-proficient group the responses with the 2nd CI were driven by visual stimuli more than those with  
the 1st CI.
CONCLUSION: Our results suggested that prelingually deafened Japanese children who underwent sequential bilateral 
cochlear implantation exhibit AV integration abilities, both in monaural listening as well as in binaural listening. We also 
observed a higher influence of visual stimuli on speech perception with the 2nd CI in the non-proficient group, sug-
 93
gesting that Bi-CIs listeners with poorer speech recognition rely on visual information more compared to the proficient 
subjects to compensate for poorer auditory input. Nevertheless, poorer quality auditory input with the 2nd CI did not in-
terfere with AV integration with binaural listening (with Bi-CIs). Overall, the findings of this study might be used to inform 
future research to identify the best strategies for speech training using AV integration effectively in prelingually  
deafened children.
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The Polish Universal Neonatal Hearing Screening Program (PUNHSP) has been carried out in Poland for 14 years. The 
main aim of this Program is to organize hearing screening tests and to gather the information about risk factors of hear-
ing loss in almost all newborns in Poland. It consists of 496 centers at 3 referral levels. A total of 5 458 114 children had 
been registered in the Central Database (CDB) of PUNHSP by the 22nd of August 2017. Bilateral sensorineural hearing 
loss was the most frequently appearing hearing impairment in children. It was diagnosed in 260 cases in 2016. This re-
port presents the most important results and conclusions concerning the running of the PUNHSP in 2016.
 
